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ABSTRACT
L-Gliitamate is the major excitatory neiirotransniitter in the CNS, where it activates both its 
ionotropic and metabotropic receptors. Excessive levels o f glutamate lead to increased 
intracellular free calcium concentrations, which activate calcium-dependent events resulting in 
the production of reactive oxygen species (ROS) such as nitric oxide, superoxide and 
hydrogen peroxide. Glutamate-induced neuronal damage in stroke and neurodegenerative 
diseases may be mediated by these ROS, which are loiown to promote oxidative stress.
Glutamate receptors are also expressed in non-neuronal peripheral tissues such as bone, where 
osteoblasts actively secrete glutamate and express glutamate receptors showing strildng 
electrophysiological, biochemical and molecular similarities to those found in the CNS.
The responses o f osteoblastic and neuronal cultures to culture conditions, glutamate and ROS- 
generated oxidative stress were therefore the focus of this study. Murine MC3T3-E1
-
osteoblast cells were used as a suitable in vitro model of bone-forming osteoblasts, compared 
with cerebellar granule neurones (CGNs) from 8-day old Sprague - Dawley rat pups. The 
major inducer of oxidative stress employed was hydrogen peroxide (H2 O2 ), although other 
sources have also been examined to a limited extent. Osteoblast cultures were used mostly at 
10 div, a time when they are sufficiently differentiated to express fimctional glutamate 
receptors. MC3T3-E1 cell maturation was enhanced by the addition o f ascorbate and (3- 
glycerol phosphate. Neuronal experiments were carried out at 8 div, except excitotoxicity
I
studies which were conducted at 9 div. Cytosine arabinoside (lOpM) was added to the CGN 
cultures 20 h after plating to eliminate non-neuronal population o f cells (mainly glial). The 
purity of the neuronal cultures was confirmed by inimunostaining for the beta-III isoform of
tubulin, which is specific for neurones. Cell viability in the presence or absence of
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experimental agents was determined with the alamar blue (AB) reduction assay, which relies 
on metabolic activity. Morphological effects of experimental agents were also monitored using 
both light and phase-contrast microscopy.
Addition of ascorbate and (3-glycerol phosphate at 3 div (switching) significantly increased the 
proliferation of MC3T3-E1 cells, and their differentiation as measured by ALP activity.
Switch and non-switch cells survived equally well in medium containing 10% Foetal Calf 
Serum (FCS), while semm withdrawal for up to 3 days prior to 10 div resulted in less than 
18% reduction in viability. A high potassium ion (IC )^ concentration (50mM) was potentially 
toxic to these cells. In the case of CGNs, serum withdrawal for 1 h at 8 div had no effect on 
suiwival, but the absence o f serum for 6 h caused more than 32% reduction in viability. 
Similarly, withdrawal o f high K'*’ for 2 days also reduced viability >31%.
Glutamate (lOjuM - 1 mM) applied for 1 h caused concentration-dependent damage to CGNs 
when the cells were allowed a recovery period of 6 h. This effect was more pronounced 
following the longer recovery period of 24 h. The more specific agonist NMDA also produced 
concentration-dependent damaging effects, but was less potent than glutamate. Glutamate or 
NMDA neurotoxicity was blocked by the non-competitive NMDA receptor antagonist 
dizocilpine (MK-801), the competitive antagonist D-AP5, and the NMDA glycine-site blocker 
kynurenic acid, but glutamate toxicity was not prevented by the non-NMDA (AMPA/kainate) 
receptor antagonist CNQX, confirming the effects were mediated mainly by the NMDA 
receptor. Mechanisms of glutamate neurotoxicity involved activation o f both apoptotic and 
necrotic pathways. The caspase-3 inhibitor, Z-DEVD-fmk, even at 40pM, and the poly (ADP- 
ribose) polymerase-1 inhibitors, DPQ (lOpM) and nicotinamide (ImM), prevented or 
attenuated the effect of glutamate. The membrane permeability transition pore blocker,
III
cyclosporin A (CsA) (0.5 - lOpM), also completely protected neurones against glutamate.
Using the osteoblast cells, glutamate and NMDA were not toxic but significantly trophic.
Further experiments focussed on ROS, especially H2 O2 , which produced concentration- and
time-dependent viability reductions in the two cell types that correlated well with
morphological damage, although the osteoblasts were less sensitive to its effect. The more
differentiated (switch) osteoblast cultures proved more sensitive to peroxide damage than the
less differentiated (non-switch) cultures. Prolonging the recovery period to 24 h after peroxide
treatment resulted in further neuronal damage, while in osteoblasts, variable effects were
observed at a low H2 O2 concentration (depending on the treatment duration), but with no effect
at a high concentration. The effects of H2 O2 were prevented by the antioxidant enzyme
catalase (CAT), but not by superoxide dismutase (SOD) or the COX inhibitor aspirin. In the
presence of Cif"^, the effect o f H2 O2 was potentiated, presumably tlirough the Fenton reaction
generation of the hydroxyl radical ( OH), although the "OH scavenger mannitol paradoxically
worsened, rather than protected, against this damage. Mechanisms o f damage by peroxide in
MC3T3-E1 osteoblasts and CGNs involved both apoptotic and necrotic pathways. The free
radical-generating system of xanthine (X) and xanthine oxidase (XO) elicited a trophic
influence on osteoblast cells but caused pronounced damage to the CGNs. Xanthine oxidase 
.alone was also toxic to the CGNs, an effect prevented by the inhibitor allopurinol. In the 
presence of CAT, but not SOD, the neurotoxic effects of either X or X/XO were abolished, 
indicative of mediation by H2 O2 rather than superoxide. 3 -hydroxykynurenine was profoundly 
neurotoxic even at lOpM (6 h), but only reduced osteoblast viability at ImM (1 or 6 h). An 
inducer of nitrosative stress, S-nitroso-A-acetylpenicillamine (SNAP), had no significant 
damaging effect on osteoblasts until when applied at 5mM for 24 h, but produced a
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concentration- and time-dependent reduction in CGN viability (significant even at lOOpM for 
6 h and blocked by the nitric oxide synthase inhibitor L-NAME, but not by the soluble 
guanylate cyclase inhibitor ODQ). An attempt to probe whether mitochondrial impainnent 
underlies the differences in sensitivities o f MC3T3-E1 and CGN cultures to oxidative damage 
revealed that the integrity of the osteoblasts was not significantly compromised in the presence 
of the mitochondrial poisons: potassium cyanide (KCN) and 3-nitropropionic acid (3-NPA) 
(except for 24 h application o f 3-NPA at lOOpM and ImM). The neurones “succumbed” to 
lower concentrations and shorter exposures to the poisons. The neurotoxic effects of the 
poisons were mediated by the NMDA receptor, since they were blocked by the antagonist D- 
AP5. Thus, while neurones depend critically on mitochondrial oxidative phosphorylation for 
energy production (ATP synthesis), the osteoblasts might follow preferentially the glycolytic 
pathway.
The stable adenosine analogue, 2-chloroadenosine (2-ClA), and the A; and A2 A receptor 
agonists, CPA and CGS21680, respectively, each conferred partial but significant protection 
against H2 O2 damage to osteoblasts, while the respective A| and A 2 A antagonists, DPCPX and 
ZM241385 had no effect. Glutamate- and H202-induced damage to CGNs were significantly 
prevented by CPA and ZM241385, but not by DPCPX or CGS21680.
Therefore, while osteoblasts and neurones may be similar in terms o f glutamate receptor 
expression, they exhibit differences in their manner of responses and the degree of sensitivity 
to toxic agents. Further elucidation of underlying mechanisms m aybe furnished tluough 
molecular biology-based approaches.
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11. INTRODUCTION
The work presented in this thesis is a study of factors that affect the viability o f cells from 
two different tissues. The work has examined the responses of the osteoblast-like cell line 
of MC3T3-E1 cells, and cerebellar granule cells as a neuronal cell population. The effects 
on the viability of these two cell types o f agonists and antagonists at glutamate and 
adenosine receptors have been examined, as well as the effects of oxidative stress induced 
by hydrogen peroxide (H2 O2 ), other reactive oxygen species (RO S) - generating systems 
and some kynurenines. The mechanisms o f damage by ROS-induced oxidative stress and 
the role o f glutamate and adenosine receptors in protection have also been investigated. 
This introduction will provide background information, firstly on the receptors that have 
been studied - for glutamate and adenosine, then on reactive oxygen species and oxidative 
stress, and finally on mechanisms o f cell death and the two types of cell tested.
1.1. Glutamate and its receptors in the CNS and bone
Glutamate (Glu) is the major and most important excitatory amino acid (EAA) 
neurotransmitter in the mammalian central nervous system (CNS), where its effects are 
exerted by the activation of ionotropic receptors (iGluRs) containing cation-specific ion 
channels and the G protein-coupled metabotropic receptors (Hollman and Heinemann,
1994). Glutamate (the most abundant amino acid in the diet) and related EAAs, such as L- 
aspartate, are released by an estimated 40% of all synapses (Meldrum, 2000; Fonnum, I
1984). There is also now compelling evidence for the presence o f glutamate and its 
receptors in non-neuronal peripheral tissues such as bone (Skerry & Genever, 2001 ; Skerry 
& Taylor, 2001). The discovery o f the excitatory action of glutamate dates back to more 
than four decades ago, and a role for glutamate has been demonstrated in most aspects of 
normal brain functioning including cognition, learning and memory (Headley & Grillner,
1990). In addition, glutamate has been shown to be involved in synaptic development and 
plasticity (Komuro & Rakic, 1993). In fact, EAA agonists like quinolinic acid (QA) and A- 
methyl-D-aspartate (NMDA) have been shown to promote biochemical differentiation of 
cultured neurones- including the cerebellar granule neurones (CGNs)- at early 
developmental stages (Balazs et al., 1989; Hunt & Patel, 1990) and endogenous glutamate 
could stimulate neurite outgrowth from CGNs through activation o f NMDA receptors 
(Pearce et al., 1987). However, besides these physiological roles, the pathological 
sigiificance o f glutamate has also been well reported. Thus, excessive glutamate levels in
A
the extracellular space or the overactivation of glutamate receptors leads to the death of 
central neurones (Stone & Addae, 2002) such as occurs during stress to the brain induced 
by ischaemia, hypoxia, hypoglycaemia, head trauma and epileptic seizure. Almost five 
decades ago, degeneration o f neural retina o f neonatal mice by systemic administration of 
glutamate or aspartate was demonstrated (Lucas & Newhouse, 1957). However, the term 
“excitotoxicity” tluough massive efflux of glutamate from neurones and glia was coined by 
Olney (1969), who, alongside co-workers, later described a correlation between the 
neurotoxic effects and the neuroexcitatory potency o f a number of peripherally 
administered acidic amino acids in the arcuate nucleus o f the hypothalamus (Olney et ah, 
1971). Subsequently, the finding that kainic acid could cause an axon-sparing lesion o f the 
striatum (Coyle & Schwarcz, 1976; MeGeer & McGeer, 1976) has inspired intensive 
research leading to massive evidence that glutamate neurotoxicity is involved in the 
pathology of neurological conditions such as stroke (Coyle & Puttfarcken, 1993) and 
various neurodegenerative diseases, such as Alzheimer’s (AD), Parkinson’s (PD), and 
Huntington’s diseases and amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) 
(Choi & Rothman, 1990). It is therefore not surprising that, due to its neurotoxic potential, 
the concentration o f glutamate in the extracellular space is kept quite low, with 
cerebrospinal fluid concentrations o f approximately 0.3 pM and average brain parenchyma 
concentration o f 3mM, representing a 10,000-fold gradient (Coyle & Puttfarcken, 1993). It 
is now widely known that the neuronal damage following stroke is largely attributable, not 
to the immediate hypoxia or ischaemia, but to the massive release of glutamate from 
neurones and glia which then activates its receptors resulting in a cascade of events leading 
up to neuronal death (Obrenovitch & Urenjak, 1997). It has been reported in cultured 
cortical neurones, however, that the development of EAA receptors mediating release 
responses (e.g., GABA release) precedes the maturation of intracellular mechanisms 
involved in excitotoxic neuronal injury (Cai & Erdo, 1992). Glutamate is also now known 
to exhibit glial toxicity through its receptors (Follet et al., 2004).
Receptors for glutamate are classified into the ionotropic (ion channel-forming) receptors 
and the metabotropic (G protein-coupled) receptors, based on their differential intracellular 
signal transduction mechanisms and molecular homologies (Hollmann et al., 1989).
1.1.1. Ionotropic glutamate receptors (iGluRs)
Glutamate activates, at least, tliree types of ionotropic receptors, sensitive, respectively, to 
A-methyl-D-aspartate (NMDA), kainate and a-amino-3-hydroxy-5-methyl-4-isoxazole
-propionic acid (AMPA) (Harris, 1995), all o f which could increase intracellular calcium 
levels and thus lead to the generation o f nitric oxide (NO) and other reactive oxygen 
species (ROS), the end result of which is cell death (Ogura et ah, 1988). The AMP A and 
kainate receptors are sometimes collectively termed the non-NMDA receptors. The orphan 
receptors delta 1 and delta2 (GluRSl and GluR52) have also been proposed, the functions 
o f which are not yet known (SkeiTy & Genever, 2001), although it is believed that delta2 
receptors play important roles in the cerebellum (Yuzaki, 2003) and delta 1 receptors in the 
auditory and vestibular system (Safieddine & Wenthold, 1997). While most excitatory 
postsynaptic potentials (EPSPs) are generated tlu'ough activation o f both AMP A and 
NMDA receptors (McBain & Mayer, 1994), it is the AMP A and kainate receptors that 
mediate fast excitatory postsynaptic potentials (fast EPSPs) whereas the NMDA 
component is much slower and smaller. Permeability to Ca^ "*" in non-NMDA receptors is 
about 100 times less than for NMDA receptors, except for particular subtypes of the 
NMDA receptor (Ogura et ah, 1990; lino et ah, 1990). The non-NMDA currents also show 
little voltage dependency and can be blocked by the selective antagonist 6-cyano-7- 
nitroquinoxaline-2, 3-dione (CNQX). Biophysical studies revealed that ion channels gated 
by non-NMDA glutamate receptors are highly selective for Na”* and iC  (Jahr & Stevens, 
1987; Macdermott et ah, 1986), while the NMDA receptor channel is permeable to Ca^^ as 
well as Na"^  and R"*" (Jahr & Stevens, 1987; Mayer & Westbrook, 1987).
1.1.1.1. NMDA receptors 
The NMDA receptor, like other ligand-gated ion channels, is thought to be a 
heteroligomeric protein (Yamakura & Shimoji, 1999), existing in multiple forms, probably 
as pentameric assemblies, with different physiological and pharmacological properties and 
distributions throughout the brain. It is composed of an N R l (NMDAR 1) subunit and at 
least one isoform o f the NR2 (NMDAR2) subunit and possibly NR3 subunits. So far, two 
major subunits, N R l and NR2, have been cloned from the rat CNS, with alternative 
splicing revealing eight functional isoforms for the N R l subfamily (NRIA-NRIH). The 
NR2 subfamily consists o f four individual subunits, NR2A-NR2D (Collingridge & 
Watkins, 1994) while there are three NR3 subunits (Hollmann, 1999). The NR2C subunit 
is expressed in high levels only in the CGNs (Cull-Candy et al., 2001). NR3 subunits are a 
dominant-negative family that suppresses opening o f functional NMDA receptor channels 
(Das et al., 1998). Glutamate recognition site is thought to be located on the NR2 subunit. 
Well-established ligands at the NMDA receptors include simple structural derivatives of
glutamate, such as 2-amino-5-phosphono-pentanoic acid (Perkins et ah, 1981; Davies et 
al., 1981) whose applicability as CNS neuroprotectants has been precluded by their 
inability to cross the blood-brain barrier (BBB) owing to lipophobicity. Selfotel is a related 
compound with improved ability to cross the BBB (Stone & Addae, 2002). Non­
competitive NMDA receptor antagonists include dizocilpine (MR-801), ketamine, 
dextromethorphan, memantine and phencyclidine, which all block the NMDA channel in 
the open site (Collingridge & Watkins, 1994). A variety of allosteric modulatory sites exist 
on the NMDA receptor-channel complex that are amenable to pharmacological 
modifications, e.g., the polyamine site (at which spermine and spermidine are possible 
endogenous ligands, with biphasic effects), the zinc-binding site, the phencyclidine- 
binding site, and the redox site (Watkins et ah, 1990; Stone & Addae, 2002). The redox 
site is also known as the target site where agents with oxidising or reducing activity can 
modulate the NMDA receptor in the same manner as they would other ligand-gated ion 
channel receptors. The redox site could therefore switch the receptor between the less 
active (oxidized) state and the more efficacious (reduced) state. This site is now believed to 
be the target for agents that are laiown to suppress NMDA receptor activation such as 
reactive oxygen species like the superoxide and hydroxyl radicals (Aizenman et al., 1990) 
and possibly nitric oxide (Lei et al., 1992), though it is possible that there may be several 
different redox sites and that nitric oxide and other free radicals act largely at different 
ones (Fagni et al., 1995). These intrinsic redox properties of the NMDA receptor can 
explain the developmentally regulated expression of exeitotoxieity in vitro. NMDA 
receptors at earlier developmental ages prefer a more oxidized state and neurotoxicity 
would therefore be produced in the presence of a reducing agent in normally resistant 
younger neurones (Sinor et al., 1997). However, Marks et al. (2005) have also 
demonstrated that mitochondrial nitric oxide synthase (NOS) mediates much o f the 
decreased vulnerability o f hippocampal neurones to NMDA while cytosolic NOS 
contributes to NMDA toxicity in mature neurones.
In 1987, Johnson and Ascher described the essential co-factor role for glycine, which acts 
at an allosteric site located on the N R l subunit of the NMDA receptor while kynurenic 
acid, a metabolite along the kynurenine pathway o f tryptophan metabolism, was shown by 
Perkins and Stone (1982) to be an antagonist at this site, having an especially high affinity 
there (Birch et al., 1988; Stone, 1993), though it could also be an antagonist at the 
glutamate-binding site. Each receptor unit appears to have two glycine and two glutamate 
binding sites (Laube et al., 1998). Because it is the most salient modulatory site, the
glycine modulatory site (GMS) has been refeiTed to as the glycine B receptor, which must 
be occupied before glutamate can open the NMDA receptor channel (Schell, 2004). 
Kynurenic acid is also able to antagonize actions mediated by the non-NMDA glutamate 
receptors (Perkins & Stone, 1982). However, most interest has been devoted to the more 
potent activity o f kynurenic acid at the strychnine-resistant glycine site on the NMDA 
receptor because, under physiological conditions or at resting potentials, the ion channels 
associated with the NMDA receptor are blocked by the voltage-dependent Mg^^ ions and 
only after initial depolarization, for example, by AMP A or kainate receptors, is the Mg^^ 
block relieved enough to allow activation of the NMDA receptor (Stone & Addae, 2002). 
These conditions (blockade in a use and voltage-dependent manner) are noticed in 
pathological circumstances like hypoxia, ischaemia, epilepsy, and traumatic brain injury, 
each o f which is associated with raised levels of extracellular glutamate (Stone & 
Simmonds, 1991; Latini & Pedata, 2001). It is therefore reasonable that NMDA receptor 
antagonists would interfere less with normal fast glutamatergic transmission, essential in 
the control of many autonomic functions, e.g., cardiovascular and respiratory mechanisms 
and movement control by the basal ganglia and cognitive functions, than antagonists at 
kainate and AMP A receptors (Stone & Addae, 2002).
Interestingly, a neuromodulatory role in NMDA receptor activation has also been found for 
the putative glial neurotransmitter D-serine. It is synthesized from L-serine by a novel 
pyridoxal-5'-phosphate (B(6 ))-requiring enzyme, serine racemase, in astrocytic glia 
ensheathing synapses, especially in regions o f the brain abundant in NMDA receptors, 
although significant amounts o f serine racemase and D-serine have recently been reported 
in primary neuronal cultures and neurones in vivo (Kartvelishvily et al., 2006). D-serine 
seems to be released physiologically in response to activation by glutamate of AMP A 
receptors on D-serine-containing glia, causing the glutamate receptor-interacting protein, 
which binds serine racemase, to induce enzyme activity and D-serine release. Matsui et al. 
(1995) reported that D-serine in vivo plays a role in the forebrain while glycine is most 
significant in the cerebellum. However, it has now been postulated that this amino acid is 
more likely to be the endogenous ligand for the glycine site of the NMDA receptor than 
glycine in many, if not most, parts of the brain, as it activates the glycine site of the 
NMDA receptor with a potency at least three times that o f glycine and its localizations 
resemble that o f NMDA receptors more closely than glycine (Schell et al., 1997). It is 
interesting to note that D-serine also plays a role in neural development by being released 
from Bergmann glia thereby chemokinetically enhancing the migration of granule cell
cerebellar neurones from the external to the internal granule layer (Mustafa et ah, 2004). 
The catabolism o f D-serine occurs via the peroxisomal enzyme D-amino acid oxidase 
(DAO) (Mustafa et ah, 2004; Schell, 2004). This glial source o f the neuromodulator 
perhaps further underpins the importance and active participation of glial cells in the CNS 
(the macroglia, comprising astrocytes and oligodendrocytes, and the microglia) in the 
modulation o f neurotransmission. Glial cells outnumber neurones and are in intimate 
contact with neuronal cell bodies, axons, and synaptic terminals (Gallo & Russell, 1995). 
About 65% of rat or mouse brain cells are glial, whereas the human brain is almost 95% of 
glia. However, because they are smaller than neurones, glia contribute about 50% of the 
volume of the human brain. Evidence now mounts to disprove the initial preconception of 
glia as mere bystanders in the event o f neurotransmission (the neurocentric approach), 
whose sole responsibility is to provide a nutritive microenvironment for the effective 
survival and functioning of neurones (Ullian et ah, 2004). Most of the known 
neurotransmitter/neuromodulator receptors are expressed by astroglia in primary culture 
and regulate a variety of second messenger systems (Enkvist et ah, 1989) and ion channels 
(Barres et ah, 1990). Though glia cells lack the excitability usually associated with 
neurones (Barres, 1991), astrocytes in the brain, which constitute almost 50% of cells in 
the CNS (Hu et ah, 2004), form an intimately associated network with neurones and 
respond to neuronal activity and synaptically released glutamate by raising intracellular 
calcium concentration (Dani et ah, 1992). This could represent the start o f back-signalling 
to neurones (Nedergaard, 1994). It is now known that a bidirectional signalling occurs 
between astrocytes and neurones (Carmignoto, 2000), which translates to a major 
involvement of the former in neurotransmission, with glial cells being able to release 
glutamate through a calcium-dependent mechanism that resembles the synaptie release of 
neurotransmitters at the nerve terminal (Innocent! et ah, 2000; Parpura & Haydon, 2000). 
Physiological astrocytic calcium levels have been reported to stimulate glutamate release 
to modulate adjacent neurones (Parpura & Haydon, 2000). Also, astrocytes have been 
shown to regulate NMDA receptor subunit composition, with the effect of increasing 
neuronal sensitivity to exeitotoxieity (Daniels & Brown, 2001). In fact, the availability of 
modulators o f the NMDA receptor such as D-serine, glycine, and kynurenines including 
kynurenic acid, 3-hydroxykynurenine and quinolinic acid, is determined, not by neurones, 
but by astrocytes and microglia (Schousboe, 2003; Coyle & Schwarcz, 2000; Coyle, 2006). 
The multiple roles o f glia include the regulation o f external potassium released by 
neurones into the extracellular space.
The channels to which the NMDA receptors are coupled exhibit high conductance and are 
permeable to K^, Na^ and Ca^^. The opening o f the NMDA receptor mediates the entry of 
a considerable amount of Ca^^ into the intracellular space, much more than does any of the 
other ionotropic (AMPA/kainate) receptors (Ogura et al., 1990; lino et al., 1990). This 
elevated level of free cytosolic calcium is critical to NMDA neurotoxicity, although a
recent report by Lin et al. (2005) showed that inhibition o f P2 receptor may directly
2+modulate NMDA receptor-mediated neurotoxicity through a Ca -independent mechanism. 
In support o f the critical role o f calcium in NMDA-induced exeitotoxieity, cortical 
neurones containing calcium-binding proteins such as calbindin, paiwalbumin, and 
calretinin are selectively resistant to calcium overload and exeitotoxieity in vitro (Lukas & 
Jones, 1994). Much evidence suggests the co-localization of AMP A and NMDA receptors 
and therefore their co-activation by glutamate released into the synaptic cleft, but it seems 
that the AMP A receptor has low affinity, thus becoming unbound quickly after the 
clearance o f the transmitter, whereas the NMDA receptor has a greater affinity that favours 
long binding (Ozawa et al., 1998). The peculiar properties o f the NMDA receptor have 
made it to be a subject o f intense investigation in relation to various phenomena such as 
neuronal plasticity and exeitotoxieity. However, as mentioned earlier, immature neurones 
are resistant to glutamate neurotoxicity and this may be related to maturation of the NMDA 
receptor complex (Peterson et al., 1989).
1,1.1.2. AM P A and kainate receptors
Due to the inability o f agonists or antagonists to clearly distinguish between a-amino-3- 
hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and kainate receptors, they are 
often collectively referred to as non-NMDA receptors. The AMP A receptors were initially 
called quisqualate receptors but were renamed AMP A receptors because quisqualate was 
found to additionally act on niGluRs while AMP A affected the ionotropic receptors more 
specifically (Krogsgaard-Larsen et al., 1980).
Mammals express four AMP A receptor subunits, G luRl-GluR4, distributed throughout the 
CNS (Danysz et al., 1995). The AMPA receptor has, at least, tlmee separate binding sites at 
which agonists or antagonists can act: glutamate-binding, desensitization and intra-ion 
channel-binding sites, AMPA receptor channels are permeable only to Na"*" and and 
almost impermeable to Ca^ "^  in central neurones. They display a slight outward rectification
and low permeability to Ca^^ (Ozawa et al., 1998), although it has also been found that
AMPA receptors display a substantial permeability to Ca^^ and a strong inward
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rectification in cultured rat hippocampal neurones. There are now several claims o f cell 
death induced by AMPA receptor-mediated Ca^”^ influx. The Ca^^ influx is largely 
determined by the GluR2 subunit. Most AMPA receptors contain the GluR2 subunit and 
are therefore impermeable to calcium while those without this subunit pass calcium which 
can mediate synaptic plasticity and, if in excess, neurotoxicity (Petralia et al., 2004). It is 
possible to induce inactivation o f the NMDA receptor by the activation o f the AMPA 
receptor (Bai et ah, 2002) and the co-localization of AMPA and NMDA receptors occurs at 
synapses in different parts of the CNS (Bekkers & Stevens, 1989).
Kainate activates a distinct class o f iGluRs called the kainate-preferring receptors, although 
it is also a potent agonist at the AMPA receptor. A family of kainate (KA) receptors has 
been cloned and the five subunits already identified are GluR5, GluR 6 , GluR7, K Al and 
KA2. The modulatory actions of kainate receptors may vary from synapse to synapse 
(Ozawa et al., 1998).
1.1.2. Metabotropic glutam ate receptors (m GluRs)
Metabotropic glutamate receptors, in contrast to ionotropic receptors, mediate their action 
through intermediary G proteins (Miller, 1991). These G protein receptors can control ion 
channels or intracellular messenger systems. In general, the action o f glutamate on the 
metabotropic receptors produces changes in cellular function and membrane conductance 
on a slower time scale than the ionotropic receptors (Stone & Addae, 2002). Activation of 
presynaptic mGluRs causes a widespread reduction o f glutamatergic transmission in the 
CNS. It is also now becoming clear that mGluRs regulate different neurotransmitters in a 
number of brain stmctures. They are highly enriched in the prefrontal cortex, a brain region 
critically involved in the regulation o f cognition and emotion (Tyszkiewicz et al., 2004).
At the moment, cloning has identified eight mGluRs and they have been subdivided into 
thi'ee groups based on the homology o f their amino acid sequences, the coupled signal 
transduction mechanisms, and their pharmacological properties investigated in transfected 
mammalian cell lines (Conn & Pin, 1997; Nakanishi, 1994). Group I niGluRs comprises 
the mGluRl and the mGluRS subtypes, which are positively coupled primarily to 
phospholipase C (PLC), resulting in increased phosphoinositide turnover, the subsequent 
activation of protein kinase C, and the release of Ca^^ from intracellular stores (e.g., the 
endoplasmic reticulum). On the other hand, groups II (niGluR2 and mGluR3) and III 
(mGluR4, mGluR 6 , mGluR7, and mGluRS) subtypes are all negatively coupled to 
adenylyl cyclase, resulting in the reduction of cAMP formation in the cell (Baskys, 1992;
IConn & Pin, 1997). Some of the important roles o f the mGluRs include the regulation of 
synaptic transmission via their modulation of ion channels and ionotropic glutamate 
receptors in diverse neuronal cell types (Pin & Duvoisin, 1995; Conn & Pin, 1997) and 
modulation of different subtypes of potassium channels in several types o f neuronal cells 
(Conn & Pin, 1997). They have also been observed to have a role in various forms of 
synaptie plasticity (Bashir et al., 1993; Riedel et al., 1995; Aiba et al., 1994; Linden & 
Connor, 1993; Hartell, 1994). The mGluRs can exist on both postsynaptic and presynaptic 
sites (Pin & Duvoisin, 1995). However, groups II and III appear primarily localized to the 
presynaptic terminals and Group I to the postsynaptic sites (Shigemoto et. al, 1997). The 
presynaptic sites are mainly involved in glutamate release. Several mGluRs have been 
shown to modify Ca^ "^  levels, either at presynaptic or postsynaptic sites (Stone & Addae, 
2002).
Due to the various identified effects of metabotropic receptors, they are now widely 
believed to modulate neuronal cell death. Activation o f group I receptors promotes 
neuronal damage and antagonists are therefore neuroprotective (Pellegrini-Giampietro et 
ah, 1999; Bruno et ah, 1999). However, it has been reported that sustained (> 24 h) 
antagonist treatment can render niGluI receptors in CGNs supersensitive to agonists, with 
a simultaneous decrease in the effectiveness o f antagonists (Lavreysen et ah, 2005). Group 
II receptor agonists protect against NMDA-induced cell damage (Battaglia et ah, 1998; 
Bond et ah, 2000; Colwell & Levine, 1999), perhaps by a process involving the synthesis 
o f a new protein and the generation of transforming growth factor-(3 (TGF-p) (Bruno et ah, 
1998). NMDA is the primary cause o f insults that has been examined by most workers. 
However, it was recently shown that Group II receptor activation protects against damage 
caused by traumatic brain injury (Zwienenberg et ah, 2001). The group III receptors have 
been given less attention, though their agonists appear neuroprotective (Gasparini et ah, 
1999; Pizzi et ah, 2000). Group III agonists are not protective in mGluR4 (-/-) knockout 
mice, suggesting this receptor is primarily responsible for the neuroprotection (Bruno et 
ah, 2000). The mGluR5 receptors are involved in the regulation of striatal glutamate 
release and this may imply an involvement o f adenosine Aza receptors in mGluRS- 
mediated effects (Pintor et ah, 2000). The niGluR2/3 play a protective role against 1- 
methyl-4-phenyl-1, 2, 3, 6 -tetrahydropyiidine (MPTP) toxicity, but the efficacy of the 
agonist, LY379268, critically depends on the extent of the nigro-striatal lesion (Battaglia et 
ah, 2003). Glutamate receptors communicate with NaYK’^ -ATPase in rat cerebellar granule 
cells, according to a study that demonstrated the differences in the actions of several
metabotropic and ionotropic glutamate agonists on intracellular reactive oxygen species 
and the sodium pump (Boldyrev et al., 2003).
1.1.3. Glutam ate production an d m etabolism
No evidence exists for any extracellular enzyme responsible for the metabolism of 
glutamate. Cellular uptake (the rapid route) and simple diffusion are the substantial means 
by which glutamate is removed from the extracellular space. Glutamate is mainly taken up 
into astrocytes. Glutamate transporters are important for the termination of signal 
transduction mediated by it and also for the prevention o f its neurotoxicity (see Hinoi et al., 
2004). These Na'^-dependent transporters are classified into five different subtypes: 
GLAST (glutamate aspartate transporter) or EAATl (excitatory amino acid transporter 1); 
GLT-1 (glutamate transporter-1 or EAAT2); EAACl (excitatory amino acid carrier 1) or 
EAAT3; EAAT4, and EAAT5. GLAST is known to predominate in the cerebellum. On the 
other hand, there are thi'ee vesicular glutamate transporters (VGLUT): VGLUT 1, 
VGLUT2, and VGLUT3 (Gonzalez & Robinson, 2004; see Hinoi et al., 2004). Reactive 
oxygen species (ROS) oppose the removal o f glutamate from the extracellular space by 
inhibiting the high-affmity glutamate transporters (Coyle & Puttfarcken, 1993). Uptake of 
glutamate into astrocytes can be followed by two pathways of metabolism. The first is the 
ATP-dependent conversion to glutamine for release into the extracellular fluid. The 
released glutamine is then taken up by neurones and reconverted to glutamate for reuse as 
transmitter. This is the glutamate-glutamine cycle (Fonnum 1993; Laake et al., 1995; 
Danbolt, 2001). The second possible metabolic route for glutamate involves its metabolism 
to a-ketoglutarate either by deamination or transamination, a-ketoglutarate may then be 
converted to succinate, fumarate and malate in the tricarboxylic acid (TCA) cycle. Malate 
may undergo further metabolism in the TCA cycle or be decarboxylated to pyi'uvate and 
lactate, a possibility already demonstrated in vitro (McKenna et al., 1996; Danbolt, 2001). 
The generated lactate is transported from astrocytes into the extracellular fluid from where 
it can enter into the neurones.
1.1.4. Glutamate signalling and receptor expression in bone
Research in the past few years has revealed that agents developed for use in neuroscience 
applications might be useful in the modulation of pathology in non-neuronal peripheral 
tissues, thus impacting on conditions such as osteoporosis, diabetes and wound healing 
(Skerry & Genever, 2001). An example o f such tissues is bone, in which there is the
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existence o f glutamate signalling in a way similar to how this signalling occurs in the CNS 
(see review by Skerry & Taylor, 2001) (Other aspects o f  bone biology including the 
specific characteristics o f  osteoblasts have been discussed in section 1.3 o f  this thesis). 
Interest in identifying sites where glutamate signalling could occur outside the CNS 
evolved as a result of studies o f the distribution of radiolabelled glutamate receptor binding 
agents in vivo (Samnick et ah, 1998; Nasstrom et a l ,  1993). Other non-neuronal peripheral 
tissues in which recent molecular biological analyses have given support to the expression 
of particular glutamate signalling molecules include the testis, pancreas, adrenal gland, 
pituitary gland, pineal gland, taste buds, lung, hepatocyte, thymus, cerebral endothelium, 
megakaryocytes, kératinocytes, lymphocytes, platelets, and heart (see Hinoi et a l , 2004). 
Osteoblasts are now known to actively secrete glutamate, with several osteoblastic cell 
types spontaneously releasing between 2-7 nmoles glutamate per mg protein, which is 
equivalent to or greater than reported levels of glutamate release from depolarized 
neurones (Genever & Skerry, 2001; Skerry & Taylor, 2001). In MC3T3-E1 osteoblast-like 
cells, the anticonvulsant riluzole, which inhibits neuronal glutamate release, has been 
reported to inhibit glutamate release and ALP activity and, at higher concentrations, it 
induces apoptosis, suggesting a trophic role for glutamate in bone development (Genever 
& Skerry, 2001). Chenu et a l  (1998) have also obseiwed that, glutamate receptors, 
especially the N M D A Rl, are expressed by bone cells and are involved in bone resorption. 
There is also evidence o f expression of NM DARl and NMDAR2D subunits by human and 
rat osteoblasts and osteoclasts, suggesting a novel glutamate signalling pathway in bone 
(Patton et a l , 1998). The same authors also found evidence o f the expression o f post­
synaptic density-95 (PSD-95), the NMDA receptor clustering protein associated with 
signalling in the CNS, while expression of the non-NMDA clustering protein, glutamate 
receptor interacting protein (GRIP), has similarly been reported (Skerry & Taylor, 2001). 
Functional NMDA receptors are also expressed by bone marrow megakaryocytes (Genever 
et a l , 1999). A later development confirmed the expression in rat calvaria and MG63 
osteoblastic cells of several NR2 subunits inRNAs, including NR2A, NR2B, and NR2D 
(Itzstein et a l ,  2001). A study by Genever and Skerry (2001) found that, in the presence of 
the NMDA channel antagonist MK-801 (lOOpM), glutamate release was moderately but 
significantly inhibited. Through binding studies and electrophysiological recordings from 
patch-clamped clonal human osteoblast-like cells, it was shown that the NMDA receptor 
displayed similar but not identical gating characteristics to the same receptors in the CNS 
(Laketic-Ljubojevic et a l ,  1999). Subsequently, it was demonstrated that primary rat
osteoblasts exhibited much closer electrophysiological characteristics to neuronal cells, and 
that the responses were regulated by metabotropic receptor function (Gu & Publicover,
2000). Gu et al. (2002) showed that the NMDA type glutamate receptors expressed by 
primary rat osteoblasts have the same electrophysiological characteristics as neuronal 
receptors. However, currents in the human osteoblastic MG63 cells, unlike those of 
mammalian neurones, are blocked by Mg^^ in a voltage-insensitive manner. Osteoblasts 
are also known to constitutively express mRNA for non-NMDA receptors such as the 
GluR3 subunit of AMPA receptors and K A l and KA2 subunits o f kainate receptors (Hinoi 
et ah, 2002). The identification of glutamate receptors in bone cells points to a novel means 
o f paracrine communication in the skeleton (Laketic-Ljubojevic et al., 1999). As ftirther 
evidence. Mason et al. (1997) reported the mechanically regulated expression of a neural 
glutamate transporter in bone, implicating a role for excitatory amino acids as osteotropic 
agents. In fact, it has been proposed that, in bone, a mechanism similar or identical to long 
term potentiation (LTP) in the CNS regulates long-term osteogenic responses resulting 
from brief periods o f mechanical loading (Spencer et al., 2001). In addition, osteoblasts 
have been shown to express a functional glutamate transporter GLAST (EAATl), which is 
responsible for cellular glutamate uptake, and many SNARE (soluble A-ethyl maleimide- 
sensitive factor (NSF) attachment protein (SNAP) receptor) and related vesicular proteins 
required for regulated transmitter release, which colocalize with immunoreactive glutamate 
(Mason et al., 1997; Bhangu et al., 2001). Another glutamate transporter, GLT-1, has also 
been shown to reside in bone (Huggett et al., 2000). In addition to glutamate transporters, 
osteoblasts express the exocytotic machinery needed for complete glutamate release, with 
their glutamate release appearing to be dependent on an AMPA-type glutamate 
autoreceptor (Genever & Skerry, 2001). These authors found that blockade o f AMPA-type 
glutamate receptors with the highly selective non-competitive antagonist CFM-2 resulted 
in a significant, dose-dependent inhibition o f glutamate release in MG63 cells at 5-50pM 
concentrations but the antagonist did not affect depolarization-induced inhibition of 
glutamate release. Bhangu et al. (2001) also reported evidence for targeted vesicular 
glutamate exocytosis in osteoblasts (mimicking presynaptic glutamatergic neurones) and 
demonstrated that osteoblastic cells actively release glutamate in a differentiation- 
dependent manner. It has been suggested that L-glutamic acid may, at least in part, play a 
role in mechanisms associated with cellular proliferation and/or differentiation through 
group III mGluRs frmctionally expressed in rat calvarial osteoblastic cells (Hinoi et al.,
2001). By reverse transcriptase polymerase chain reaction (RT-PCR), expression of
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niG luRlb (but not m G luRla, 2, 3, 4, 5, or 6 ) has been detected in rat femoral osteoblasts 
and this shows that complex glutamatergic signalling can occur in bone tissue (Gu & 
Publicover, 2000). It is therefore now understood that osteoblasts express the whole range 
o f glutamate receptors which display the same electrophysiological characteristics as their 
neuronal counterparts. Since bone cells need to undergo changes in cell mass in response 
to exercise, for example, it has been hinted that glutamatergic transmission could play a 
vital role in these skeletal adaptations, not only as a trophic factor but also perhaps by 
inducing a long term potentiation-like process (Skerry & Taylor, 2001). The need for a 
tissue like bone - that is slow to respond to changes in circumstances - to have a system 
capable o f responding to rapid changes in the millisecond scale could be conceived in the 
light of a requirement for bones to be capable of discriminating the difference between the 
same force applied quickly or slowly (Skerry & Taylor, 2001). Thus, glutamate receptor 
agonists and antagonists may play a role in the treatment o f bone disease and manipulation 
o f bone cell function by moderators o f glutamate action could lead to novel therapies for 
disorders o f bone such as osteoporosis (Mason et al., 1997). However, more in vivo studies 
are being undertaken to specifically delineate the physiological roles o f glutamate in bone 
(Skerry & Taylor, 2001). One major challenge in this arena is that the use o f antagonists 
that cross the blood-brain barrier (BBB) in in vivo bone studies could cause alterations in 
the CNS and thus make interpretations difficult. Some efforts are being made to get round 
this by the use of quinoxalinediones, which do not cross the BBB. These agents have been 
shown to potentiate the effects o f mechanical loading, resulting in more new bone formed 
than in the limbs of animals treated with vehicle alone (Skerry & Taylor, 2001).
1,2. Adenosine and its receptors
Because adenosine is well established as neuroprotective against glutamate-induced 
neurotoxicity in the CNS, we would now consider some aspects o f the biological functions 
o f this purine nucleoside and its receptors, both in health and in disease states.
L2.L Physiological roles
Adenosine is now widely accepted to be a major non-peptide neuromodulator that acts 
tlrrough specific ectocellular receptors, having a multitude o f effects on many different 
organs (Stone & Simmonds, 1991). This purine nucleoside has been observed to act as 
both a homeostatic modulator and a neuromodulator at the synaptic level and is known as a 
substantial metabolite in neurones and other mammalian cell types, participating in the
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synthesis of nucleic acids, amino acids metabolism and modulation of cellular metabolic 
status (Stone, 1985). In relation to its homeostatic role in the control of cellular 
metabolism, adenosine has been called a “local hormone” (Arch & Newsholme, 1978), and 
in terms of its role in stressful conditions has been termed a “retaliatory metabolite” 
(Newby, 1984). It also fulfils the criteria o f an autacoid (Klinger et ah, 2002). There are 
circumstances in which the intracellular concentration o f adenosine increases from the 
nanomolar range to micromolar concentrations, and it is released to the extracellular 
medium to maintain the metabolism of neighbouring cells (Meghji, 1991).
In the CNS, adenosine has profound effects, including major behavioural (e.g., sedation 
and anti-seizure activity) (Snyder, 1985) and neuroprotective effects (Dragunow & Faull, 
1988). In fact, in various conditions like hypoxia, ischaemia and brain injury, the 
extracellular levels o f adenosine are increased. Many experimental and pathological 
conditions are known in which there is increased release o f glutamate from cells. In these 
conditions, increase in the extracellular levels of adenosine has also been observed (Stone 
& Simmonds, 1991; Latini & Pedata, 2001). The neuroprotective potential of adenosine 
exploits the mechanisms of blocking the presynaptic release of glutamate after excessive 
stimulation of glutamate receptors and blocking the postsynaptic sensitization of NMDA 
receptors (Nishizawa, 2001). This is relevant to most pathological conditions including the 
ischaemic stroke caused by transient or permanent reduction o f cerebral blood flow, which 
is a leading cause o f death and disability in humans (Nishizawa, 2001).
The effects of adenosine are widespread and pleiotropic (Klinger et ah, 2002). In the 
periphery, extracellular adenosine modulates many physiological events in several organ 
systems by activating Ai receptors. These include the inhibition of lipolysis and 
stimulation of glucose uptake in adipocytes and the cardiovascular effects of negative 
inotropy and clrronotropy (Olsson & Pearson, 1990; Pelleg, 1993). On the other hand, in 
vascular beds, Aia receptor activation causes smooth muscle relaxation, leading to 
vasodilatation and reduction in blood pressure (Olsson & Pearson, 1990), while in platelet 
membranes, A%A receptor activation increases intracellular cAMP levels, with the resultant 
effect o f inhibiting platelet aggregation (Palmer & Stiles, 1995). Neutrophil activation 
could be inhibited by adenosine, leading to decreased neutrophil adhesion and prevention 
of capillary plugging (Miller & Hsu, 1992). A number of aspects o f renal and respiratory 
physiology could also be affected by exogenous adenosine.
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1.2.2. Formation, release, transport and metabolism
Adenosine can be synthesised either intracellularly de novo or retrieved by salvage and 
transported across the membrane, or it can result from the metabolism o f ATP.
The final stage o f the de novo pathway of adenosine production involves the 
dephosphorylation o f adenosine monophosphate (AMP) to adenosine by cytosolic 5'- 
nucleotidase (Stone & Simmonds, 1991; Meghji, 1991), while the salvage pathway occurs 
through the tiansmethylation of S-adenosylmethionine (SAM) to S-adenosylhomocysteine 
(SAH), which is metabolised further by SAH-hydrolase to adenosine and homocysteine 
(Ueland, 1982). Another salvage route is the recycling o f hypoxanthine to inosine 
monophosphate (IMP) by the enzyme hypoxanthine-guanine phosphoribosyl transferase 
(HGPRT) (Stone & Simmonds, 1991).
Adenosine is released in a calcium-dependent manner from nerve terminals following 
nerve stimulation (Meghji, 1991), although there is no evidence o f its storage in synaptic 
vesicles and release from neiwe terminals like other neurotransmitters (Wliite & Hoehn,
1991). Much o f the released adenosine arises from the intracellular adenosine that can pass 
bidirectionally via a facilitated diffusional transporter. The accumulation of adenosine 
during conditions such as ischaemia, hypoxia, head injury, and seizures (Hagberg et al., 
1987; Phillis, 1990; Bell et ah, 1998) is due to increased adenosine formation resulting 
from the imbalance between energy supply and demand (Bardenheuer & Sclmader, 1986). 
Therefore, adenosine levels can be regulated by the balance o f energy supply and demand 
(Stone et al., 1991). Potassium, veratridine and electrical stimulation have been shown to 
release adenosine both in vivo and in vitro from various brain regions (White & Hoehn, 
1991; Sciotti et al., 1993). The adenosine released during EAA activation could provide 
much protection against EAA-mediated exeitotoxieity in the CNS. Some of the adenosine 
is produced from the extracellular metabolism o f adenine nucleotides, in particular ATP 
(Wieraszko et al., 1989; Cunha et. al., 1996), released into the extracellular space by a non- 
synaptic mechanism (Stone et al., 1991; Bmndege & Dunwiddie, 1997). ATP is co-stored 
with either noradrenaline in the sympathetic nerves or acetylcholine in the cholinergic 
synaptosomes (Morel & Meunier, 1981; White, 1988; Silinsky, 1975; Lew & Wliite, 1987; 
von Kilgelgen & Strake, 1991a; 1991b; Zimmermann, 1994). This ATP is subsequently 
converted to adenosine by ectonucleotidases.
Adenosine is taken up into neurones and neighbouring cells and appears to be converted 
back into ATP intracellularly (Bender et ah, 1981). Its uptake occurs via nucleoside 
transporters, which operate bidirectionally by a facilitated diffusion mechanism. However,
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this process of adenosine uptake is regulated by the concentration gradient for adenosine, 
implying that uptake into cells is only possible if  the intracellular concentration of 
adenosine is kept below the extracellular concentration. Adenosine becomes inactivated 
either via the breakdown to inosine by cytosolic adenosine deaminase and subsequently 
hypoxanthine and xanthine, or via conversion to adenosine monophosphate tlirough 
phosphorylation by cytosolic adenosine kinase (Arch & Newsholme, 1978; Meghji, 1991). 
Because o f the presence of adenosine deaminase in an extracellular membrane-associated 
form, adenosine can also be inactivated extracellularly without any need to be taken up 
(Meghji, 1991). It seems that phosphorylation occurs at low adenosine concentrations 
whereas the deamination pathway is important at higher adenosine concentrations (Arch & 
Newsholme, 1978b; Meghji, 1991).
1.2.3. Adenosine receptors
To date, four adenosine receptors, Ai, A 2 A, Aiu, and A 3 (all o f them members of the PI 
purinoceptor) have been cloned and pharmacologically characterized. All of them belong 
to the family of G protein-coupled receptors acting tlirough intracellular second 
messengers and have the seven transmembrane helices common to G protein-associated 
receptors. They are most closely related to the receptors for biogenic amines (Jacobson & 
Gao, 2006). Among the human adenosine receptors, the most similar are the A | and the A 3 
adenosine receptors (49% sequence similarity) and the A 2 A and the A 2 B adenosine 
receptors (59% similarity) (Jacobson & Gao, 2006).
Information about the distribution o f adenosine receptors has come from the studies of 
biochemical and physiological roles of adenosine as well as radioligand binding studies. Ai 
receptors predominantly exist in the molecular layer o f the cerebellum and in the CAI and 
CA3 regions o f the hippocampus (Goodman & Snyder, 1982; Lee & Reddington, 1986), 
while moderate A | receptor levels are found in the thalamus, caudate-putamen, septum and 
cerebral cortex. Northern blot analysis of mRNA from various tissues has shown that Ai 
receptor message is also found in kidney, heart, testis, and epididymal fat (Stehle et ah,
1992). On the other hand, while A 2 A receptor expression is limited to the striatum, nucleus 
accumbens and olfactory tubercle, A 2 B receptor mRNA is distributed tlu'oughout the brain 
(Stehle et al., 1992). The more sensitive RT-PCR technique has shown that A 2 A receptor 
mRNA could be detected in all brain regions (Dixon et al., 1996). High levels o f A 2 A 
receptor exist in striatum and nucleus accumbens but lower levels are found in the cortex, 
amygdala, olfactory tubercles, hippocampus, hypothalamus, thalamus, and cerebellum. Co­
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localization o f A 2 A receptors with other binding sites for other neurotransmitters has been 
found in some brain areas. For example, A ia receptors and dopamine Di receptors have 
been found co-localized on striatopallidal neurones on the same cell and they are known to 
influence each other’s function (Johansson et a l , 1997). Peripherally, the use of Northern 
blotting experiments has shown reasonable expression o f the A 2 A receptors in the heart, 
lung, thymus, and epididymal fat and has also demonstrated the A 2 A receptor message in 
the caecum, lung, intestine, and urinary bladder, though with lower distribution in the lung 
(Stehle et a l ,  1992). In fact, in neutrophils, adenosine A 2 A receptor activation delays 
apoptosis (Walker, et a l ,  1997), while theophylline induces apoptosis o f neutrophils 
through adenosine A 2 A receptor antagonism (Yasui et a l ,  2 0 0 0 ).
Interactions between adenosine Ai and A2 A receptors have been reported. It is known that 
activation o f adenosine A 2 A receptor inhibits Ai receptor activation (Cunha, 2001). The 
A 2 A receptor agonist, 2-p-(2-carboxyethyl)phenethylamino-5'-W 
ethylcarboxamidoadenosine hydrochloride (CGS21680), attenuates neuronal sensitivity to 
the Ai agonist CPA (O ’Kane & Stone, 1998) and also induces a low-affmity receptor site 
for another Ai agonist, 2-chloropentyladenosine (CCPA) (Dixon et a l , 1997), possibly 
through protein kinase C (Stone, 2005). However, upon agonist stimulation, the A 2 A 
receptor response rapidly desensitizes, though reversibly, within a time frame o f less than 
an hour (Klinger et a l , 2002). According to Cassada et a l  (2002), “adenosine A 2 A agonists 
may exert neuroprotective effects by binding to inducible neuronal A 2 A receptors that are 
upregulated during spinal cord reperfusion and reduced in response to administration o f an 
A 2 A receptor-specific agonist”.
The A 3 receptor subtype was cloned and characterised in the early 1990s (Meyerhof et a l, 
1991; Zhou et a l , 1992) and its activation mediates the inhibition o f adenylate cyclase 
(Abbracchio et a l , 1998).
1.2.3,1. Agonists and antagonist ligands
Known agonists for the adenosine receptor are analogues o f adenosine modified in either 
the purine or ribose portions o f the molecule (Williams, 1991). Adenosine analogues have 
the potential to interact with nucleoside transporter sites as well as to function as adenosine 
potentiators in addition to acting at extracellular receptor sites (Engler, 1987).
A]-selective agonists include A^-cyclohexyladenosine (CHA) and R-A^-phenylisopropyl 
adenosine (R-PIA) (Williams, 1987), but A^-cyclopentyladenosine (CPA), (2S)-A^-[2- 
endo-norbornyl]adenosine (5'-ENBA) and CCPA are the most potent and selective (Miller
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& Hsu, 1992). The most selective A 2 A receptor agonist is CGS21680, which has high 
affinity and selectivity (140-fold) for A 2 A over Ai receptors. CGS21680 and similar 
radioligands can directly label the A 2 A receptor in rat brain without the need to block the 
binding activity at the Ai receptor (Jarvis et ah, 1989). However, a number o f reports have 
indicated that CGS21680 could also be quite potent at rat, and particularly at human, A 3 
receptors (Muller, 2000). To date, no usefril radioligands for the A2 B receptors have been 
developed. A^-(3-iodobenzyl)-adenosine-5'-A-methylcarboxamide (IB-MECA) was the 
first highly potent and selective A 3 receptor agonist both in vivo and in vitro (von Lubitz et 
al., 1994; Stambaugh et al., 1997; Jacobson et al., 1997). 2-chloro-A^-(3-iodobenzyl)- 
adenosine-5'-A-methylcarboxamide (2C1-IB-MECA) is also very potent at the A 3 receptor 
(Jacobson, 1998).
The 8 -phenylxantliines were developed as potent Ai-selective antagonists by the 
replacement of the phenyl on the 8 -position o f xanthine with cyclopentyl, resulting in 
compounds with improved affinity, aqueous solubility and selectivity for A | receptors. 1,3- 
dipropyl-8 -cyclopentyl xanthine (DPCPX) is a highly selective Ai antagonist (Linden,
1991). KFM19 is a keto derivative o f DPCPX, reported to have increased aqueous 
solubility (Ad Ijzerman & van Galen, 1990). The most commonly used A 2 A antagonists are 
9-chlorO“2- (2-furanyl)[l, 2, 4] triazolo [1,5-c] quinazolin-5-amine (CGS15943), a 
nonxanthine antagonist; 4-(2-[7-aniino-2-[2-furyl][l,2,4]triazolo[2,3-a][ 1,3,5]triazo-5-yl- 
amino] ethyl)phenol (ZM241385), and 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo 
[4,3-e]-l,2,4-triazolo [1,5-c] pyrimidine (SCH58261). A study by Ongini et al. (1999) 
showed ZM241385 and in particular SCH58261 as having good A 2 A selectivity. 
ZM241385 is 80-fold selective for A 2 A versus A 2 B receptors, and 500- to 1000-fold 
selective for A 2 A versus Ai receptors (Palmer et al., 1995). No selective antagonists have 
been reported for the A 2 B receptor (Jacobson et ah, 1993). In fact, the availability of 
specific agonist and antagonist ligands has greatly facilitated studies o f the distribution of 
A] adenosine receptors while the characterization of A2  receptors has proceeded somewhat 
more slowly due to a lack o f specific ligands (Reddington & Lee, 1991). Jacobson et al. 
(1997) reported putative A 3 receptor antagonists belonging to tlmee diverse chemical 
classes, namely the flavonoid MRS 1067, the 6 -phenyl-1, 4-dihydropyridines MRS 1097 
and MRS 1191, and the triazoloquinazoline MRS 1220. Natural phenolic derivatives and 
other compounds such as triazolonaphthyridine, thiazolopyrimidine and a derivative of the 
triazoloquinazoline, CGS15943 (9-Chloro-2-(2-furanyl)-[l,2,4]triazolo[l,5-c]quinazolin-5- 
amine), have also been reported as high-affinity A 3 receptor-selective antagonists
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(Jacobson et al., 1996; Kim et al., 1996). Generally speaking, studies using adenosine 
antagonists must be aware that long-term (e.g., 24 h) treatment with these antagonist 
compounds can have effects that resemble the acute (e.g., 1 h) effects of adenosine 
receptor agonists, and vice-versa (Jacobson et ah, 1996).
1.2.3.2. G-protein coupling
Adenosine receptors are linked to many effectors via various classes of G proteins 
(Fredholm et ah, 1989). It does appear that the postsynaptic effects of adenosine are 
mediated by a pertussis toxin (PTX)-sensitive G protein (M ynlieff & Beam, 1994), as it 
has been shown that these effects could be blocked by peitussis toxin in vivo (causing 
adenylate cyclase inhibition and increased K^ conductance), while presynaptic effects have 
not been affected by PTX (Gilman, 1987). Ai receptor-mediated responses are coupled via 
pertussis toxin-sensitive G proteins to different effectors including adenylate cyclase, 
phospholipase C, Ca '^  ^channels, CP channels and K^ channels (Dascal, 2001). Adenylate 
cyclase (AC), the enzyme that converts ATP to cAMP, is regulated by hormones, 
neurotransmitters and other regulatory molecules through its interaction with G proteins 
and reeeptors. A total of nine isoforms o f adenylate cyclase has been cloned in mammals, 
numbered AC1-AC9 (Hanoune et ah, 1997). Sattin & Rail (1970) showed that adenosine 
increases cyclic AMP accumulation in cortical slices. Conversely, in cultured rat forebrain 
neurones, elevation o f intracellular cAMP evokes activity-dependent release of adenosine 
(Lu et ah, 2004). A biphasic effect o f adenosine on cAMP accumulation has been reported, 
as low micromolar concentration stimulates adenylate cyclase while higher micromolar 
concentration inhibits it (Haslam & Lynham, 1972). These biphasic concentration- 
dependent effects o f adenosine are suppressed by Ai and A 2 antagonists such as caffeine 
and other methylxanthines, i.e., Ai and A 2 adenosine receptor antagonists block both the 
stimulatory and the inhibitory actions of adenosine on adenylate cyclase (Sattin & Rail, 
1970; Hanoune, et ah, 1997). In general, A 2 receptor agonists increase the rate o f ATP 
metabolism to cAMP by enhancing the activity o f adenylate eyclase tlu’ough its action on 
stimulatory G protein (Gg), while adenosine A] receptor agonists inhibit the rate of ATP 
metabolism to cAMP by attenuating the activity o f adenylate cyclase through its action on 
inhibitory G protein (GJ.
Another group o f intracellular second messengers includes inositol-1, 4, 5-triphosphate 
(IP3) and diacylglycerol (DAG), which are generated from the breakdown o f the 
phospholipid, phosphatidylinositol-4,5-biphosphate (PIP2 ), via the action of PLC. These
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compounds act as second messengers mediating the effects of many neurotransmitters 
including acetylcholine (ACh), 5-hydroxytryptamine (5-HT) and noradrenaline and form 
internalization o f the extracellular signal. However, adenosine does not seem to have an 
effect on phosphatidylinositol turnover, even though there have been some reports that 
adenosine and its several analogues mediate the regulation o f phosphatidylinositol (PI) 
responses to histamine and neurotransmitters such as noradrenaline (Morgan, 1991).
1.2.4. Adenosine and neiiroprotection
It is known that purine nucleosides such as adenosine have the ability to modulate Ca^^ 
activity within cells and especially at the presynaptic sites, where adenosine Ai receptors 
decrease the release o f several neurotransmitters while adenosine A 2 A receptors increase 
the release o f some transmitters (Chen & Lambert, 1997; Goncalves et al., 1991; 
Goncalves & Ribeiro, 1996). The manner o f this calcium modulation has yet to be fully 
elucidated. Under most experimental conditions, the effect of adenosine or adenosine 
receptor agonists is an inhibition of neuronal activity mediated by Ai receptor activation. 
The Ai receptors are linked to inhibition of the release o f the most classical 
neurotransmitters, including glutamate, gamma-amino butyric acid (GABA), 
norepinephrine, acetylcholine, 5-hydroxytryptamine and dopamine (Dunwiddie, 1985; 
Greene & Hass, 1991). The most profound inhibitory effects are generally seen on 
excitatory glutamatergic systems. Because inhibitory modulation of inhibitory systems 
(e.g., GABA) is less frequently observed, the net effect o f adenosine receptor activation in 
almost all regions of the brain is to reduce excitability. The inhibitory action of adenosine 
in the CNS is predominantly due to its presynaptic action (Lupica et al., 1992). 
Intracellular calcium buffers do not prevent the inhibitory effects of adenosine on 
acetylcholine release (Silinsky et al., 1989), a study which, alongside others, suggests that 
adenosine inhibits transmitter release from motor nerves by reducing the responsiveness of 
some component o f the secretory apparatus to Ca^^. Adenosine, by inhibiting 
phospholipase, could inhibit neurotransmitter release by reducing intraneuronal Ca^ "^  
mobilization and by attenuating the activation of PKC. Adenosine could also modulate 
potassium currents in presynaptic terminals. This is evidenced by the demonstration that 
blockers of potassium channels such as 4-aminopyridine are able to prevent the inhibitory 
effects o f adenosine on transmitter release in peripheral sympathetic nerves (Stone, 1981) 
and in glutamate-releasing fibres in the hippocampus (Scholfield & Steel, 1988). As further 
evidence o f neuroprotection, Gupta et al. (2002) observed the protective effect of
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adenosine against neuronal injury induced by middle cerebral artery occlusion (MCAO) in 
rats as evidenced by diffusion-weighted imaging.
hi general, the Ai receptor mediates, at least, tliree cellular mechanisms, including 
inhibition o f transmitter release (glutamate in particular), hyperpolarization of neurones, 
and direct inhibition of certain kinds o f Ca^^ channels. The inhibitory modulation of 
transmitter release by adenosine depends on a direct inhibition, via G protein, o f mainly N- 
type calcium channels, although this is still a subject o f much debate (Wu & Saggau, 1994; 
Ribeiro, 1995). Further inhibitory mechanisms appear to operate in motor neurones. These 
mechanisms are capable of reducing excitotoxicity by decreasing Ca^^ entry, which is 
thought to be a key step in excitotoxic damage. Again, by reducing metabolic rate, 
adenosine helps to preserve ATP stores that are essential for pumping Ca^^ out of the cell 
(Dunwiddie & Masino, 2001). It should be noted, however, that, while activation of A, 
receptors can provide neuroprotection, the protective effect appears to become saturated by 
high levels of endogenous extracellular adenosine during oxygen-glucose deprivation 
(Lobner, 2002). Deletion o f the Ai receptor gene in a study by Olsson et al. (2004) did not 
alter neuronal damage following ischaemia in mice in vivo or in vitro, suggesting that the 
effects o f the receptor are compensated for in knockout animals. Evidence exists for a 
direct effect o f adenosine on Ca^ "^  fluxes into synaptic temiinals, though there are also 
indications that adenosine might alter the availability o f intraterminal Ca^”^ to the 
secretory/release process. These adenosine effects on Ca^^ activity therefore often oppose 
the effects induced by a rise in calcium levels that occurs with agents such as glutamate. 
Even though adenosine receptors may also enhance neurotransmitter release, these actions
are less common than the inhibition of transmitter release (Cunha et ah, 1994). In striatal 
cholinergic neiwe terminals, at the neuromuscular junction and in hippocampus 
GABAergic nerve terminals, modification o f neuro transmitter release via A 2 A receptors is 
decreased by inhibitors o f adenylate cyclase (Cunha & Ribeiro, 2000a; Gubitz et ah, 1996). 
Protein kinase C (PKC) or phospholipase C inhibitors are able to inhibit the effects of A 2 A 
receptors, whereas protein kinase A (PKA) inhibitors slightly inhibit or do not change the 
effects o f A 2 A receptor activation. It has been demonstrated further that, activation o f A 2 A 
receptors triggers cAMP accumulation but a parallel signalling system via PKC is also 
activated by presynaptic A2 A receptor activation (Cunha & Ribeiro, 2000b). The A2 A 
receptor can also modify neurotransmitter release via P-type calcium channels where its 
activity seems to be modified by both PKC and PKA. However, it is not clear whether both
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pathways can modulate this same target or just P-type calcium channels are the main target 
for PKC pathway (Cunha, 2001).
The adenosine A 2 A receptor can preferentially elicit excitatory amino acid release over 
inhibitory amino acid release from rat cerebrocortical synaptosomes (Marchi et al., 2002) 
and can also increase glial glutamate efflux (Li et al., 2001). It seems that it is the 
antagonism o f this action that most probably underlies the neuroprotective effect o f A 2 A 
receptor blockade, which has been demonstrated in vivo. Antagonists at adenosine A 2 A 
receptors have been shown to be neuroprotective in animal models o f ischaemia 
(Sheardown & Knutsen, 1996; Monopoli et ah, 1998; Ongini et al., 1997) and 
excitotoxicity (Jones et al., 1998a; b; Stone et al., 2001). It has been shown that the A 2 A 
receptor can inhibit evoked GABA release in the striatum (Kirk & Richardson, 1995), 
although Sebastiao & Ribeiro (1996) have suggested that this effect may only be specific 
to receptors from these brain regions that are already proposed as being atypical, owing to 
their enhanced Gg coupling. Blockade o f striatal adenosine A 2 A receptor reduces, tlirough a 
presynaptic mechanism, quinolinic acid-induced excitotoxicity, implying a possible 
relevance to neuroprotective interventions in neurodegenerative diseases of the striatum 
(Popoli et ah, 2002). Because blockade of A 2 A receptors has differential effects on striatal 
cell death in vivo depending on its ability to modulate presynaptic over postsynaptic 
receptor activity, therapeutic use o f A 2 A antagonists in Huntington's as well as in other 
neurodegenerative diseases could exhibit undesirable biphasic neuroprotective-neurotoxic 
effects (Blum et ah, 2003). The results of studies by Petzer et al. (2003) suggest that 
monoamine oxidase B (MAO-B) inhibition may contribute to the neuroprotective potential 
o f A 2 A receptor antagonists such as KW-6002 and open the possibility of designing dual­
targeting drugs that may have enhaneed therapeutic potential in the treatment of 
Parkinson’s disease.
An interesting conundrum is the observation through in vivo data that both adenosine A 2 A 
receptor agonists and antagonists are neuroprotective. The neuroprotection that is 
paradoxically seen with adenosine A 2 A receptor activation in vivo could be due to effects 
on cerebral blood flow, glucose utilization, platelet aggregation and superoxide generation 
from neutrophils (Stella et ah, 1996; Hourani, 1996; Nehlig et al., 1994; Cronstein et al.,
1985). It is possible that adenosine could reduce free radical-associated cell damage that 
occurs in ischaemia and excitotoxicity (Lafon-Cazal et ah, 1993; Reynolds & Hastings,
1995; Patel et al., 1996). In PC12 cells, hypoxia stimulates the expression o f the adenosine 
A 2 A receptor gene (Kobayashi & Millhorn, 1999) and chronic hypoxia is Imown to reduce
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adenosine A ia receptor-mediated inhibition of calcium current via downregulation of PKA 
(Kobayashi, et ah, 1998). Adenosine A 2 A receptors could therefore exert neuroprotection in 
vivo via peripheral mechanisms of action while centrally, e.g., in hippocampal 
synaptosomes, they could enhance evoked GABA release (Cunha & Ribeiro, 2000a), 
resulting in a general reduction of neuronal excitability and hence limiting cell death 
during an ischaemic insult. It is also becoming clear that the adenosine A 2 A receptor has a 
wide range o f intracellular effectors that can influence neuronal excitability and viability, 
thus exerting a direct neuroprotective effect. These effectors include the PLC / IP3 / 
calmodulin and calmodulin kinase II pathway (Wirkner et ah, 2000); ATP-sensitive 
potassium channels (Haynes, 2000), and growth factors, especially nerve growth factor 
(NGF) (Arslan et ah, 1997; Arslan & Fredholm, 2000).
A number o f interactions at the receptor level have been identified between purines and 
glutamate (Stone & Addae, 2002), where activation o f NMDA receptors or group I 
metabotropic glutamate receptors could suppress the presynaptic inhibitory effects of 
adenosine in the hippocampus (Bartrup & Stone, 1988; 1990; Shahraki & Stone, 2003). 
The converse has also been demonstrated with adenosine and NMDA (de Mendonca et ah, 
1995; Norenberg et ah, 1997). Nitric oxide and superoxide anion, which are generated 
upon NMDA receptor activation, have been reported to block presynaptic adenosine Ai 
receptor responses in rat hippocampus (Shahraki & Stone, 2004). Agonists at other 
ionotropic glutamate receptors did not reduce responses to adenosine (Stone, 2005). It 
seems that the interaction between NMDA and adenosine involves the enhancement of 
responses mediated by A 2 A receptors, so that A 2 A reeeptors can, in turn, suppress Ai 
receptor activation (Stone, 2005).
The effects o f adenosine A 3 receptor stimulation depend on the differential impact o f this 
receptor on both neuronal and non-neuronal elements o f the cerebral tissue, for example, 
astrocytes, microglia, and vasculature (von Lubitz et ah, 2001). Adenosine A 3 receptors, 
though cardioprotective, proved severely cerebrodestructive when administered prior to 
global ischaemia in gerbils and the stimulation o f the A 3 adenosine receptors appears to 
reduce the efficacy o f some o f the neuroprotective actions mediated by adenosine Ai 
receptors (von Lubitz, 1999). Data from pyramidal cells of the rat cingulate cortex show 
that a high level of endogenous adenosine (occurring during hypoxia) activates A 3 
receptors, mediating a depression o f the synaptic transmission. The A 3 receptors inhibit 
glutamate release additionally to and also independently o f the Ai receptors. These two 
distinct mechanisms of synaptic modulation could contribute to the neuroprotective action
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of adenosine during hypoxia and therefore offer new approaches for therapeutic strategies 
(Lewerenz et ah, 2003). The A 3 adenosine receptor induces cytoskeleton rearrangement in 
human astrocytoma cells via a specific action on Rho proteins (Abbracchio et ah, 2001).
1.2,5. Adenosine and bone cell development
Alongside growth factors, cytokines and glutamate, adenosine is also a modulator of bone 
remodelling in the osseous micro environment. Shimegi (1996) reported that adenosine has 
a mitogenic effect on MC3T3-E1 cells. Adenosine could enhance MC3T3-E1 cell 
proliferation by itself and it was shown to also enhance platelet-derived growth factor- 
induced mitogenicity in them (Shimegi, 1998). Cyclopentylxanthine and peitussis toxin 
(PTX) partly antagonised this proliferating effect, confirming Ai receptors partly mediated 
the action. PTX-sensitive G proteins have been reported to be potent mediators of cell 
proliferation and alkaline phosphatase (ALP) activity o f osteoblast-like cells in response to 
factors acting through G protein-coupled receptors such as epineplriine (adrenaline)
(Suzuki et ah, 1998). However, some of the mitogenic effect of adenosine was not 
xanthine- and PTX-sensitive, meaning that other adenosine receptors played a part in the 
effect as well. Nevertheless, despite these reports, controversy still surrounds the 
expression o f PI receptors (adenosine receptors) in osteoblasts, with evidence for (Lerner, 
et ah, 1987) and against (Jones et ah, 1997) their expression. There is growing evidence 
that extracellular nucleotides, signalling through P2 receptors, might also play a significant : 
role in modulating osteoblast and osteoclast fmrction (Hoebertz et ah, 2003). Osteoblast 
responses to nucleotides were recently shown to increase during differentiation (Orriss et 
ah, 2006).
1.3. Aspects of bone biology
This section would introduce the bone tissue in relation to the active process of 
remodelling and then consider the bone-forming osteoblasts in some detail.
1.3.1. Bone tissue
Traditionally, the skeleton is recognised as a means of locomotion, protection of vital 
organs and provision o f a readily available source of phosphorus and calcium, but only 
recently was it recognised as a dynamic tissue constantly remodelling itself. Two main cell 
types carry out this act; osteoclasts and osteoblasts. In order to achieve bone renewal, 
osteoclasts erode cavities removing old or damaged bone tissue while osteoblasts, upon
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recruitment and activation, synthesise new bone matrix (Genever & Skerry, 2001). Bone 
matrix is composed o f type 1 collagen and several noncollagenous proteins (Raynal et al., 
1996) and inorganic materials, mainly calcium hydroxyapatite. According to Weinstein & 
Manolagas (2000), remodelling or turnover is carried out by juxtaposed osteoclasts and 
osteoblasts comprising temporary anatomical structures known as basic multicellular units 
(BMUs). An imbalance between osteoblasts and osteoclasts has been implicated in the 
pathogenesis of certain metabolic diseases including osteoporosis, Paget’s disease, and 
osteopetrosis (Ducy et al., 2000; Teitelbaum, 2000).
Bone turnover involves activation, the conversion of an inactive skeletal surface to a 
remodelling site. The reconstitution by osteoblasts of previously osteoclast-resorbed cavity 
with new bone occurs through a process known as coupling. The adult skeleton, containing 
approximately 35 million bone structural units (BSUs) (one from each previous BMU), is 
almost completely regenerated every 10 years (Corral et al., 1998). It is loiown that bone 
sialoprotein (BSP), which is one of the most prominent o f noncollagenous proteins in the 
bone matrix, stimulates in vitro bone resorption (Raynal et ah, 1996). Recently, a role was 
defined for acetylcholinesterase (AChE) as a bone matrix protein. Using Western blot 
analysis, Inkson et al. (2004) identified expression of two AChE species in osteoblastic 
cells, a major species of 68 kDa and a less abundant species o f about 55 kDa. They also 
confirmed that AChE secretion levels corresponded with ALP activity and its expression 
was regulated by mechanical strain both in vitro and in vivo. As bone formation 
approaches completion, some osteoblasts differentiate into osteocytes (the primary sensors 
o f strain in bone) and become enveloped by the developing matrix; others become 
quiescent bone-lining cells, and the remainder most probably undergo apoptosis (Lynch et 
ah, 1998; Jilka et ah, 1998; Skerry & Taylor, 2001).
Postmenopausal osteoporosis is one of the prevalent disorders of bone remodelling. It is 
characterised by low bone mass and microarchitectural deterioration o f the skeleton, 
leading to an increased risk of fracture after minimal trauma. It stands as the most common 
form o f osteoporosis and the most common o f all systemic osteopathies. The fractures 
result from the accelerated loss of bone that occurs in women after natural or surgically- 
induced menopause. The oestrogen loss that occurs during menopause causes an increase 
in interleukin-1 (IL-1), IL-6 and tumour necrosis factor-a (TNF-a) production, which 
mediates an increase in osteoblast and osteoclast numbers and consequently an increased 
frequency of their activation (Jilka, 1998). As well as changes that occur in the number of
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bone cells, deeper-than-normal erosion of cavities also takes place and this increased 
remodelling alone causes a loss of bone mineral density because bone resorption is faster 
than bone formation and new BMUs are less dense than older ones. The accelerated loss of 
bone that occurs after oestrogen deficiency is not only from an increase in osteoclast 
number but also from an increase in osteoblast and osteocyte apoptosis. However, in 
osteopetrosis, increases, rather than decreases in bone mass, occur.
In bone, alkaline phosphatase (ALP) is a ubiquitous membrane-bound tetrameric enzyme 
and is commonly used as a marker of osteogenic development in vitro and in the clinic 
(Henthorn, 1996). Robison (1923) was the first to postulate that alkaline phosphatase plays 
a role in bone development, concluding that there is an “enzyme present in the ossifying 
cartilage of young rats and rabbits which rapidly hydrolyzes hexosemonophosphoric acid 
in yielding free phosphoric acid” . This enzyme has come to be known now as alkaline 
phosphatase, which has been hypothesized to be involved in the mineralization process, 
even though its precise physiological significance has yet to be elucidated. Its expression is 
partly transcriptionally regulated but there is little evidence for translational and post- 
translational control (Henthorn, 1996). This shows ALP as involved in mineralization by 
MC3T3-E1 cells. There is now evidence for a role of p38 mitogen-activated protein kinase 
(p38 MAPK) in the expression of ALP during osteoblastic cell differentiation (Suzuki et 
al., 2002).
1,3.2. The osteoblasts 
Osteoblasts are the skeletal cells that synthesize and regulate the deposition and 
mineralization o f the extracellular matrix (Aubin & Liu, 1996). They are thought to arise 
from mesenchymal stem cell precursors (Franceschi & Iyer, 1992) and are located on the 
surface of bone. The balance between cell populations in an organism is controlled by the 
rates o f proliferation, differentiation and programmed cell death or apoptosis (Quarles et 
ah, 1992). Bone formation during bone development and remodelling necessitates stringent 
control o f osteoblast proliferation and differentiation (Stein et ah, 1996). By responding to 
systemic hormonal influences and secreting a variety of autocrine and paracrine signalling 
factors, osteoblasts are important for coupling the activities of osteoclasts and osteoblasts 
as well as ensuring the maintenance of bone mass (Genever & Skerry, 2001). During the 
initial period of differentiation in vivo, osteoblasts are responsive to physiological 
requirements for expression o f genes that support competency for proliferation, cell cycle 
progression and extracellular matrix biosynthesis as well as those that suppress expression
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of post-proliferative bone phenotypic genes (Stein et al., 1996). In the mature phenotype is 
found the ability o f the cells to synthesize collagen type 1 (COLL-1) and a wide variety of 
noncollagenous proteins such as osteocalcin, bone sialoprotein (BSP), osteopontin, 
proteoglycans and hormone as well as growth factor receptors. However, different 
osteoblasts may express just a subset o f molecules from the potential osteoblast repertoire 
(Aubin & Liu, 1996). Collagen constitutes approximately 90% o f bone matrix proteins 
(Harada et al., 1991). Expression o f the bone/liver/kidney (tissue non-specific) isoform of 
ALP is positively correlated with bone formation. As the specific activity o f the enzyme in 
a population of bone cells increases, there is a corresponding shift to a more differentiated 
state (Aubin & Liu, 1996). An essential transcription factor for osteoblast differentiation 
and bone formation is Core binding factor alpha 1 (Cbfal) (Harada et al., 1999) and the 
suppression o f osteoblast function by the cAMP pathway occurs through proteolytic 
degradation of Cbafl involving the ubiquitin/proteasome-dependent mechanism (Tintut et 
al., 1999).
1.4. Reactive oxygen species (ROS)
One of the major sources of reactive oxygen species is the overactivation of glutamate 
receptors. In fact, these ROS are now widely believed to mediate glutamate-induced 
neurotoxicity in a variety of conditions, leading to neuronal death. This section therefore 
endeavours to introduce the nature and effects o f the ROS, their sources, the natural 
antioxidant defence systems in the body, and ROS production by glutamate receptor 
activation and kynurenines.
1.4.1. Chemical nature (reactivity) and sources in biological systems 
Intracellular free radicals (free low molecular weight molecules with an unpaired electron) 
are often ROS and vice versa and the two terms are usually seen as equivalents (Nordberg 
& Arnér, 2001), although some ROS such as hydrogen peroxide (H 2 O2 ) are, strictly 
speaking, not free radicals. According to Olanow (1993), free radicals are partially reduced 
and contain an orbital with an unpaired electron. Therefore, in order to gain stability, as 
they are chemically reactive, the radicals “steal” electrons (hence are called electron 
lovers) or hydrogen atoms from their neighbours, turning these molecules also to radicals 
(Phillis, 1994) and thereby instigating a continuous chain of reactions. Free radicals or 
ROS are involved in several normal (Rice-Evans, 1994) or aberrant (Coyle & Puttfarcken,
1993) biological (metabolic) processes in vivo. It is estimated that 2-4% of the oxygen
27
consumed during oxidative phosphorylation in the mitochondria is converted to ROS.
Apart from the mitochondria, NADPH-oxidase 1 (Nox 1) also generates a significant 
amount o f ROS in the cell (Desouki et ah, 2005). NADPPI oxidase is a multi-component, 
membrane-associated enzyme that catalyzes the one-electron reduction of oxygen to 
superoxide using NADH or NADPH as the electron donor. ROS include a number of 
chemically reactive molecules that are obtained from oxygen (Fridovich, 1999; Betteridge, 
2000; Halliwell, 1996; 1999). Some of them are very reactive, e.g., the hydroxyl radical, 
while some are less so, e.g., the superoxide anion and H 2 O2 , both of which are established 
products of the respiratory burst when the plasma membrane NADPH oxidase of 
neutrophils and macrophages is activated (Burdon, 1995).
Reactive oxygen species (ROS) are produced and degraded by all aerobic organisms, and 
this leads to either physiological concentrations required for normal cell function, or 
excessive quantities, a state referred to as oxidative stress (Nordberg & Arnér, 2001). 
Because of their high reactivity, ROS are prone to cause damage and are thereby 
potentially toxic, mutagenic, or carcinogenic (Nordberg & Arnér, 2001), their intracellular 
production threatening the integrity o f various biomolecules including proteins (Stadtman 
& Levine, 2000), lipids, as well as nucleic acids such as DNA (Marnett, 2000; Gilgun- 
Sherki et al., 2001), as these molecules are oxidized by them (Gilgun-Sherki et al., 2001). 
The initiated chain reactions generate numerous toxic reactants that rigidity membranes by 
cross-linking (Coyle & Puttfarcken, 1993). The oxygen radicals can occur as alkyl or 
peroxyl radicals in lipids (Sies, 1997). In certain disease states such as ischaemia, radicals 
can be produced at elevated rates. Other pathways leading to free radical production 
include nitric oxide synthesis and arachidonic acid metabolism. In the process of 
generating energy during aerobic metabolism, cells reduce oxygen to water and there is 
transfer of electrons. The result o f the leakage o f high-energy electrons is the formation of 
reactive oxygen species (ROS). Several enzymes in the brain including monoamine 
oxidase (MAO), tyrosine hydroxylase and L-amino oxidase generate H 2 O2 as a normal by­
product o f their activity while auto-oxidation of endogenous substances such as ascorbic 
acid and catecholamines also yields H 2 O2 . Phospholipase A 2 (PLA 2 ), when activated in a 
Ca^^-dependent process, can generate arachidonic acid (AA) from membrane 
phospholipids and AA could in turn yield superoxide anion when subsequently 
metabolised tlirough the cyclooxygenase or lipoxygenase pathway that leads to the 
production of eicosanoids. Similarly, calcium-dependent activation of nitric oxide synthase 
(NOS) can produce the gaseous free radical nitric oxide (NO), which rapidly reacts with
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the superoxide anion producing peroxynitrite (ONOO"), although it can also be converted 
to other reactive nitrogen species (RNS) such as nitrosonium cation (NO^) or nitroxyl 
anion (NO"), depending on the micro environment (Stamler et ah, 1992). Peroxynitrite has 
the activity of hydroxyl radical and nitrogen dioxide radical, although it does not readily 
decompose into these entities (Dawson & Dawson, 2004). It also has the ability to directly 
nitrate and hydroxyl ate aromatic rings on amino acid residues and as a potent oxidant 
reacts readily with sulfhydryls and zinc-thiolate (Ischiropoulos & Beckman, 2003; Dawson 
& Dawson, 2004). Wlien accumulated hypoxanthine and xanthine are converted by 
xanthine oxidase to uric acid, superoxide anion is produced. This xanthine oxidase can 
derive from xanthine dehydrogenase through a calcium-dependent conversion (involving 
calcium-activated peptidases, such as calpain I) under conditions o f energy failure and 
elevated intracellular calcium levels (Coyle & Puttfarcken, 1993).
1.4.2. ROS-induced cell proliferation
Reactive oxygen species signal cascades are involved in cell growth, cell death, 
mitogenesis, angiogenesis and carcinogenesis (Desouki et ah, 2005). Growth responses 
have been seen to be elicited by H 2 O2  in mouse osteoblastic cells (MC3T3) (Nose et ah, 
1991), even though its cytotoxic effects are well known and have been studied by a number 
of groups (Burdon, 1994). Exogenously added superoxide and H 2 O2  as active oxygen 
species stimulate the expression of early growth-regulated genes such as c-fos and c f un  
and such observations have led to suggestions that superoxide and H 2 O2 might fiinction as 
mitogenic stimuli through biochemical processes common to natural growth factors 
(Burdon, 1994). The observation that superoxide (or its dismutation product, hydrogen 
peroxide) are released by cells, either constitutively in the case o f tumour cells, or 
following cytokine stimulation, has led to the speculation that they might possibly serve as 
a sort o f “autocrine” growth stimulation system or a means of “intercellular 
communication” (Burdon, 1995). Therefore, in mammalian cells, low concentrations of 
H 2 O2  are known to stimulate growth while high concentrations are damaging, leading to 
cell death (Burdon, 1994; 1995).
1.4.3. Induction o f oxidative stress
Oxidative stress is toxic free radical damage arising from an imbalance between radical 
generating and radical scavenging systems in the body, in favour o f the former, which can 
occur when the amount o f free radicals is increased or when the antioxidant enzymes levels
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are decreased (Harris, 1992; Sies, 1984; Sies & de Groot, 1992; Stogner & Payne, 1992).
This is, o f course, an important pathway leading to neuronal degeneration and is implicated 
in many neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, 
and Huntington’s disease. The brain is at risk from oxidative damage due to high oxygen 
consumption (20% of the total body basal 0% consumption), critically high levels o f both |
iron and ascorbate, relatively low levels of antioxidant protective agents and tendency to 
accumulate metals (Gaeta & Hider, 2005). Neurodegeneration increases with aging, 
particularly of the CNS, and this is related to damage inflicted by free radicals, as there are 
regions of increased iron (which catalyzes free radical formation) within the brain and 
neural tissue which are rich in polyunsaturated fatty acids and are therefore susceptible to 
attack by free radicals (Reiter, 1995). Also, decrease in defence mechanisms with age
causes increased oxidative damage and free radical generation. It has been proposed that 
oxidative stress is involved in the aging process both by inducing damage to mitochondrial 
DNA and by other mechanisms (Cadenas & Davies, 2000; Finkel & Holbrook, 2000).
Oxidative events implicated in toxic oxidative stress also include alterations in 
mitochondrial lipids (e.g., cardiolipin) and mitochondrial proteins (e.g., aconitase and 
uncoupling protein 2) (Fariss et al., 2005). It is known that a major consequence of 
oxidative stress is lipid peroxidation, which results from an interaction of ROS with 
polyunsaturated lipids in cell membranes (Callaway et al., 1998). Subsequently, changes 
occur in structure, function and permeability of the membrane, leading ultimately to cell y
death. Lipid peroxidation is, therefore, an important cause o f neuronal damage in 
neurodegenerative diseases. The accumulation o f lipid peroxidation products like 
malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) has been demonstrated in 
affected regions in brains o f Alzheimer’s disease patients (Neely et ah, 1999).
Oxidative damage is caused by ROS including superoxide anion radical, hydrogen 
peroxide, and the hydroxyl radical, which is the most toxic and reactive. The one, two and 
three electron reductions o f O2 generate, respectively, the O2 ' , H 2 O2  and OH (Reiter et ah,
2002). The superoxide anion (O2 ' ), obtained from molecular oxygen by the univalent 
reduction (addition o f an electron) o f triplet-state oxygen (^0 2 ) (Droge, 2002), is not highly 
reactive, even though it is a free radical. This is because it lacks the ability to penetrate 
lipid membranes and is therefore enclosed in the compartment where it is produced 
(Nordberg & Arnér, 2001). However, it can combine with nitric oxide to produce the 
highly toxic radical, peroxynitrite (Droge, 2002). On the other hand, H 2 O 2 is not a free 
radical, but because it is stable (with a long half-life), produced by almost all tissue types
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where its concentrations can rise, and has the ability to penetrate biological membranes by 
diffusing within and across cells, it is highly important (Reiter et ah, 2002). Hydrogen 
peroxide is a mediator o f damage in certain pathological conditions and has been shown to 
induce lipid peroxidation in rat brain homogenates (Garcia et ah, 2000). Increased 
production of H 2 O2 in the CNS has been implicated in the pathogenesis of several 
neurodegenerative diseases, including PD and AD, and in ischaemic reperfusion and stroke 
(Mazzio & Soliman, 2003). In Parkinson’s disease, H 2 O2 generated from presynaptic Lewy 
body a-synuclein may be associated with neurodegeneration o f nigral cell bodies in the 
substantia nigra and destruction to the nigrostriatal tract (Turnbull et ah, 2001). In 
Alzheimer’s disease, p-amyloid plaque builds up in the brain and causes intracellular 
accumulation o f hydrogen peroxide (Belli et ah, 1995). The use o f H2 O2 as an inducer of 
damage is, therefore, a potentially clinically important model o f oxidative stress. 
Nevertheless, a number o f reports have indicated that the modulatory and pathological 
consequences of H 2 O 2  are often mediated by the hydroxyl radical and not by H2 O2  per se 
(Halliwell, 1992; Avshalumov et ah, 2000).
The hydroxyl radical is possibly capable of doing more damage to biological systems than 
any other ROS, owing to its strong reactivity with biomolecules (Nordberg & Arnér,
2001). It has been theorized that in excess o f 50% of the free radical-mediated molecular 
destmction o f cells is a direct consequence o f the hydroxyl radical, although its absolute 
significance to cellular malfunction, diseases and aging has been difficult to define 
unequivocally (Reiter et ah, 2002). It is not generated directly by any laiown enzymatic 
reaction, but can be produced by H 2 O2 through slow decomposition, a process profoundly 
accelerated in the presence o f Fe^^ by the Fenton reaction (Coyle & Puttfarcken, 1993). It 
is agi'eed that iron is known to be critically vital to biological reactions in living cells and 
in the brain is required for sustenance o f brain’s high respiratory activity, myelinogenesis, 
and for the production of many neurotransmitters including dopamine, noradrenaline, and 
serotonin and for generation o f GABAergic activity (Moos & Morgan, 2004). However, 
the divalent state o f iron makes it very reactive and therefore extremely toxic if  its 
intracellular concentrations are not tightly regulated (Lee et al., 2006). Iron overload in the 
early stages of life has been reported to induce cognitive impairment, possibly by inducing 
oxidative damage in the brain (de Lima et ah, 2005). This is why proteins such as ferritin 
and transferrin, which sequester transition metal ions such as iron, have neuroprotective 
properties. While iron has been clearly identified with the pathology o f Parkinson’s 
disease, iron, copper and zinc have all been associated with the progression of Alzheimer’s
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endothelial toxicity (Degnim et ah, 1998). On the other hand, it readily reacts with the 
superoxide radical, forming the extremely toxic peroxynitrite. The rate of this reaction is 
about tliree times faster than the rate at which superoxide dismutase (SOD) catalyzes the 
dismutation o f superoxide radical to hydrogen peroxide.
disease (Gaeta & Hider, 2005). Unlike superoxide anion and H 2 O2  whose cellular levels are 
regulated by antioxidant enzymes such as superoxide dismutase (SOD), glutathione 
peroxidase (GPx) and catalase (CAT), there are no analogous enzymes for regulating the 
highly reactive OH. Its management therefore depends on the endogenous antioxidants 
ascorbate and reduced gluthathione (GSH) (Cohen, 1994; Rice, 2000).
Another example o f reactive species is nitric oxide. Nitric oxide (NO), formerly identified 
as Endothelial-Derived Relaxing Factor (EDRF), is rather an odd member o f the free 
radical family with a multiplicity of roles in the CNS and the periphery, including 
neurotransmitter functions and mediation o f both proliferation and death, depending on 
tissue types and hence has been referred to as a Janus molecule. Studies o f NO now mainly 
span the cardiovascular, nervous and immune systems (Moncada & Fliggs, 2006). It is 
produced through the metabolic action of nitric oxide synthase (NOS) on L-arginine 
(oxidation of its guanidine group) with a stoichiometric formation of citmlline, though 
direct reduction of nitrite to NO has also been reported in the ischaemic heart (Zweier et 
al., 1995; Zhang & Snyder, 1995). NO is known to be the mediator o f tumoricidal and 
bactericidal actions of macrophages and is a likely transmitter o f nonadrenergic, 
noncholinergic neurones (Zhang & Snyder, 1995). There are three isoforms of NOS: the 
calciuin/calmodulin-dependent neuronal NOS (iiNOS or NOS 1) and endothelial NOS 
(eNOS or N 0S3), and the calcium-independent, inducible NOS (iNOS or N 0S2). nNOS 
and eNOS are the constitutive nitric oxide synthases. The inducible form (iNOS) is now 
known to bind, S-nitrosylate and activate cyclooxygenase-2 (Kim et al., 2005).
Physiologically, NO activates soluble guanylate cyclase (sGC), leading to increase in 
cGMP, although it is now also Imown to inhibit mitochondrial cytoclu'ome c oxidase.
According to Nordberg & Arnér (2001), NO is similar to superoxide in many aspects in 
that it does not readily react with most biomolecules, despite its having an unpaired 
electron, but easily reacts with other free radicals (e.g., peroxyl and alkyl radicals), 
generating mainly less reactive molecules and thus functioning somewhat as a free radical 
scavenger. In fact, it has been shown that nitric oxide inhibits peroxide-mediated
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1.4.4. Generation o f ROS by glutamate receptor activation
Glutamate is the major effector of oxidative stress in the brain where excessive stimulation 
o f glutamate receptors results in excitotoxicity (Coyle & Puttfarcken, 1993) and has 
already been shown to induce oxidative stress in vitro (Behl et ah, 1995). Glutamate- 
induced oxidative stress alone or combined with other glutamate-independent sources of 
ROS (such as the pathological event of reperfusion injury) (Siesjo, 1992) has been 
implicated in the aetiology o f neurodegenerative diseases such as PD, ALS, and HD 
(Coyle & Puttfarcken, 1993). It is now Imown that overstimulation o f glutamate receptors, 
especially the NMDA receptors, leads to significant elevation of intracellular calcium 
concentration. However, though less significant, additional calcium influx is also possible 
through the voltage-dependent calcium channels (VDCC), the sodium-calcium exchanger, 
and non-specific membrane leakage (Choi, 1988). Release of calcium from intracellular 
calcium stores could also contribute to the net pool of free cytosolic calcium (Nicoletti et 
al., 1986). This results in the activation of calcium-dependent enzymes (lipases, 
phosphatases, etc.), including neuronal nitric oxide synthase (nNOS), which produces 
nitric oxide (NO) from the substrate L-arginine. However, this elevated intracellular 
calcium level also leads to the generation o f reactive oxygen species such as superoxide 
anion and H2 O2 , and all o f these ROS are now believed to mediate glutamate neurotoxicity. 
Some authors have argued that distinct, membrane receptor-specific, neurotoxic signalling 
pathways transduce calcium-dependent excitotoxicity and the precise relationship, at the 
molecular level, between Ca^^ loading and neurotoxicity has yet to be defined (Sattler & 
Tymianski, 2000). Free intracellular calcium ([Ca^'^ji) is maintained around lOOnM 
compared to approximately IniM  found in the extracellular space ([Ca^^je) (Pringle, 2004). 
An increased production of superoxide has been shown to mediate glutamate-induced 
neuronal death (Luetjens et al, 2000). Nitric oxide is able to compete with superoxide 
dismutase (SOD) for the superoxide radical, resulting in the formation o f the very toxic 
product, peroxynitrite. A study by McManus et al. (2004) showed that hypothermia, which 
has long been known to be an effective neuroprotective strategy against a variety of brain 
injuries, protected against ischaemic insults in cultured hippocampal slices by reducing 
free radical production, further strengthening the view that excessive glutamate release, as 
occurs in ischaemia, could induce substantial oxidative stress mediating neuronal damage. 
The mitochondria appear to be the major component involved in glutamate-induced 
formation of ROS, as this process is inhibited by 85-90% in the presence of mitochondrial 
inhibitors such as rotenone and oligomycin (Brocard et al., 2001).
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In this context, quinolinic acid (QA), a potent endogenous excitant and selective agonist at 
the NMDA receptors (Stone & Perkins, 1981), and whose potential as a neurotoxin was 
first demonstrated by Lapin (1978), has similarly been shown to induce lipid peroxidation 
in vitro by a number of authors, e.g., Rios & Santamaria (1991). It seems that quinolinic 
acid may act by mechanisms additional to activation o f NMDA receptors, perhaps 
involving lipid peroxidation and ROS formation (Stone et al., 2000). In fact, some reports 
have argued that quinolinate does not have a direct neurotoxic effect, but modulates lipid 
peroxidation via its interaction with iron (Stipek et ah, 1997). All cell types, including the 
NADPH diaphorase-positive neurones, appear to be sensitive to the toxic effect of 
quinolinic acid (QA) depending on the amount injected (Boegman, et al., 1987), although 
some authors insist that this neuronal population is spared QA toxicity (Beal et al., 1991). ||
The NADPH diaphorase has been identified as nitric oxide synthase (NOS) (Dawson et al.,
1992; Lipton et al., 1993; Behrens et al., 1996). QA is increasingly implicated in 
neurodegenerative disorders, especially the AIDS-dementia complex and Huntington’s 
disease (Stone, 2001).
There is also now a well-characterized form o f glutamate-induced neurotoxicity that results 
from oxidative stress, mediated, not by glutamate-gated ion channel, but by a cystine 
transporter to which glutamate binds (Bannai & Kitaniura, 1980). The cystine deprivation 
that occurs through glutamate binding leads to reduced glutathione levels and the 
intracellular accumulation of oxidants (Coyle & Puttfarcken, 1993).
1.4.5. Kynurenines and ROS production
Even though it has been shown that tryptophan is also metabolised in the gut by bacterial 
tryptophanases resulting in the formation of indole, which in turn yields a strongly sedative 
compound oxindole (Vederas et ah, 1978; Kawata et al., 1991), the kynurenine pathway 
metabolizes over 90% of dietary tryptophan that is not used in protein synthesis to generate 
the essential co-factors nicotinamide adenine dinucleotide (NAD) and nicotinamide 
adenine dinucleotide phosphate (NADP). This metabolic pathway was well investigated in 
the 1950s and 1960s, with a view to understanding its contribution to the synthesis of NAD 
and NADP, which are two ubiquitous co-enzymes involved in basic cellular processes 7
(Wolf, 1974). Products of the pathway include quinolinic acid, an endogenous agonist 
ligand which remains the only known endogenous compound able to activate selectively J;
receptors for NMDA (Stone & Perkins, 1981; Stone, 2001), and kynurenic acid, a broad- 
spectrum glutamate receptor antagonist that acts at the strychnine-resistant, glycine- f
J
%sensitive site on the NMDA receptor (Perkins & Stone, 1982). Three different enzymatic 
activities, at least, may metabolize kynurenine in mammalian tissues, involving kynurenine 
hydroxylase (forming 3-hydroxykynurenine), kynurenine aminotransferase (forming 
kynurenic acid), and kynureninase (forming anthranilic acid). An excellent review of the 
roles of kynurenines in the CNS and their therapeutic importance has been published (see 
Stone, 2001).
Quinolinic acid can be excitotoxic to hippocampal neurones at concentrations not injurious 
to neurones by itself in the presence o f donors of nitrosative and oxidative stress (Behan & 
Stone, 2002), However, a number o f kynurenines are now known to generate substantial 
levels o f ROS. They include 3-hydroxyantliranilic acid (3-HAA) and 3-hydroxykynurenine 
(3-HK). In fact, 3-HK may be the most toxic of all kynurenines or tryptophan metabolites 
(Okuda et al., 1998). It is toxic to neurones mainly as a result o f conversion to 
quinonimines and ROS that initiate apoptosis (Eastman & Guilaite, 1990), but its toxicity 
can also result from its metabolism to 3-HAA, which can undergo auto-oxidation to yield 
superoxide anions (Stone & Darlington, 2002). Quinolinic acid and 3-HK are known to 
damage cells by different mechanisms (Chiarugi et al., 2001). These obseiwations have 
frirther strengthened the argument that ROS are major contributors to the process of 
neurodegeneration, since these kynurenines are involved in the pathology of 
neurodegenerative diseases.
I1,4.6. Antioxidant defence mechanisms
Defence mechanisms to prevent and keep the damage caused by free radicals under control 
are present in the body under normal circumstances (Reiter, 1995). However, these 
defences are complex and tissues are equipped with different patterns of anti oxidant 
defence based on cell type and function, as well as on physiological states (Sies & Stahl,
1995). The cellular antioxidant defence systems are classified into two groups, enzymatic 
and non-enzymatic, of which there are indirect and direct acting agents (Gilgun-Sherki et 
al., 2001). The antioxidant enzyme systems include superoxide dismutases (SOD), 
superoxide reductases (SOR), catalases, peroxiredoxins (Prx), glutathione peroxidases 
(GPx) and other glutathione-related enzymes. The low molecular weight antioxidant 
compounds include vitamin C (a hydrophilic antioxidant) and vitamin E or alpha- 
tocopherol (a chain-breaking hydrophobic antioxidant), different selenium compounds, 
lipoic acid, and ubiquinones, all o f which interact with the mammalian thioredoxin system, 
a ubiquitous oxidoreductase system with antioxidant and redox regulatory roles (Coyle &
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Puttfarcken, 1993; Nordberg & Arnér, 2001). However, the superoxide dismutases, 
catalases and glutathione peroxidases are the three main classes o f protective enzymes. 
There are also free radical-induced cytoprotective genes, such as the antioxidant-like stress 
protein haem oxygenase-1 (HO-1), which catabolises the pro-oxidant haem to generate 
biliverdin, iron, and the vasodilator carbon monoxide (CO). Elevated HO-1 activity has 
been shown to be protective against several pathological conditions (Maines, 1997). 
Biliverdin is subsequently converted by biliverdin reductase to bilirubin, an antioxidant 
that can scavenge lipid peroxyl radicals (Baranano et ah, 2002), while CO has both anti- 
apoptotic and anti-inflammatory properties (Otterbein et al., 2000).
Superoxide dismutase (SOD) catalyses the formation of hydrogen peroxide from 
superoxide radical. There are three forms o f SOD expressed in the eukaryotic cells, 
encoded by tluee separate genes: the copper-zinc SOD (CuZnSOD) or SOD 1 found in the 
cytosol, the manganese-containing SOD (MnSOD) or SOD 2 localized to the 
mitochondrial matrix, and the extracellular form o f CuZnSOD, which is expressed at low 
levels in plasma and extracellular fluids where it partially protects nitric oxide by reducing 
the concentration o f superoxide radical (Fridovich, 1989; Nakazono et ah, 1991). However, 
when the activity o f SOD is clmonically elevated above normal, as occurs in Down 
syndrome subjects, it can be pro-oxidative, which is why the disease is believed to be, at 
least in part, a consequence of excessive free radical generation (Busciglio & Yankner, 
1995; Reiter et ah, 2002). Catalase (a haemoprotein with four haem groups) and 
glutathione peroxidase (GPx) (containing selenium as a prosthetic group) catalyse the 
breakdown o f hydrogen peroxide to water and oxygen, with glutathione peroxidase being 
more important in neural tissue (Reiter, 1995), perhaps partly because, relative to GPx 
which is found in high concentrations in the brain, there is little catalase in both grey and 
white matter (Coyle & Puttfarcken, 1993). In addition, aside from its ability to eliminate 
FI2 O2 , GPx is also involved in the detoxification of lipid peroxyl radicals (Coyle & 
Puttfarcken, 1993) or lipid hydroperoxides (Podratz & Windebank, 2005). These lipid 
hydroperoxides can decompose to alkoxy radicals and aldehydes in the presence of Fe^^ 
(Coyle & Puttfarcken, 1993). Gluthathione peroxidase makes use o f reduced gluthathione
(GSH), a tripeptide synthesized intracellularly (Coyle & Puttfarcken, 1993), as a substrate 
that donates hydrogen, thus becoming converted to oxidized gluthathione or gluthathione 
disulphide (GSSG). Glutathione disulphide (GSSG) can be converted back to gluthathione 
by gluthathione reductase in an NADPFI-consuming process (Droge, 2002). Another 
cytosolic enzyme, quinone reductase, first noted for its protection against carcinogens, also
catalyzes a two-electron reduction of quiiiones to hydroquinones, which are more stable 
and less reactive (Lind et ah, 1982).
Wang et al. (2004) reported that overexpression of antioxidant enzymes protects cultured 
hippocampal and cortical neurones from necrotic insults. 17(3-oestradiol has been found to 
reduce lipid peroxidation induced by quinolinic acid in brain homogenates (Heron & Daya, 
2000). Similarly, Ran et al. (2003) showed that oestradiol attenuates programmed cell 
death after stroke-like injury while vitamin E has been reported to reduce lipid 
peroxidation induced by nitric oxide in rat brain homogenates (Escames et al., 1997).
1.5. Mechanisms of cell death
Agents (such as ROS and glutamate in the CNS) which induce cell death in biological 
tissues bring about demise by either apoptosis or necrosis, which are the two classical 
extreme pathways o f cellular death, each with its distinct features. The classification has 
been primarily based on morphological criteria (Wyllie et al., 1980). However, there is 
growing evidence that a number of death processes may simultaneously activate the two 
pathways, thus resulting in a form of “hybrid” death that is neither entirely apoptotic nor 
entirely necrotic (Cheung et al., 1998; Martin et al., 1998).
i .  5.L Apoptotic mechanisms
Apoptosis, a term first coined in 1972 (Kerr, 1998), is the basis of programmed cell death 
(PCD), a delayed form of cell death from less severe insults that is energy-dependent and 
associated with activation o f a genetic programme (Kam & Perch, 2000). Apoptosis is an 
important mechanism for the selective elimination of mammalian cells distinct from the 
process o f cell death by necrosis (Wyllie et ah, 1994). Recent widespread interest in cell 
death processes has generated controversy over definitions that distinguish apoptosis from 
other forms o f cell death (see Sloviter, 2002). According to Cohen (1997), apoptosis is 
defined as the process o f cell death associated with caspase activation or caspase-mediated 
cell death, a view that presumes that caspases represent its final common mechanistic 
pathway. However, this definition may need to be expanded, as a number of caspase- 
independent apoptotic mechanisms have also been recently reported, mainly involving the 
apoptosis-inducing factor (AIF). It seems there is no consensus yet on the classification of 
the different forms o f programmed cell death. In their review, Krantic et al. (2005) 
highlighted a classification that, though more constraining, is currently considered one of
A
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the most accurate. It is based on nuclear morphology and divides PCD into classical 
apoptosis, apoptosis-like PCD, and necrosis-like PCD, respectively characterized by 
nuclear condensation that is ‘crescent-like,’ partial or peripheral, or absent. Classical 
apoptosis is the best-known phenotypic expression of PCD, resulting in caspase activation. 7
Apoptosis-like PCD is broader and includes caspase-independent mitochondrial pathways.
With regard to necrosis-like PCD, cell death programme is triggered by organelles other 
than mitochondria, such as lysosomes, endoplasmic reticulum (ER) and the nucleus, and 
by proteases other than caspases, such as cathepsins and calpains originating from 7
lysosomes and the ER, respectively. Calpains play a central role in ischaemic neuronal 
death by cleaving a variety of substrates such as cytoskeletal proteins (e.g., spectrins) and
7important regulatory proteins (e.g., cyclin-dependent kinase-5 (Cdk-5)) (Patzke & Tsai, J
2002). It has been recently reported that the cleavage by calpains o f collapsin response %
■7mediator protein-3 (CRMP-3) induced neuronal death after glutamate excitotoxicity and 
ischaemia (Hou et al., 2006), and inhibitors o f calpains such as chlortetracycline and 
demeclocycline have been shown to protect mouse neurones against glutamate toxicity and 
cerebral ischaemia (Jiang et al., 2005). 7
Hallmarks o f apoptosis include shrinkage of the cytoplasm, phosphatidylserine 
translocation, and condensation o f nuclear material into “clumps” (Banasiak, et al., 2000;
|iValencia & Moran, 2004). Subsequently, the nucleus undergoes fragmentation and the 
.endoplasmic reticulum fuses with the plasma membrane forming vesicles and convoluting 
its surface. The final stages o f apoptosis witness eellular fragmentation forming 
membrane-bound apoptotic bodies that contain intact cytoplasmic organelles and nuclear 
fragments (Kerr, 1998).
There are two primary modes o f apoptosis induction. One is through the death receptors in 
the plasma membrane, called the extrinsic pathway and the other, the intrinsic pathway, is 
via mitochondrial dysfunction (Verdaguer et al., 2004). The extrinsic pathway involves 
cell surface death receptors which are members of the nerve growth factor/TNF 
superfamily of receptors and include Fas (CD95/APO-1), tumour necrosis factor (TNF) 
receptor 1 (TNFRl), as well as DR-3, DR-4, and DR-5 (Ashkenazi & Dixit, 1998; 
Krammer, 1999; Kinloch et ah, 1999; Sheikh & Fornance, 2000). They can be activated by 
both cell surface-bound and soluble ligands such as FasL (CD95L), tumour necrosis factor- 
a (TNF-a), lymphotoxin-a (LT-a) and TNF-related apoptosis-inducing ligand (TRAIL) 
(Aslikenazi & Dixit, 1998; Ki'ammer, 1999). These receptors are widely distributed in the 
body and are often found in cells from the immune system and in many somatic tissues
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(Kinloch et al., 1999). Tumour necrosis factor type I receptor (TNFRI) was shown to be 
required for amyloid-p protein-induced neuronal death (Li et ah, 2004). It is also becoming 
increasingly recognised from a molecular perspective that neuronal PCD consistently 
shows a unique property o f pathological re-initiation of the cell cycle (Kiantic et ah, 2005).
1.5.1.1. Caspase-dependent mechanisms
It is well recognized that in apoptosis, the effector molecules are the cysteine-dependent, 
aspartate-directed proteases called caspases (cysteine-aspartate proteases), even though 
BAD (Bcl-XL/Bcl-2-associated death promoter) can initiate apoptosis and a reciprocal 
regulation o f Bcl-2 and Bax expression seems to occur in glutamate-induced excitotoxicity 
(Schelman et ah, 2004). The tumour suppressor p53 is able to upregulate Bax transcription 
and repress Bcl-2 transcription, thereby altering the Bcl-2 : Bax ratio in favour of apoptosis 
via the mitochondrial pathway (Miyashita & Reed, 1995; Bates & Vousden, 1999), while 
pro-apoptotic Bcl-2 family proteins can also induce the release of cytochrome c from 
isolated mitochondria (Fariss et ah, 2005), leading to apoptosis. In contrast, anti-apoptotic 
Bcl-2 members can target the protein kinase Raf-1 to mitochondrial membranes, allowing 
this kinase to phosphorylate BAD or other protein substrates involved in apoptosis 
regulation, with the resultant effect o f promoting resistance to apoptosis (Wang et ah, 
1996).
Caspases were discovered over a decade ago with two aspartate cleavage sites, one of 
which excises the prodomain while the other cleaves the large domain from the small 
domain. They are distinct from other proteases because o f their aspartate specificity, as the 
only other protease that shares this substrate specificity is granzyme B, though its own 
active site is serine (Earnshaw et ah, 1999; Sarin et ah, 1996). It is Icnown that caspases are 
synthesised and exist mostly in the cytoplasm of viable cells as inactive pro-enzymes. 
Activation of caspase-zymogens is an early event in the process of apoptosis. Once 
cytochrome c (a water-soluble, basic, haem-containing protein that binds to the anionic 
phospholipid cardiolipin, located exclusively on the inner mitochondrial membrane of 
eukaryotic cells (Tuominen et ah, 2002)) is released from the mitochondria, it combines 
with Apaf-1 (apoptotic protease-activating factor-1) and the duo recruits and activates pro- 
caspase 9 to form the apoptosome by means o f which cleavage and activation of pro- 
caspase-3 into caspase-3 occur. There are upstream initiator caspases that begin the 
proteolytic cascade in apoptosis (caspases 8 and 9) and downstream effector caspases that 
cleave cellular proteins (caspases 3, 6, and 7) (Stepanichev et ah, 2005). For the extrinsic
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pathway, the binding o f members of the death receptor family (e.g. Fas-TN FR-l-TRA IL- 
R l) and their cognate ligands (Nagata, 1997) results in an oligomerization of receptors and 
a subsequent activation of procaspase-8 and, depending on the cell type, active caspase-8 
either cleaves and activates procaspase-3 directly or it cleaves the proapoptotic Bcl-2 
protein Bid to tBid, which then recruits the mitochondrial apoptotic pathway, resulting in 
the activation of procaspase-3 and other effector caspases (Robertson et ah, 2004). It 
therefore means that the two pathways of apoptosis converge on caspase-3 induction, 
which is possibly why, out of the 14 caspases identified to date (Los et ah, 2001), caspase- 
3 has been recognised as a central player in mediating apoptosis and hence is the most 
widely investigated. Both pathways are associated with activation of caspase-activated 
DNase (CAD) and also with typical internucleosomal DNA fragmentation (Flengartner, 
2000). There is, however, a paucity of studies addressing the role of caspase-3 induction in 
apoptosis in MC3T3-E1 osteoblast-like cells, though staurosporine and hypoxia were 
reported to induce activation o f the protease in these cells (Chae et ah, 2000; 2001).
The X-ray crystal structure o f caspase-3 reveals the formation o f a tetramer having two 
small and two large subunits, which is believed to be the catalytically active form. Despite 
its association with apoptotic cell death, a beneficial role has been suggested for caspase-3- 
mediated mechanisms in neuronal plasticity when Stepanichev et ah (2005) showed that Z- 
DEVD-frak, a caspase-3 inhibitor, blocked long-term potentiation in hippocampal slices, 
thus impairing spatial memory in the water maze. There is also growing evidence that 
caspases and other apoptosis regulators participate not only in cell death, but also in the 
control o f cell cycle (Los et ah, 2001).
1.5.1.2. Caspase-independent mechanisms
It is now clear that a number o f apoptotic events could occur independently o f caspase 
activation. The best example of an effector o f caspase-independent cell death is the 
apoptosis-inducing factor (AIF) (Susin et ah, 1999; Joza et ah, 2001), which is normally 
localized to the inter-membrane mitochondrial space. AIF is a 67-kDa flavoprotein that is 
similar to bacterial oxidoreductases (Susin et ah, 1999) and is evolutionarily conserved. It 
also displays NADP(H) oxidase and monodehydroascorbate reductase activities (Miramar 
et ah, 2001). Upon mitochondrial outer membrane permeabilization (following cytotoxic 
insults), it translocates to the nucleus where it induces peripheral chromatin condensation 
and large (high-molecular-weight (50kb)) DNA fragmentation. This translocation of AIF 
to the nucleus seems to be a general feature of apoptosis in mammalian cells (Cande et ah.
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2002; Dawson & Dawson, 2004). However, because AIF lacks any intrinsic endonuclease 
activity, once in the nucleus, it recruits a number of downstream nucleases including 
cyclophilin A and, at least in the nematode Caenorhabditis elegans, endonuclease G 
(Cande et ah, 2004; Wang et al., 2002). Although its physiological role is not clear, it has 
been suggested to participate in scavenging ROS (Klein et ah, 2002). DNA binding by AIF 
may be required for its apoptogenic function in the nuclear compartment (Dawson & 
Dawson, 2004).
1.5.L3, Membrane Permeability Transition (MPT)
This is the phenomenon whereby there is an opening of an unspecific pore, permeability 
transition pore (FTP), on the mitochondrial inner membrane, allowing the flow of solutes < 
1.5 kDa out of the mitochondrial matrix (Connern & Halestrap, 1994). This leads to the 
collapse o f the mitochondrial membrane potential, Ym- Cytochrome c leaks thi ough the 
multiprotein complex (containing hexokinase, porin, and adenine nucleotide translocator 
(ANT)) (Beutner et ah, 1996) into the cytosol where it combines with Apaf-1 to activate 
procaspase-9 to caspase-9, hence forming the apoptosome, which in turn activates caspase- 
3, the terminal caspase that executes the apoptotic command. Agents that block the FTP 
are therefore able to protect against apoptotic death. Such agents include cyclosporin A 
(CsA), which is also known to block calcineurin (protein phosphatase 2B). The protection 
by CsA against glutamate excitotoxicity has been reported to occur through calcineurin- 
dependent and independent mechanisms (Dawson et ah, 1993; Ruiz et ah, 2000). The 
opening o f the pore may be involved in cellular apoptosis, as AIF is released from the 
mitochondrial intermembrane space (IMS) as a result of the destruction o f the 
mitochondrial outer membrane after excessive mitochondrial matrix swelling (Susin et ah,
1996). FTP formation is enhanced by increased production of ROS (Connern & Halestrap,
1994). The manifestation o f FTP is inhibited by substrates for the mitochondrial ANT, e.g., 
ADP and bonkiegic acid, or CsA (Bernardi, 1992).
1.5.2. Necrotic mechanisms
Generally speaking, necrosis results from severe insults such as anoxia and cell trauma and 
is associated with changes in calcium and sodium ion homeostasis. Major morphological 
hallmarks o f necrotic cell death include the swelling of cells and o f organelles (mainly the 
mitochondria), followed by dismption of the organelles. The plasma membrane ruptures 
permitting the leakage of cellular contents into the extracellular compartment. Random
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DNA degradation also occurs following histone proteolysis. Necrotic cell death is distinct 
from apoptotic cell death in a number of ways. Large groups o f adjacent cells are usually 
affected -as opposed to individual cells in apoptosis- and there is a promotion of an 
inflammatory reaction, unlike in apoptosis where no inflammation is evident. Overall, 
necrosis is usually a pathological event while apoptosis could either be physiological or 
pathological. In necrosis, the early compromise of the integrity of the cell membrane 
allowing leakage o f intracellular contents is the basis for the use of a number of assays that 
rely principally on this phenomenon such as the Lactate Dehydrogenase (LDH) Assay for 
cell death quantification. This perhaps makes the use of these assays for apoptotic cell 
death measurements unreliable, as the integrity o f the cell membrane is not compromised 
until very late in the apoptotic process.
However, the binary classification of cell death as apoptotic or necrotic now appears 
severely challenged, as it has been obseiwed that a number o f cell death processes such as 
excitotoxic death often appear as neither entirely apoptotic nor entirely necrotic in that they 
simultaneously show distinct features o f these two death types. This emerging pattern now 
constitutes what is now referred to as “hybrid cell death,” which has recently become a 
subject o f intense investigation (e.g., see Cheung et ah, 1998; Martin et al., 1998).
1.5.2,]. Role o f  poly (ADP-rihose) polymerase (PARP)
Poly (ADP-rihose) polymerase (PARP) (also laiown as poly (ADP-ribose) synthetase or 
poly (ADP-ribose) transferase), is a family o f abundant chromatin-bound nuclear proteins 
responsible for the repair of DNA strand nicks and breaks (Cosi et ah, 1994). It is therefore 
important for the maintenance of genomic stability and nuclear homeostasis, although its 
exact physiological function is still a matter o f intense debate. Poly (ADP-ribosyl)ation is 
now suggested to also regulate gene expression and gene amplification, cellular 
differentiation and malignant transformation, cellular division, DNA replication, and 
apoptotic cell death (Chiamgi, 2002). The best imown and most important of the 18 
members of the PARP family identified to date is PARP-1, a 116-kDa protein that 
generates more than 95% of the total ADP-ribose polymers in a cell (Dawson & Dawson, 
2004; Hong et ah, 2004). The family also includes PARP-2, PARP-3, vault PARP and 
tankyrases (Smith, 2001). PARP-1 generates nicotinamide and long-chained, branched 
polymers of ADP-ribose (PAR) from oxidized nicotinamide adenine dinucleotide (NAD^), 
attaching these polymers (50-200 residues) to nuclear proteins including histoires, 
topoisomerases I and II, DNA polymerases, DNA ligase-2, high-mobility group proteins,
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transcription factors, and itself (Smulson et al., 2000; Shall & de Murcia, 2000; Dawson & 
Dawson, 2004). In response to DNA damage, PARP-1 activity becomes rapidly increased 
up to 500-fold upon binding to DNA strands and breaks (Dawson & Dawson, 2004). 
Poly(ADP-ribosyl)ation is a unique biochemical pathway, with PAR synthesis and 
degradation Imown to be present in all mitotic and post-mitotic cells with few exceptions in 
mammalian organisms (de Murcia & Shall, 2000). Despite its important reparatory role, 
however, overactivation of PARP-1 leads to cell death by a mechanism that involves 
metabolic derangement resulting from the depletion of NAD"^ and ATP, as the synthesis of 
every molecule o f NAD^ requires four molecules of ATP. Overactivation therefore leads to 
a continuous depletion of NAD^ and ATP, which over time brings about irreversible 
cellular energy failure and the demise o f the cell in a characteristically necrotic manner (Ha 
& Snyder, 1999). Moroni et al. (2001) reported that PARP inhibitors attenuated necrotic, 
but not apoptotic, neuronal death in experimental models o f cerebral ischaemia. Loss of 
energy-dependent cellular fiinction also occurs tluough impairment o f the oxidoreduction 
capacity of NAD^, which is required in the mitochondrial electron transport chain to 
maintain its proton gradient and thereby generate ATP (Koh et al., 2005). This is the 
suicide hypothesis. In fact, it is now recognized that caspase-3 could inactivate PARP in 
order to turn off an energetically expensive DNA repair pathway and therefore maintain 
ATP levels required for the execution o f apoptosis (Fischer et al., 2003). The extent of 
oxidant-induced ATP depletion and cell fate could be modified by PARP inhibition (Aito 
et al., 2004).
Recently, a number o f other mechanisms have been mooted to explain the basis for cellular 
death from PARP-1 overactivation. The most vocal at the moment is the now established 
link between overactivation of PARP-1 and apoptosis, specifically in relation to the 
induction o f AIF, as it is now known that a variety o f environmental and chemical stimuli 
(e.g., the DNA-alkylating agent 7V-methyl-A'-nitro-A-nitrosoguanidine or NMD A) and free 
radical/oxidant attacks (e.g., induced by H 2 O2 ) can trigger the overactivation o f PARP-1 in 
response to DNA damage (Dawson & Dawson, 2004, Hong et al., 2004). This in turn 
stimulates the translocation of AIF from the mitochondrial intermembrane space to the 
nucleus triggering chromatin condensation, massive DNA fragmentation and nuclear 
slirinkage (Yu et al., 2002; Dawson & Dawson, 2004; Flong et al., 2004). Following this, 
phosphatidylserine becomes exposed, cytochrome c is released at a later time point and 
caspase-3 is activated. In the context of excitotoxicity, NMDA-induced release o f AIF is 
PARP-dependent and AIF toxicity is caspase-independent (Dawson & Dawson, 2004),
1.6. Experimental systems and models
This section introduces the cell culture technique, the types of cultures commonly 
employed, and in particular the MC3T3-E1 osteoblast-like cell line and primary cultures o f
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while in general, AIF could mediate both caspase-dependent and caspase-independent cell 
death, although the cross-talk between AIF and the caspase pathway is complex (Koh et 
a l ,  2005). Interestingly, it is also known that cleavage o f PARP-1 could be induced by 
caspases and the presence of cleaved PARP-1 is now a diagnostic tool for the confirmation 
of apoptosis in many cell types (Lazebnik et a l ,  1994; Koh et a l ,  2005). Pharmacological 
inhibition o f PARP-1 or genetic knockout of PARP-1 has been shown to be therapeutically 
efficacious in experimental models o f disorders characterized by DNA damage, such as 
ischemia, ischemia-reperfusion injury, diabetes, shock, inflammation, ROS-induced injury, 
cancer, and excitotoxic neuronal cell death (Virag & Szabo, 2002; Skaper, 2003; see 
Dawson & Dawson, 2004). Excessive PARP-1 activation has also been implicated in 1- 
methyl-4-phenyl-l, 2, 3, 6-tetrahydropyiidine (MPTP)-induced Parkinsonism and 
traumatic spinal cord injury (Skaper, 2003). The microglial migration that occurs in 
secondary neuronal damage is strongly controlled in living brain tissue by the expression 
of the integrin CD l la, which is under the regulation of PARP-1, thus making PARP-1 
downregulation an appealing strategy in protecting neurones against secondary damage 
(Skaper, 2003). The ability of PARP-1 to modulate neuronal cell death may also arise 
through regulation o f transcriptional activation by modulating the function o f NF-kB (Koh 
et a l ,  2005). PARP-1 might also modulate the activity o f p53 and possibly other effector 
proteins (Chiarugi, 2002).
The termination o f PARP-generated PAR effect occurs through the rapid action of another 
enzyiue, poly (ADP-ribose) glycohydrolase (PARG), which is the only Imown intracellular 
enzyme shown to specifically and efficiently catalyze the exo- and endoglycosidic 
hydrolysis o f PAR into free ADP-ribose (Brochu et a l , 1994; Ame et a l , 2000), although 
PAR was initially found to be cleaved by phosphodiesterases to generate adenosine 5' 
monophosphate (AMP) and phosphoribosyladenylate (Miwa et a l ,  1979). This has a 
protective role, since the accumulation o f PAR leads to cell death by apoptosis. The final, 
protein-proximal ADP-ribose residue is proposed to be removed from the acceptor protein 
tlirough a putative ADP-ribosyl protein lyase (Oka et a l ,  1984). In the CNS, PARP and 
PARG are present throughout the brain and spinal cord (Koh et a l ,  2005).
granule neurones from the cerebellum, highlighting why they were chosen for the 
experiments.
1.6.1. Cell culture
The cell culture technique is a valuable tool for life science researchers providing a means 
to maintain and manipulate the cells. Cell culture models permit the study o f a single cell 
group and also allow measurements o f cell responses to conditions that are more tightly 
regulated than the complex environment presented by an entire organism {in vivo), e.g., in 
neurotoxicological studies (Stacey & Viviani, 2001) and thus are a reductionist approach.
It allows the in vitro investigation o f the actual roles o f agents in cellular processes.
Culture conditions are well optimized with respect to media composition, incubation 
conditions and cell density, and manipulations are done aseptically. According to Harry et 
al. (1998), vitro tests have their greatest potential in providing information on basic 
mechanistic processes in order to refine specific experimental questions to be addressed in 
the whole animal”.
Primary cultures and cell lines are the two main culture systems used as in vitro models of 
excitotoxicity. By definition, primary cultures are “cells harvested directly from the 
organism, dissociated into single cells before seeding into the culture vessel, and 
maintained in vitro for periods exceeding 24 hours” (Harry et al., 1998). On the other hand, 
cell lines are “cultures that have been serially transplanted or sub cultured through a 
number of generations and can be propagated for an extended period o f time”. Primary cell 
cultures are the preferred system for use in excitotoxic studies, as it is generally accepted 
that they more closely represent the in vivo situation (Buchhalter & Dichter, 1992). While 
neuronal cell lines are commercially available, they are generally derived from endogenous 
tumours or from chemically or virally transformed cells and so often have an atypical 
nature when established in culture (Lowndes et ah, 1994). Some cell lines such as 
phaeochi'omocytoma cells are usefiil for investigating cell death in peripheral neurones, but 
central neuronal cell lines are expensive and difficult to set up and maintain.
The second culture system comprises the continuous cell lines, which are transformed cells 
from tumourigenic tissues, with a life span o f about 50 divisions. Cell lines initially with 
limited life span could undergo crisis changing their growth potential and thus making 
their lifespan unlimited. Clonal cell lines are homogeneous and large quantities o f cells 
could be easily grown from them. Established cell lines have the ability to undergo an 
unlimited number o f cell divisions, altered cell and colony morphology, lack of
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locomotion, lack of contact inhibition, lack o f density-dependent inhibition of cell 
multiplication, loss of anchorage dependence and high fibrinolytic activity (Diamond & 
Baird, 1977). Once the phenotype o f the cell line is established, it does not change, 
although as the number o f passages increases, the cells may drift in their physiological 
responsiveness (Harry et a l , 1998).
1.6.2. The MC3T3-E1 osteoblast-like cell line
Lack o f reliable in vitro models to study the developmental sequence associated with 
replication of osteoblast precursor and differentiation makes the understanding o f the 
regulation of osteogenesis incomplete. For the investigation o f bone formation in vitro, a 
number of cell lines are available. Transformed malignant osteoblast cell lines have 
uniform phenotype, but also possess unrepressed replicative activity and fail to display the 
normal coupling o f differentiation and growth arrest (Pardee et a l , 1978). Thus, they 
express partially differentiated and replicative functions and so are not ideal as models for 
studying the process o f osteoblast development. On the other hand, studies in primary 
osteoblast cultures support the concept o f sequential expression of the osteoblast 
phenotype, but various cell populations at various developmental stages as well as de­
differentiated cells are present in isolated calvarial and primary cell cultures, making data 
interpretation difficult. Again, subcultivation of primary cultures results in loss of 
osteoblast-specific characteristics (Aronow et a l ,  1990). However, primary cultures of 
osteoblasts are becoming increasingly important, as it has been demonstrated that primary 
rat osteoblasts exhibit much closer electrophysiological characteristics to neuronal cells 
(Gu & Publicover, 2000), although in terms of experimental studies so far, understanding 
of the osteoblast developmental sequence has been greatly facilitated by an immortalized 
cell culture system that allows independent investigations o f osteoprogenitors, osteoblast 
differentiation and mature osteoblast function, which is the MC3T3-E1 cell line. It was 
derived from newborn murine calvariae and is Imown to display osteoblast-like 
characteristics after repeated passages (Quarles et a l ,  1992). It is capable o f type 1 
collagen synthesis, alkaline phosphatase activity and nodular extracellular matrix 
mineralization resembling woven bone (Sudo et a l ,  1983), observations that were 
supported by Quarles et al. (1992) when they revealed that, in culture, these cells show a 
temporal sequence o f development characterized by distinct proliferative and differentiated 
stages. They therefore represent immature osteoblasts that undergo a temporal program 
consistent with osteoblast differentiation in stages analogous to in vivo bone formation.
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Because the expression patterns of hone-related proteins are temporally regulated during 
MC3T3-E1 cell differentiation and their regulations are unique compared to other systems, 
the cell line is also a useful in vitro system for the study o f developmental regulation of 
bone-related proteins in relation to the different stages during osteoblast differentiation 
(Choi et ah, 1996).
1.6.3. The cerebellum and cultures o f cerebellar granule neurones
The cerebellum is the part o f the vertebrate hindbrain that is concerned mainly with 
somatic motor function, muscle tone control as well as the maintenance o f balance (Bear et 
ah, 1996). In a unique way, it represents an important model for cell migi'ation in 
developing mammalian brain, in view o f the well-studied migratory pathway o f the granule 
neurones. Almost all voluntary actions rely on fine control o f motor circuits, and the 
cerebellum is crucial to their optimal adjustment, e.g., with respect to timing (British 
Neuroscience Association, 2003). Recent evidence suggests that the cerebellum plays a 
vital role in learning, memory, fear conditioning, and cognitive processing (Wu et al., 
2005). In the mammalian brain, cerebellar granule cells are the most abundant neuronal 
subtype (Burgoyne & Cambray-Deakin, 1988).
In cell culture experiments, cortical, cerebellar granule and hippocampal cultures are the 
most frequently employed. There is no significant difference between receptor expressions 
for the “classic” neurotransmitters between these brain areas and the choice of which of 
these tissues to use in cell culture could be largely dependent on the investigator’s personal 
preference or experience. However, there are certain cases when one of these regions is 
particularly desirable or more suited to an experimental design or question. For example, 
the cortex and cerebellum are much larger than the hippocampus, affording the ease of 
dissection as well as the plating of many more testable cultures when these brain regions 
are used (Cambray-Deakin, 1995). On the other hand, with regard to electrophysiological 
studies, some laboratories prefer to use hippocampal cultures to see if a certain 
electrophysiological property extends to neurotoxicity, as the hippocampus is often used 
for electrophysiological studies (Buchhalter & Dichter, 1992). It is known that cultured 
cerebellar granule neurones obtained from young rat or mouse represent an in vitro model 
widely used to study factors that control early neuronal differentiation and cell death such 
as excitotoxicity (Vaudry et al., 2003). In studying the mechanisms involved in apoptosis, 
cerebellar granule neurones (CGNs) are frequently more desirable (Kalda and Zharkovsky, 
1999), which is why they are most often used in neuropharmacology for studying pathways
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of drug-induced apoptosis. For example, they have been used to assess the neurotoxic 
effects o f glutamate (Schramm et al., 1990; Slagsvold et al., 2000) (as did this study), 
kainic acid (Smith et al., 2003), l-methyl-4-phenylpyiidinium ion (MPP^), and colchicine 
(Gorman et al., 1999). In addition, it has been reported that cerebellar interneuron-enriched 
primary cultures are known to provide an almost pure population o f a single type of live 
neurones (granule cells) (Levi et al., 1989). This therefore overcomes in a unique way one 
o f the main problems encountered in neurobiological or neurochemical studies, which is 
the great cellular heterogeneity o f the CNS preparations available (Levi et al., 1989). 
Cerebellar granule cells are highly enriched in primary culture (-95%  granule cells) and 
are susceptible to the neurotoxic effect of glutamate (Schramm et al., 1990), although they 
may be less susceptible to neurodegeneration than the neocortex (cerebrum and cerebral 
cortex) (Wu et al., 2005). During normal development of the neiwous system, neurones are 
produced in abundance to ensure the target areas are well inneiwated and neurones that fail 
to reach their target sites are removed by programmed cell death (apoptosis) (Oppenheim, 
1991; Jacobson et al., 1997; Pettmann & Henderson, 1998). This natural arrangement is 
clearly evident in the cerebellum during the postnatal stage, when neurones migrate from 
the external to the internal granule layers. Granule cells that receive excitatory inputs from 
mossy fibres survive and differentiate, while those without this benefit die by apoptosis 
(Williams & Herrup, 1988; Wood et al., 1993). This requirement for excitatory inputs is 
simulated in vitro by culturing CGNs in medium containing a depolarizing concentration 
o f potassium chloride (e.g., 25mM) (Gallo et al., 1987), or maintaining them in the 
presence o f exogenous trophic agents such as NMDA (Gallo et a l ,  1987; Balazs et a l ,  
1988) or BDNF (Lindholm et a l ,  1993). Interestingly, it has been recently reported that 
foetal chicken CGNs, which develop excitotoxicity rapidly in culture (3 div), may be 
grown successfully in a physiological concentration of KCl (5mM) (Jacobs et a l , 2006). 
The granule cell migration is prevented by the degradation o f the NMDA glycine site 
neuromodulator, D-serine, or of the enzyme that produces it, serine racemase (Mustafa et 
a l ,  2004). Cultured CGNs develop similarly to their in vivo counterparts (Gallo et a l , 
1987), thus making interpretation o f data valid for in vivo predictions or extrapolations.
1.7. Rationale for the study
The discovery that glutamate is actively secreted in osteoblasts where most of its receptors 
are also functionally well expressed in a way very similar to their expression patterns in the 
CNS provided the basis for this comparative study. However, emphasis was on the NMDA
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receptors, partly because they are the glutamate receptors that have been most extensively 
studied so far in osteoblasts and also because they are the receptors that predominantly 
mediate cell death in the CNS, thus providing a convenient basis for comparison o f the 
responses of the two tissue types- bone and brain- to experimental agents.
3. To investigate the relative involvements o f apoptotic and necrotic pathways in the 
mechanisms o f glutamate-induced excitotoxic and ROS-induced cell death, in cultures 
o f osteoblasts and central neurones.
4. To explore the potential roles of adenosine A; and A ia receptors in protection against 
the phenomena of glutamate-induced excitotoxic and ROS-induced damage, in cultures 
o f osteoblasts and central neurones.
1.8. Aims
In the light o f the basis for this study as explained, the aims of this work were:
1. To examine the roles o f culture media compositions, adenosine and its Ai and A 2 A 
receptors, and glutamate and its NMDA receptors in the modulation of viability of 
osteoblasts and central neurones.
2. To determine the responses o f osteoblasts and central neurones to reactive oxygen 
species (ROS) generated directly or from a number of other sources, including the 
kynurenine pathway, since ROS are known to be a major mediator o f glutamate- 
induced damage in the CNS.
I:
i
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2. MATERIALS AND METHODS
2.1. Cell culture reagents and materials
The following reagents and materials were used in setting up the MC3T3-E1 osteoblastic and 
cerebellar granule neuronal cultures, arranged based on their sources:
(1) GIBCO (Invitrogen), Paisley, Scotland, UK: Minimum Essential Medium (MEM),
Cat. No. 32360-026; Foetal Calf Serum (FCS) (heat-inactivated), Cat. No. 10500-064; 
L-glutamine (200 mM stock), penicillin-streptomycin (P/S) ( 10,000U/10,000|ug per 
ml); gentamicin (50mg/ral); trypsin (IX), liquid 0.25% (1:250), Cat. No. 25050-014; 
diethylpyi’ocarbonate (DEPC)-treated water; cell culture freezing medium (with 10%
DMSO), phosphate buffered saline (PBS) and Hanks’ Balanced Salt Solution (HBSS).
(2) Sigma, Poole, Dorset, UK: Foetal Calf Serum (FCS) (heat-inactivated), Cat. No.
F9665; L-ascorbic acid (sodium salt), glycerol 2-phosphate (p-glycerol phosphate)
(disodium salt hydrate); bovine serum albumin (BSA), trypsin 1:250 (powder, from 
porcine pancreas); soybean trypsin inhibitor (SBTI), Cat. No. T6414; poly -D- lysine 
(PDL), hydrobromide; DNase 1, cytosine arabinofuranoside (Ara C) and sodium 
bicarbonate (NaHCOg) solution 7.5% (sterile-filtered, endotoxin-tested).
(3) Fisher Scientific UK Ltd., Leicestershire, UK: D(-t-)-glucose.
(4) FSA Laboratory Supplies, Loughborough, England, UK: Magnesium sulphate 
(MgS04).
(5) BDH Laboratory Supplies, Poole, England: Potassium chloride (KCl).
All reagents and materials were stored at the appropriate temperature and humidity, as 
recommended by the respective suppliers. Cell culture materials (dishes, plates, centrifuge
. v ;tubes, Eppendorf tubes, pipette tips, Pasteur pipettes, millipore filters, hand gloves, etc.) 
were obtained from a variety o f sources based on availability in the University Biomedical 
Research (IBLS) Stores. However, most plastic (96-well and 24-well) plates were from 
Corning Incoi*porated (New York, USA). Glassware and other materials were sterilized by 
autoclaving.
' i l l
2.2. Cultures of MC3T3-E1 osteoblastic cells
2.2.1. Stock source and handling
The murine-calvaria derived MC3T3-E1 osteoblast-like cell line (mouse C57BL/6 calvaria, 
ECACC No. 99072810) used in this study was purchased from the European Community of 
Animal Cell Culture (ECACC) in partnership with SIGMA. The cells, obtained in a frozen 
form inside a 1ml plastic cryotube packed in solid carbon dioxide pellets, were of passage two
(2) and their expected viability was 99% (viability was monitored during study and average 
value was 90%). Upon arrival, the ampoule was left for approximately 1 min at room 
temperature and then transferred to a 37°C water bath until frilly thawed (1-2 min). Rapid 
thawing of cells was ensured so as to minimize any damage to the cell membranes. The 
ampoule was removed from the water bath and wiped with a tissue soaked in 70% alcohol 
prior to opening. Its entire content was slowly pipetted into a 25cm^ tissue culture flask 
containing 10ml of MEM (supplemented with 10% FCS and 2mM glutamine), as 
recommended by the supplier. Forty-eight hours later, when the cells were at least 80% 
confluent, they were harvested with 0.25% trypsin, washed by centrifrigation, and resuspended 
in MEM. The suspension was then split into four parts. Each of the first tlmee parts was 
transferred into a 25cm^ flask and incubated at 37°C in a humidified atmosphere of 5%C02 / 
95%02, while the fourth part was frozen down and kept at -80°C for short-term storage, and in 
liquid nitrogen for long-term storage. All these procedures were canied out under strict aseptic 
conditions.
2.2.2. Subculturing o f cells and treatments
In order to obtain subcultures for experiments, the cells were removed from the flask by 
trypsinization when the flask had become confluent (>80%). They were then washed and 
resuspended in fresh medium. Cell density was determined using the haemocytometer and the 
suspension diluted accordingly with medium in order to obtain the desired seeding density of 1
1X 10  ^cells/ml. Cells were then seeded into either the 96-well plates or the 24-well plates. The 
glass bottle containing the cells was constantly but gently swirled at intervals as the seeding 
process continued in order to ensure that the cell density was uniform throughout the seeding 
period.
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Cultures in plates were replenished every 2 to 3 days by aspirating the spent medium and
adding fresh medium (cells in the culture flasks were fed by aspirating half of the spent
.medium and replacing it with half of the fresh medium). The medium in which they were 
maintained was MEM supplemented with 20% (or 10%) FCS and 1% P/S antibiotic 
combination. The final concentrations of the antibiotics were lOOIU/ml for penicillin and 
lOOjug/ml for streptomycin and the medium was stored at 4“C for no longer than 4 days. 
Subculturing was done on gi’owing cultures that were at least 7 days in vitro.
L-ascorbic acid and (3-glycerol phosphate are Imown to accelerate the proliferation and 
differentiation of the MC3T3-E1 cells (Harada et al., 1991; Quarles et al., 1992). It has also 
been reported that these supplements are required for the cells to express a maximal 
glutamatergic phenotype at the time of treatment. Cultures were therefore either continuously 
maintained in the original culture medium (MEM supplemented with 20% FCS and 1% P/S), 
referred to as “non-switch” medium, or switched after 3 days to the same MEM but 
supplemented with 10% FCS, and additionally with 1% of a combination of ascorbate and 13- 
glycerol phosphate (ascorbate and (3-glycerol phosphate added to final concentrations of 
50jug/ml and 5mM, respectively, from a 100-fold stock), referred to as “switch medium”.
The cultures were used at 10 div, except otherwise stated, a stage when they are Imown to 
have sufficiently differentiated to express functional (including glutamate) receptors. Agents 
were diluted (from their filter-sterilized stock solutions) to the desired concentrations in 
culture medium or in MEM only, based on the experiment(s) to be performed.
2.2.3. Freezing down the cells
As it was necessary to keep a stock of cells for future experiments, and as a safeguard against 
any loss due to contamination, some of the MC3T3-E1 cells were frozen down upon arrival 
and then routinely afterwards, according to the following protocol:
1. Wlien cells were at least 80% confluent, they were trypsinized by removing the culture 
medium and adding a volume o f 0.25% trypsin solution (preheated to 37°C) sufficient 
to cover the monolayer o f cells. This was 5ml for a 25cnf tissue culture flask and 10ml 
for a 75cnf tissue culture flask.
2. The flask was returned to the incubator and checked under the microscope every 5 min 
for cell detachment.
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3. When the cells had detached (evidenced by cells floating in the trypsin solution), the 
flask was flooded with medium.
4. The entire content of the flask was transferred into a 15ml centrifuge tube (for a 25cm 
tissue culture flask), removing as many of the detached cells as was practically |  
possible.
5. The cells were washed in culture medium by initially centrifuging gently (3 min at 
500g).
6. The supernatant (medium) was aspirated and the pellet (cells) resuspended in 5ml of 
medium.
7. Step 5 was repeated and the supernatant was aspirated.
8. The cell culture-freezing medium was added to the pellet o f cells.
9. The cells were redispersed by gently and carefully pipetting up and down in the 
freezing medium and dispensed into 1ml aliquots in sterile plastic cryotubes. The 
cryotubes were sealed.
10. The aliquots were put in a styi'ofoam box (or a rack) and cooled at 4°C (fridge) for 30 
min.
11. The styi'ofoam box (or rack) containing the cooled aliquots was then placed in -20°C 
freezer for 30 min. 7
12. The frozen aliquots were transferred to -80“C freezer for short-term storage and later to
liquid nitrogen for long-tenn storage.
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Î2.2.4. Resurrecting the frozen cells
The previously frozen cells in each plastic cryotube were gently but rapidly thawed by heating 
the lower end of the tube in a water bath (37“C). To avoid contamination, complete 
submersion of the tube was avoided. The entire content of the cryotube was then transferred 
into a centrifuge tube. 10ml of medium was added and the cells were washed by centrifuging 
at 500g for 5 min. The medium was aspirated and the cells resuspended in 10ml of medium (or S
5ml of medium when the 25cm^ flask was used). The whole suspension was then transferred 
into a flask. In order to ensure all the cells were transferred into the flask, the centrifuge tube t
was flooded with 10ml of medium and its content again transferred into the flask. This was
repeated so that the cells were finally seeded in 30ml of medium in a 75cm^ flask. Half of the 
medium was replaced after 24 h and then every 2-3 days until subculturing.
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2.2.5. Assay for alkaline phosphatase (ALP) activity
Alkaline phosphatase is a marker of osteogenic differentiation in vitro. As cell lines could 
show phenotypic drift with multiple passages, it was necessary to characterize the MC3T3-E1 
cell line with regard to its development. Cells were maintained for 7, 10 and 17 days, in order 
to assess and compare the levels o f differentiation at these time points for non-switch and 
switch cultures. At the end o f each culture period, ALP activity was assessed. ALP catalyses 
the conversion of the colourless substrate, p-nitrophenylphosphate (4- nitrophenylphosphate) 
to free p-nitrophenol (4-nitrophenol), which is yellow and in alkaline solution has strong 
absorption at a wavelength of 410nm at which the substrate has little or no absorption (Lowry 
et al., 1954). The equation for this reaction is:
ALP
p-nitrophenylphosphate + H2 O —> p-nitrophenol + Pi
The method used was adapted from Lowry et al. (1954) and Boy an et al. (1989) as follows:
1. Medium was aspirated from MC3T3-E1 cells in a 24-well plate. The cells were maintained 
at 4^C by placing and keeping the plate on dry ice.
2. Cells were washed with 0.5ml per well of ice-cold PBS,
3. PBS was aspirated and 0.5ml per well of radioiramunoprecipitation assay (RIPA) buffer 
was added to lyse the cells. Each 10ml of the RIPA buffer contained 60mg (50mM) TRIS 
(hydroxymethyl) aminomethane hydrochloride (TRIS-HCl) salt, 87.6mg (150mM) NaCl, 
lOOgl (1%) Igepal, 50jul (0.5%) Triton, and lOmg (0.1%) SDS. These were obtained from 
suppliers to the University (IBLS) Stores, in most cases Sigma. One tablet o f a protease 
inhibitor (complete mini EDTA-free, ROCHE) was added per 10ml of RIPA buffer a few 
hours before use to prevent proteolytic degradation.
4. The plate sitting on dry ice was transferred to a shaker and left for 30 min.
5. After gentle scratching using a blue pipette tip, the content of each well was aspirated into 
an Eppendorf tube and centrifuged at 13 000 rpm for 5 min. The supernatant was 
collected.
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6. 150pl of each of the seven concentrations of the standard was added in triplicate to blank 
wells in a 96-well plate. The standard consisted of 0.002 - 0.014 pmol /lOOpl /well of p- 
nitrophenol (4-nitiophenol) in aminomethylpropanol buffer (0.5M solution of 2-amino-2- 
methylpropanol, made up in water, pH 10; 8mM p-nitrophenylphosphate, and 2mM 
MgCb). 150jil o f the aminomethylpropanol buffer was used for blanking.
7. 50 pi of the supernatant was used for the detection of ALP activity, added to blank wells in 
triplicate after vortexing.
8. lOOpl of the p-nitrophenylphosphate-containing buffer was then added to sample wells.
9. The plate was left at 37°C for a defined period (usually between 60 and 90 min) in a water 
bath.
10. lOOpl of 0.5M NaOH was added to each well to terminate the reaction.
11. The plate was read at 405nm using the ELISA plate reader (DYNEX Technologies, USA). 
ALP activity was expressed as pmol/min/mg protein: the value from ALP assay (pmol/ml) 
was divided by the time (min) taken to incubate in water bath before reading the plate; this 
new value was then divided by the protein assay value (mg/ml).
2.2.6. Protein assay
This assay was performed using the BIORAD Protein Assay reagent. The stock standard 
consisted of 20mg BSA in 100ml of distilled water, stored in the refrigerator for a maximum 
of one month. This stock standard was diluted 1 in 10 with distilled water just prior to use. For 
the standard curve, BSA concentrations o f 0, 0.25, 0.5, 1.0, 1.5 and 2.0 mg/ml (each 
multiplied by 100, as samples were diluted 1:100) were prepared each in duplicate by making 
up 0, 50, 100, 200, 300 and 400pl, respectively, of the diluted BSA stock standard to 400pl 
with distilled water (i.e., adding 400, 350, 300, 200, 100, and 0 pi of water, respectively). The 
BIORAD reagent (Coomassie Brilliant Blue) was diluted with an equal volume of distilled 
water prior to use. In order to be able to express the results in mg/ml, 4pi of the supernatant 
(for each sample) was taken after vortexing and made up to 400pl with distilled water. 200pl 
o f diluted BIORAD reagent was added to every standard and sample and all tubes were 
vortexed. 200pl of each standard and sample containing diluted BIORAD reagent was pipetted 
into the wells of a 96-well plate in duplicate and the plate read at 595nm.
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2.3. Cultures of cerebellar granule neurones (CGNs)
2.3.1, Stock solutions, preparation buffer, culture medium, well coating and materials
Stock solutions
The following solutions were prepared from their respective original stocks, aliquotted and 
stored at appropriate conditions:
1 mg/ml trypsin inhibitor (SBTI), 5mg/ml trypsin (from trypsin powder), lOOOU/ml DNase I, y 
1.25mg/ml poly-D-lysine, 1ml o f 3.82% w/v MgS0 4 , and 10 mM Ara C.
A day before passaging, a concentrated solution of SBTI and DNase was prepared by adding 
9ml o f preparation buffer to 0.5ml SBTI stock and 0.5ml DNase I stock. Then, a weak solution 
of SBTI and DNase was prepared by adding 3.2ml of this concentrated solution to 16.8ml of 
preparation buffer. Also, a solution of 0.25mg/ml ti-ypsin was prepared from the trypsin stock 
by adding 19ml of preparation buffer to 1ml of the stock.
Preparation buffer
This contained 250mg D(+)-glucose, 300mg Bovine Serum Albumin (BSA), and 1ml of
'I3.82%  w/v MgS0 4 , made up to 100ml with PBS (pH adjusted to 7 .4  with IM NaOH). The 
preparation buffer was then filter-sterilized using the millipore filter (Minisart®, 0.20|Lira).
CGN culture medium
The cultures were maintained in Minimum Essential medium (MEM) supplemented with 10%
FCS (Sigma), 2mM glutamine, 25mM KCl and 50gg/ml gentamicin, i.e., each 100ml of the 
CGN culture medium contained 88.1ml of MEM, 10ml of FCS, 1ml of glutamine (200mM),
0.8ml o f KCl (2.5M) and 0.1ml of gentamicin (50mg/ml). The KCl concentration here took 
into account its basal level in the MEM, which was approximately 5mM. The medium was 
stored at 4°C and used within 3 days of preparation.
Coating o f  wells
Wells were coated at least 4 days before seeding. Because poly-D-lysine (PDL) represents a 
good substrate for neurite outgrowth in primary culture (Buchlialter & Dichter, 1992;
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Paulssoii, 1992), each 96-well plate to be used in neuronal experiments was coated with 
SOpl/well o f 15pg/ml PDL, obtained by diluting a stock solution of PDL (1.25mg/ml) with 
DEPC-treated water. The stock solution was made by adding 4ml of DEPC-treated water to 5 
mg of thawed PDL and stored at -20“C. PDL solution was left in contact with the wells until 
24 h before seeding, when it was aspirated and an equal volume of sterile water (SOpl/well) 
added for 1 h to rinse the wells. The water was then aspirated and the plates left to air-dry.
Flame-polished pipettes
The ends of tliree (3) glass Pasteur pipettes were flame-polished (using the Bunsen burner) to 
give decreasing diameters, with the largest diameter equivalent to that o f a normal Pasteur 
pipette and the smallest to that o f a P200 yellow tip.
2.3.2, Preparation o f CGN cultures
2.3.2.1. Animal selection and surgery
8-day old Sprague-Dawley pups of either sex were obtained from pregnant female rats 
maintained under standard and hygienic conditions (ambient temperature of 21°C ± 2°C, 12-h 
light: 12 h-dark cycle, food and drinking water available ad libitum) in the Central Research 
Facility (CRF) o f Glasgow University. Each rat pup, weigliing approximately lOg at postnatal 
day 8, was anaesthetized by intraperitoneal injection of 0.1ml Euthatal (from Fort Dodge 
Animal Health, Southampton; 200mg pentobarbital sodium Ph Eur is in 100ml of Euthatal). 
Once the loss of writhing reflex was confirmed, the pup was quickly decapitated and the head 
placed in a Petri Dish containing the preparation buffer. With a pair of scissors, an incision 
was carefully made from the base of the slcull tluough to the frontal region, talcing care not to 
injure the underlying brain. The brain was then neatly exposed with the aid of a pair of 
forceps, removed and placed in a 20ml glass bottle containing about 5ml of ice-cold 
preparation buffer. Between five (5) to eight (8) brain samples were typically collected.
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2.3.2.2, Microdissection and establishment o f  CGN cultures 
The following procedures were carried out under aseptic conditions:
Brain samples were gently transferred into a 35mm Petri Dish containing a volume of the 
preparation buffer enough to preserve them during the entire microdissection period. With the 
aid of a sterile scalpel, needles and forceps, and a dissecting microscope, the cerebella were 
excised from the whole brain and the meninges and blood vessels attached to them removed as 
much as possible. All cerebella were then collected in a separate Petri Dish and thoroughly 
chopped with the scalpel.
Chopped cerebella were transferred to 0.25mg/ml trypsin solution and incubated at 37°C for 
20 min, with gentle swirling every 5 min. At the end of the incubation, 20ml of a solution of 
weak SBTI and DNase was added to the cell suspension before it was centrifuged at 1200 rpm 
for 2 min at room temperature. The supernatant was then careflilly aspirated, after which 2ml 
o f ice-cold solution (kept on dry ice) of concentrated SBTI and DNase was added to the pellet. 
The pellet was broken up by carefully pipetting up and down with a PIOOO blue tip. With the 
aid of tliree previously flame-polished glass Pasteur pipettes of decreasing diameters, the cell 
suspension was triturated, starting with the largest pipette. Approximately ten strokes per 
pipette were ensured, avoiding the generation of bubbles as much as possible. The 2ml of 
triturated suspension was made up to 20ml with the preparation buffer, after which it was 
centrifiiged as before. The supernatant was aspirated and 2ml of sterilized CGN media, pre- 
waraied to 37°C, was added. The cell pellet was again broken up as previously with flame- 
polished pipettes and the volume of suspension made up with medium to about 15ml.
The percentage o f dead cells in the suspension was determined with trypan blue. Cell viability 
was never less than 99%. Using the haemocytometer (Improved Neubauer), the cell density of 
the suspension was determined. The period of cell enumeration allowed unwanted debris to 
fall to the bottom of the suspension. A volume of the cell suspension needed to give the 
required volume and a seeding density of 1 x 10*" cells/ml was then taken and made up with 
medium. lOOpl of this suspension was seeded into each well o f the 96-well plates pre-coated 
with poly-D-lysine. The suspension was gently swirled at inteiwals to ensure even distribution 
o f cells all throughout the seeding period. The seeded plates were transferred into the 
incubator where they were maintained at 37'"C in a humidified atmosphere of 5% CO] / 95% 
O].
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2.3.23, Elimination o f  non-neuronal growth |
In order to eliminate non-neuronal growth that was predominantly due to the proliferation of
the glial population, cytosine arabinoside (Ara C) was added to the cultures 20 h after
passaging. The Ara C stock solution (10 mM) was further diluted 100-fbld with water on the
day of treatment and the diluted solution was then added to each well of the CGN cultures to |
give a final concentration of lOpM.
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2.3.2.4. Cell characterization: Immunocytochemical labelling fo r  neuronal tubulin 
The purity o f neuronal cultures used in this study was assessed using immunocytochemistry 
(ICC) to label tubulin present in neuronal cytoskeleton. The procedure was as follows:
Culture medium was aspirated from the 96-well plates containing cerebellar granule cultures |
at 8 div and the cells were washed twice with phosphate-buffered saline (PBS). They were f
then fixed with 4% paraformaldehyde in O.IM phosphate buffer (PB) for 30 min at room 
temperature (RT) inside the fume cupboard (and stored at 4°C, wrapped with tin-foil, if  the 
ICC was to be performed at a later date). They were subjected to three 5-min washes with
O.IM PB and subsequently blocked in 50pl/well of 1.5 % blocking serum (in PBS + 0.3%
Triton X-100) for 1 h on shaking table at RT. The blocking serum was from the species in 
which the secondary antibody had been raised (goat in the present study) (starting from the 
blocldng step, plates were wrapped in tin foil and shielded from light as much as possible).
The cells were then reacted at RT with 50|ul/well of the primary antibody mouse anti-human 
p-III tubulin (monoclonal) (Chemicon® International; Cat. No. CBL 412), diluted 1:50 in PBS 
containing 0.3% Triton X-100. The primary antibody was omitted from the negative control 
wells (only diluent added). The plates were gently agitated for 1 h and incubation with the 
primary antibody continued overnight at 4°C. On the next day, cells were washed at RT in 
tlu'ee 5-min changes of double strength PBS and incubated for 1 h with 50gl/well of the 
secondary antibody (goat anti-mouse, conjugated with rhodamine red; from Jackson, Soham,
UK, Cat. No. 115-295-146), diluted 1:100 in PBS containing 0.3% Triton X-100. They were 
then washed in two 2-min changes of PBS and further in PB for 2 min. The cultures were 
afterwards viewed by fluorescence microcopy on an Olympus DP50 Microscope and images 
were acquired and stored using DP-Soft Software.
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2.3.2.5. Cell treatments and excitotoxicity studies
Neuronal cultures were used for experiments at 8 div except for excitotoxicity studies when 
they were used at 9 div. Cultures were not fed prior to the day of treatment. On the day of 
treatment, agents were diluted to the desired concentrations in culture medium and added to 
cultures after aspirating the spent medium. However, excitotoxicity studies were carried out 
using Hanks’ Balanced Salt Solution (HBSS), adjusted to pH 7.4 with NaHCO], and 
treatments lasted for no longer than 1 h. Except otherwise stated, all cultures were restored 
after treatment to culture medium for at least 18 h before determination of viability. All 
procedures were carried out aseptically.
2.4. Determination of cell viability: alamar bine assay
The alamar blue assay was used for the determination of cell viability, in which alamar blue 
reduction varied directly with cell viability. The dye (alamarBlue^*^; Part No. DALI 100) was 
obtained from Biosource International, Nivelles, Belgium. The advantages of the assay over 
other viability assays have been discussed (see section 5.2). In general, the protocol was as 
follows:
1. The old medium was aspirated and 200pl (100pi for neurones) of fresh medium 
containing 10% v/v alamar blue was added to all test and control wells in 96-well 
plates (for 24-well plates, volume was adjusted accordingly). 200pl (or lOOpl for |  
neurones) o f the medium was used for blanking.
2. The plate was returned to the incubator and allowed to incubate for 4 h (6 h for 
neurones) at 37°C in an atmosphere of 5% CO] / 95% O].
3. The absorbance (A) was measured at 540nm (lower wavelength, LW) and then at 
595nm (higher wavelength, HW) using a spectrophotometric plate reader (DYNEX 
Tecluiologies, USA).
4. The absorbance of medium only (average blank value) was automatically subtracted by 
the plate reader from the absorbance of alamar blue and medium to give the 
absorbance of the oxidized form of alamar blue in medium. This was carried out at the 
two wavelengths. The absorbance o f the oxidized form at the lower wavelength was 
designated A O lw  while the absorbance of the oxidized fonn at the higher wavelength 
was designated A O hw .
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I5. The correction factor, Ro was calculated as follows:
Ro =  A O lw/A O hw
6. Alamar Blue reduction (AR) was then calculated as follows:
AR = ( A l w  -  ( A h w  X Ro))
7. The Alamar Blue reduction was calculated as a percentage of the control as follows: 
AR (% of control) = ( A l w  - ( A h w  x Ro))tw/ ( A l w  -  (A h w  x Ro))cw x 100
where "tw" and "cw" refer to test wells and control wells, respectively. Cell viability 
was expressed as a percentage of the control, except otheiivise stated.
2.5. Estimation of cell death using trypan blue
An estimation of the number o f dead cells (and hence the percentage viability) was carried out 
using the trypan blue dye. An equal volume o f 0.4% trypan blue solution (Sigma) was added 
to a suspension of cells and the mixture was incubated under standard conditions (as 
previously) for 5 min. The mixture was then gently mixed with the aid of a pipette and 
approximately 50pl was taken to fill the two sides of the haemocytometer. Cell counting was 
done under an inverted binocular microscope (xlO objective), using a hand-held tally counter. 
The total number of cells and the number of cells that had taken up the dye were determined 
and the difference between these two values represented the number of cells that had not taken 
up the dye. Cells that did take up the dye (thus appearing blue) were considered non-viable 
while those that did not take up the dye were considered viable. In order to determine 
percentage viability, the number of viable cells was expressed as a percentage of the total 
number of cells.
2.6. Assessment of morphological changes
The morphology o f control cultiues and changes to morphology induced by each experimental 
treatment were monitored on an Olympus DP50 inverted phase-contrast microscope, fitted
with a Digital Camera System, which allowed photomicrographs to be taken and saved. 4
2.7. Results presentation and statistics
The results in this thesis have been presented as mean ± standard error of the mean (SEM) for 
n cultures or experiments. Treatments were done at least in triplicate (except protein assay
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where treatments were done in duplicate). Two sets of means were compared using paired or
unpaired t-test as appropriate. For comparison of more than two means, one-way analysis of ?
1'variance (ANOVA) was used, followed by either the Dunnett’s (comparison to control) or the 
Student-Newman-Keuls’ post-hoc test, with a P-value of < 0.05 considered statistically 4
significant.
2.8. Sources and preparation of chemical agents
The chemical compounds used in this study are as follows, grouped according to their sources:
1. Sigma, Poole, Dorset, UK:
Acetylsalicylic acid (ASA, aspirin), adenosine, 2-amino-2-methylpropanol, bovine 
serum albumin (BSA) protein standard, caffeine, catalase (CAT), 2-chloroadenosine 
(2-ClA), copper (II) sulphate (CUSO4 ) pentahydrate, 7V^~cyclopentyladenosine (CPA), 
D-Mannitol, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX); 3,4-Dihydro-5-[4-(l- 
piperidinyl)butoxyl]-l(2H)-isoquinolinone (DPQ), hydrogen peroxide solution 
(30%w/w), 3-hydroxyanthranilic acid (3-HAA), 3-hydroxykynurenine (3-HK), 
kynurenic acid (ICYA), L-Glutamic acid sodium salt hydrate (Glutamate or Glu), 
nicotinamide (NAm), AG-Nitro-L-arginine methyl ester hydrochloride (L-NAME), 
magnesium chloride (MgCb), A-methyl-D-aspartate (NMDA), 3-nitropropionic acid 
(3-NPA), p-nitrophenol standard, l,3-Dimethyl-8-phenylxanthine or 8- 
phenyltheophylline (8-PT); quinolinic acid (QA), S-nitroso-#-acetylpenicillamine 
(SNAP), superoxide dismutase (SOD), xanthine (X), and xanthine oxidase (XO).
2. Tocris Cookson Ltd., UK:
2-p“(2-Carboxyethyl) phenethylamino-5'-A-ethylcarboxamidoadenosine hydrochloride 
(CGS21680), cyclosporin A (CsA), 2-amino-5-phosphonopentanoic acid (D-AP5), (+)- 
MK-801 (dizocilpine), benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)- 
fluoromethyIketone (Z-D EVD-fmk).
3. Calbiochem (EMD Biosciences Inc.): p-nitrophenylphosphate (disodium salt). |
4. BDH Biochemicals: Potassium cyanide (KCN).
5. Research Biochemicals (International): 6-cyano-7-nitroquinoxaline-2,3-dione 
(CNQX) and allopurinol (AP).
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6. Schering-Plough Centro Ricerche: 7-(2-phenylethyl)-5-amino-2-(2-fliryl)-pyi'azolo- 
[4,3-e]-1,2,4-triazolo[l ,5-c]pyi’imidine (SCH58261).
7. Alexis Biocheinicals (Axxora Ltd.), UK: lH-[l,2,4]Oxadiazolo[4,3-a]quinoxalin-l- 
one (ODQ).
8. Biorad Laboratories: Biorad reagent.
9. Dr. Ongini (AstraZeneca) gave as a gift 4-(2-[7-amino-2-[2-furyl][l,2,4]triazolo[2,3“ 
a] [ 1,3,5 ]triazo-5 -yl-amino]ethyl)phenol (ZM241385).
Most drugs were dissolved in water, with the exception of:
1. Catalase and superoxide dismutase, which were dissolved in normal saline.
2. Acetylsalicylic acid, CNQX, DPQ, kynurenic acid, ODQ, 8-PT, SCH58261, Z- 
DEVD-fmk and ZM241385, which were dissolved in dimethyl sulfoxide 
(DMSO).
3. Cyclosporin A, DPCPX and 3-NPA, which were dissolved in ethanol.
4. Allopurinol, quinolinic acid, xanthine and xanthine oxidase, which were 
dissolved in IM NaOH.
5. 3-HAA, which was prepared (2mM) in IM HCl (4% v/v) and diluted with 
ascorbic acid (lOOpM) to the desired concentration(s), with the final highest 
ascorbic acid concentration in cultures of 2.5%v/v. This vehicle had no effect 
of its own on cultures.
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SNAP was dissolved in distilled water containing 0.54mM ethylenediaminetetraacetic acid 
(EDTA) (pH of water adjusted to 9.0 before adding EDTA). EDTA only helped to stabilize 
SNAP in storage and had no effect of its own on the cultures. The final concentrations of 
DMSO, ethanol and NaOH in cultures never exceeded 0.1% (except for Z-DEVD-fmk, which 
had a final DMSO concentration of 0.2% as recommended by the supplier and for which 
control solutions therefore included the same concentration of DMSO), which when tested on 
the cultures had no effect. Normal saline also did not have any effect of its own on the
.cultures. Stock solutions were filter-sterilized using the millipore filter and stored at 
appropriate conditions of temperature and humidity as recommended by their suppliers.
' 4
3. RESULTS -  EFFECTS OF GLUTAMATE AND OXIDATIVE STRESS ON THE
VIABILITY OF MC3T3-E1 OSTEOBLASTS
3.1. Alamar Blue (AB) standardization for viability determination
The use of alamar blue (AB) for routine determination o f cell viability requires the 
standardization o f each cell type for a number of factors, the most critical being the seeding 
density and the extent o f incubation. Correlations between AB reduction, seeding density 
and the duration o f incubation for the MC3T3~E1 cells were therefore detennined.
Densities ranging from 2.5 x lO"^  to 4 x 10  ^cells per ml, in consecutive, two-fold increases, 
were employed for incubation periods of 2, 3, 4, 5 and 6 h. As shown in Fig. 3.1 A, AB 
reduction increased linearly (R^ = 0.9826) with increasing densities for selected incubation 
periods (4 h shown). Similarly, AB reduction also correlated linearly (R^ = 0.9306) with 
the incubation duration for a given seeding density (1 x 10  ^ shown) (Fig. 3 .IB). A seeding 
density o f 1 x 10  ^cells per ml and an incubation period of 4 h were eventually chosen for 
subsequent experiments, except where stated otherwise.
Despite confirmed reports o f non-toxicity to cells, it was necessary to examine whether AB 
had any injurious effect on the MC3T3-E1 cells used in the current study. A set o f cultures 
was pretreated with AB (10%v/v) for 4 h while a parallel set o f cultures was similarly 
treated with vehicle. At the end of pretreatment, at least 16 h was allowed for recovery, 
after which cell viability was determined using AB itself. There was no difference in 
viability between cultures pretreated with AB and those pretreated with vehicle (0.61 ±
0.01 vs. 0.60 ± 0.01, for AB- and vehicle-pretreated cultures, respectively; n = 4). A 
confirmatory trypan blue exclusion experiment also revealed no difference in the viabilities 
o f the two sets o f cultures (99.38% ± 0.40 vs. 99.22% ± 0.37; n -  6).
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Figure 3.1. Graphs showing the correlation between alamar blue (AB) reduction 
and (A) initial seeding density (4 h o f incubation) and (B) the duration o f AB 
incubation (seeding density of 1 x 10  ^cells per ml) in the MC3T3-E1 cultures. Each 
data point represents the mean ± SEM for (A) n = 4 or (B) n = 3 or 4 cultures.
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3.2. Switching the MC3T3-E1 cells
The MC3T3-E1 cells were used at a passage which represented immature osteoblasts. It |
j'-was necessary therefore to switch these into a differentiated state in order to be 
representative of mature and functional osteoblasts. A number of recent reports claimed 
that L-ascorbic acid and p-glycerol phosphate (BGP) are two supplements which, when 
added together to osteoblast cells in culture, can accelerate both their proliferation and y'
differentiation (Harada et al., 1991; Quarles et al., 1992). These claims were therefore 
examined to determine if the osteoblast cultures used in this study were competent.
3.2 A. Effect o f switching on the proliferation o f MC3T3-E1 cells
To assess the effects of these supplements on the proliferation of our MC3T3-E1 cell line, 
cultures were grown with or without L-ascorbic acid (50pg/ml) and p-glycerol phosphate 
(5mM) for 5 div. The number o f cells was then determined. Significantly higher cell counts 
were obtained with cultures that received the supplements than with those that were not 
given the supplements (2.9 x 10  ^± 0.15 vs. 2.3 x 10  ^± 0.21, P<0.05, n = 3) (Fig. 3.2).
3.2.2, Effect o f switching on differentiation
Throughout this thesis, the term “switching” has been used to refer to supplementation of 
culture medium at 3 div with L-ascorbic acid and BGP, combined with a reduction in ■I:
serum concentration from 20% to 10%. In order to assess the effect o f switching on the 
differentiation o f the MC3T3-E1 osteoblast-like cells, the activity of alkaline phosphatase 
(ALP), a membrane-bound enzyme known to be an unequivocal marker of differentiation 
in bone, was determined.
At 1 and 4 days after adding the switch medium, there was no significant difference |
between switeh and control non-switch cultures. At 7 days post-switch, ALP activity was f
almost three-fold higher in switch than in non-switch cultures (P<0.001). The levels of 
ALP activity in supplemented switch cultures were more than four-fold higher at 11 days 
post-switch (P<0.0001) and were still higher at 14 days post-switch (P<0.0001, n == 5 - 8)
(Fig. 3.3A).
5  ■ •When the plating density was increased three-fold to 3 x 10 cells per ml, a similar result 
was obtained. However, with this higher density, there were significantly higher levels of ■VALP activity in non-switch than in switch cultures at one day post-switch (P<0.001, n = 8), 
but these non-switch levels o f ALP activity failed to rise with increasing days post-switch 
(Fig. 3.3B).
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Figure 3.2. Histogram showing the effects of supplementation with L-ascorbic acid and p- 
glycerol phosphate on the number of MC3T3-E1 cells in cultures at 5 div. The final 
concentrations of L-ascorbic acid and p-glycerol phosphate were 50pg/ml and 5mM, 
respectively. Non-supplemented cultures had no L-ascorbic acid and p-glycerol phosphate 
in the culture medium at any stage, while supplemented cultures had L-ascorbic acid and 
p-glycerol phosphate in the culture medium from the time of plating until 5 div. Each 
column represents the mean ± SEM for n = 3 experiments. Statistically significant 
difference in cell count between supplemented and non-supplemented cultures is indicated 
as * P<0.05.
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Figure 3.3. Histograms showing alkaline phosphatase (ALP) activity in the osteoblast-like 
MC3T3-E1 cells with increasing days post-switch when initial plating density was (A) 1 x 
10^  cells/ml and (B) 3x10^ cells/ml. Switching was carried out at 3 div. N days post­
switch is therefore equivalent to (N + 3) days in vitro. Each column indicates the mean ± 
SEM for (A) n = 5 - 8 or (B) n = 8 cultures. ** P<0.001, *** P<0.0001 for switch vs. non­
switch cultures.
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3.3. Culture conditions and MC3T3-E1 viability
As it is known that the conditions in which cultures of any cell type are grown could 
significantly determine their baseline viability or survival, the responses o f MC3T3-E1 
cells were examined in a range o f culture conditions. Whether the process o f switching 
modified the observed responses was also detemiined.
3,3.1. Effects o f increasing serum concentrations and serum withdrawal
Serum is known to be highly essential for the survival of cells (including osteoblasts) in 
culture (Jilka et ah, 1998). The influence of increasing levels of serum on the survival of 
switch and non-switch MC3T3-E1 cultures and the effect o f withdrawing serum from these 
cultures were therefore investigated. Switch and non-switch cultures were maintained in 
Minimum Essential Medium (MEM) supplemented with 1,10 and 20% Foetal Calf Serum 
(FCS) until 10 div, at the end o f which viability was determined. Viabilities o f non-switch 
cultures in the presence o f 10 and 20% FCS were each very significantly higher than in the 
presence o f 1% FCS (P<0.001, n = 6) (Fig. 3.4), but there was little difference in viabilities 
between non-switch cultures maintained in the presence of 10% FCS and those maintained 
in 20% FCS. Similarly, for switch cultures, viabilities were very significantly higher in 
cultures maintained in 10 or 20% FCS compared to those in 1% FCS cultures (P<0.001), 
although viability o f switch cultures in the presence of 20% FCS was significantly higher -ithan in 10% FCS (P<0.01). With regard to cultures maintained in 1% FCS, survival was 
significantly higher in non-switch than in switch cultures (P<0.001), while there was no 
difference in survival o f non-switch and switch cultures when they were both maintained 
in 10% FCS. In contrast, maintenance o f switch cultures in 20% FCS resulted in 
significantly higher suiwival than was the case with non-switch cultures (P<0.05).
Withdrawal o f serum from switch cultures for 0.25, 1, 3 and 6 h at 10 div had no effect on 
their viabilities (n = 4) (Fig. 3.5A). The effect o f serum withdrawal for 1 ,2  and 3 days 
before reaching 10 days in vitro (div) was also examined (n = 6) (Fig. 3.5B). A pattern of 
steady decline in viability was obvious with increasing durations of withdrawal. Serum 
withdrawal one day prior to reaching 10 div had no statistically significant effect on switch 
or non-switch cultures. Semm withdrawal for 2 days before reaching 10 div reduced the 
viabilities of non-switch and switch cultures significantly to 90.92% ± 1.20 (P<0.01) and 
89.3% ± 2.20 (P<0.001) o f the control, respectively, while serum withdrawal for 3 days 
prior to 10 div more significantly lowered viabilities to 82.34% ±1.61 and 82.50% ±2.16
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of the control (P<0.001). There was, however, no difference between the sensitivities of 
non-switch and switch cultures to semm withdrawal for any given duration o f withdrawal.
3.3.2. Addition o f potassium to culture medium
The effect - on survival - o f adding potassium at 3 div to the culture medium in which 
MC3T3-E1 cells are grown was determined. This was earned out in order to verify if  these 
cells compared with neurones, which are Imown to survive better with concentrations in 
the 20-25mM range than in the lower 5-lOmM range (Gallo et a l ,  1987; Xifro et al.,
2005). At 10 div, viabilities o f non-switch cultures supplemented with 10 and 25mM 
were not different from their respective controls whereas 50mM reduced viability 
slightly but significantly to 94,06% ± 0.87 o f the control (P<0.01, n = 3) (Table 3.1). On 
the other hand, the survival o f switch cultures in lOniM was enhanced (104.39% ± 1.46 
of the control, P<0.05, n = 3), while higher concentrations o f 25 and 50mM had no effect. 
Responses o f non-switch cultures were not significantly different from those o f switch 
cultures for a given concentration of potassium.
3.3.3. Presence o f glutamine in culture medium
Glutamate is considered to suppoif the suiwival of most cells in culture. The effect of 
glutamine on MC3T3-E1 viability was therefore examined (Table 3.1). Glutamine added to 
non-switch and switch cultures at 3 div to a final concentration o f 2mM improved their 
viabilities at 10 div very significantly to comparable levels above the control, with values 
of 111.46% ± 0.29 and 111.92% ± 0.53, respectively (P<0.001, n = 4).
3.3.4. Supplementation with ascorbate andp-glycerolphosphate
The addition o f each o f the switching supplements ascorbate and P-glycerol phosphate 
alone from 3 to 10 div had no significant effect on survival (Table 3.1). In addition, non­
switch and switch cultures had comparable viabilities (expressed in absolute values o f AB 
reduction) at 10 div of 0.68 ± 0.02 and 0.68 ± 0.01, respectively (n = 4).
3.3.5. Medium change and feeding protocols
A  variety of protocols exist for adequate maintenance of cultures in vitro. Osteoblast 
cultures (in 96-well plates) in this study were fed by complete replenishment of culture 
medium every 2-3 days. However, the beneficial effect o f medium change to overall 
survival o f the MC3T3-E1 cells was assessed. Interestingly, an insignificant (6.8%)
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reduction in viability was obtained with cultures maintained without any medium change 
for 10 div compared to cultures fed every 2-3 days (0.63 ± 0.01 vs. 0.68 ± 0.02, P>0.05, n 
= 4). Again, cultures fed by replacing only half of the spent medium with fresh medium 
gave a viability value that was 98.29% ± 1.30 (n = 4) of the viability of cultures fed by 
total replacement of medium, a difference that was not statistically significant.
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Figure 3.4. Histograms showing the effects of growing non-switch and switch MC3T3-E1 
cultures in medium containing increasing concentrations of serum (1, 10, 20%). Viability 
was determined at 10 div. Each column represents the mean ± SEM for n = 6 cultures. 
*P<0.05, **P<0.01, ***P<0.001, ns = non-significant; ###P<0.001 compared to 
corresponding 1% v/v serum concentration.
71
□  MEM alone B M E M  + FCS
co
o3■o0)Û:
m<
0.8
0.6
0.4
0.2
0.25 h 1 h 3 h 6 h
B
120
100
80
60
40 . **1^
20
0
□  Non-switch H Switch
** ***
-  :
*** ***c  o o
o
g ,
c  oIp o3 ■D
S.
CO < U •  —  ---------— —^  --------
1 2 3
Duration of serum withdrawal in day(s)
Figure 3.5. Histograms showing (A) lack o f effects of serum withdrawal for 0.25, 1, 3 and 
6 h at 10 div on the viability o f switch cultures and (B) the effects o f serum withdrawal for 
1, 2 and 3 days prior to 10 div on the viabilities o f non-switch and switch MC3T3-E1 
cultures. Each column represents the mean ± SEM for (A) n = 4 and (B) n = 6 cultures.
** P<0.01, *** P<0.001 compared to control.
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CU LTU RE CO N D ITIO N
AB RED U CTIO N  (%  O F CO N TRO L)
N ON -SW ITCH SW ITC H
K f concentration (mM) 
10 
25 
50
102.26 ±0.31 (3) 
100.86 ± 0 .19  (3) 
94.06 ± 0 .87  (3)**
104.39 ± 1.46 (3)*  
97.09 ± 1.82 (3)
97.04 ± 0 .97  (3)
Glutamine 2mM 111.46 ± 0 .29  (4) *** 111.92 ±0 .53  (4) ***
Ascorbate alone 50/ig/ml 102.33 ± 1.80 (5)
(3-glycerolphosphate alone 
5mM
104.83 ± 1.67 (5)
Table 3.1. Table showing the effects of a range o f culture conditions on the viability of 
non-switch and switch MC3T3-E1 cultures at 10 div. The n values are as indicated in 
parentheses. Where no value is given (-), the indicated treatment is not applicable. 
*P<0.05, *"‘'P<0.01, ***P<0.001 compared to control.
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3.4. Ligands at glutamate and adenosine receptors
3.4.1. Glutamate and NMD A receptor agonists and antagonists
There is increasing evidence for the secretion o f glutamate and the presence o f glutamate 
receptors in peripheral tissues including bone (Bhangu et al., 2001; Genever & Skerry, 
2001; Gu et al., 2002). Agonists and antagonists at glutamate receptors were therefore 
tested for their potential effects on the viability o f well-differentiated (switch) MC3T3-E1 
cultures. All agents were added for 0.25, 1, 3 and 6 h. Fig. 3.6 (A - B) shows the effects, 
respectively, o f the agonist glutamate and the selective agonist NMDA at 10 div. 
Application o f glutamate lOpM for 3 h or less showed a trophic tendency, which was 
significant at 1 h (P<0.05, n = 4 - 5), whereas a 6 h application had no effect. Glutamate 
lOOpM applied for 1 h and IniM applied for 0.25 h had very significant trophic effects on 
the cultures (P<0.01). No concentration o f glutamate at any time point elicited any toxic 
effect. Similarly, NMDA lOOpM applied for 3 h, and ImM applied for 0.25, 1 and 3 h had 
significant trophic effects (P<0.01 and P<0.05, respectively, n = 4 - 5) on osteoblast 
cultures and none o f the treatments caused a significant reduction in viability at any time 
point investigated.
When applied for 20 h at 4 div, glutamate at lOjuM, lOOpM, ImM  and lOmM raised 
viability significantly to 109.75% ± 1.61 (P<0.05), 111.63% ± 3 .06  (P<0.01), 110.95% ± 
2.79 (P<0.01) and 112.01% ± 1.83 (P<0.01), respectively, o f the control (n = 6). Consistent 
with this, NMDA at the same concentration range gave values o f 109.01% ± 2.14 
(P<0.05), 110.06% ± 2.86 (P<0.01), 115.52% ± 2.02 (P<0.01) and 109.44% ± 0.80 
(P<0.01) of the control, respectively (n = 4).
Whether the endogenous NMDA receptor agonist, quinolinic acid, could similarly affect 
osteoblast viability was also tested. A 24 h application o f lOOjuM, ImM  and lOmM 
quinolinic acid resulted in viability values o f 108.18% ± 3.79, 105.91% ± 4.65 and 98.55% 
± 3.65 o f the control, respectively, but these were not statistically different from the 
control.
The effects of applications of the non-selective glutamate NMDA receptor antagonist 
dizocilpine (MK-801) (20pM), and the competitive antagonist D-AP5 (50pM) at 10 div 
are as shown in Table 3.2. Dizocilpine applied for 0.25 h increased viability significantly 
beyond control levels (P<0.05) but had no significant effect at other time points. D-AP5 
showed no significant effect.
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3.4.2, Agonists and antagonists at adenosine Ai and A2A receptors
Application of adenosine for 20 li at 4 div had a significant trophic effect (P<0.05) only at 
lOOpM (103.53% ± 1.40, 108.66% ± 2.72 and 103.67% ± 2.51, for lOpM, lOOpM and 
ImM, respectively; n = 4). The trophic effect by adenosine lOOpM was shown by cell 
count to correspond to a significant increase in cell number (2.38 x 10"^  ± 0.01 and 1.93 x 
10"^  ± 0.13; P<0.05 for adenosine lOOpM vs. control).
The effects of adenosine receptor ligands on basal viability at 10 div are shown in Table
3.2. Adenosine (lOpM - ImM) had no significant effect on basal viability. While the Ai 
receptor agonist CPA (50nM) showed a tendency to improve basal viability, the selective 
antagonist DPCPX (50nM) significantly raised viability above control values on 
application for 1 h. However, modulations o f viability by DPCPX and another selective A, 
receptor antagonist, 8-PT (20pM), were not clear from these data, appearing to be biphasic, 
depending on the time point used. The A 2 A receptor agonist CGS21680 (20nM) showed a 
trophic tendency on the osteoblast cultures, whereas application of the antagonists 
ZM241385 and SCH58261 at 50nM caused a reduction in viability at most time points. 
This reduction was significant when ZM241385 was applied for 0.25 h.
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Figure 3.6. Histograms showing the effects of 0.25, 1, 3 and 6 h applications o f (A) 
glutamate and (B) NMDA on the viability of MC3T3-E1 cultures at 10 div. Each column 
represents the mean ± SEM for n = 4 or 5 cultures. * P<0.05, ** P<0.01 compared to 
control.
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ALAMAR BLUE REDUCTION (% OF CONTROL)
LIGAND 0.25 h I h 3 h 6 h
NM D A receptor
MK-801 20pM 107.05 ±2.45* 102.12 ±2 .89 103.27 ± 8 .42 95.85 ±3.68
D-AP5 50pM 105.92 ± 7 .08 108.48 ±6.42 97.91 ±8 .42 98.81 ± 8.02
Adenosine  
receptors 
Adenosine lOpM 111.18±6.42 94.70 ± 2 .66 99.75 ± 8.44 106.34 ± 7.00
lOOpM 102.55 ± 5 .70 98.36 ±8.06 105.83 ± 8 .57 96.53 ± 4.79
ImM 104.30 ± 5 .04 107.47 ±6.85 99.98 ± 8.96 99.00 ± 8.19
Caffeine ImM 104.35 ±3.85 102.67 ±3.97 103.75 ± 11.68 103.92 ± 5.09
A 1 receptors
CPA 50nM 139.36 ± 19.38 114.58 ±9.95 99.80 ± 9 .87 127.32 ± 14.43
DPCPX 50nM 134.71 ±20.34 118.78 ±3.60* 69.71 ± 15.78 100.19± 5.4
8-PT 20 pM 146.82 ± 16.39 119.81 ±12.90 93.40 ± 6.66 136.12 ± 13.47
A 2a receptors
CGS21680 20nM 147.23 ±20.10 127.54 ± 15.75 109.23 ± 8.83 144.00 ± 18.92
ZM241385 50nM 90.21 ±2.68* 91.91 ± 3 .84 94.50 ± 3.58 101.64± 5.12
SCH58261 50nM 96.61 ±2 .60 90.81 ±4 .47 91.20 ± 3 .00 98.17 ± 2.89
Table 3.2. Table showing the effects o f ligands at glutamate NMDA receptors and at 
adenosine receptors on the viability o f MC3T3-E1 cells at 10 div. Each value as presented 
represents the mean ± SEM for n = 4 or 5 cultures. *P<0.05 compared to control.
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3.5. Modulation of osteoblastic viability by reactive oxygen species (ROS)
ue
3.5,1. Hydrogen peroxide and osteoblastic viability
Fig. 3.7 illustrates the concentration - response graph obtained when switch MC3T3-E1 
cultures were exposed to hydrogen peroxide (lOOpM - 5mM) at 10 div for 0.25, 1,3 and 6 
h. Hydrogen peroxide reduced osteoblast viability in a concentration- and time-dependent 
manner, compared to untreated controls (P<0.05 or P<0.01, n = 4). H 2 O 2 lOOpM had no 
significant effect. Overall, a concentration o f at least 200pM applied for 1 h was required 
to produce a statistically significant effect. The extent of damage at 6 h was not 
significantly different from that obtained at 3 h. Effects o f hydrogen peroxide on the 
morphology of osteoblast cultures were consistent with the results from AB reduction (Fig.
3.8), as there was massive loss o f cells when cultures were treated with concentrations of 
hydrogen peroxide beyond lOOpM, while the remaining cells appeared isolated and 
rounded, in contrast to control culture cells which adhered to one another at full 
confluence. A working concentration of 500pM was chosen for most o f the subsequent 
experiments- except otherwise stated- in order to allow increases or decreases in viability 
to be clearly shown.
Because H 2 O2 lOOpM did not significantly damage osteoblast cultures at 10 div, the 
possible effects o f concentrations from lOOpM and below on MC3T3-E1 cultures at an 
earlier stage of development (4 div) were investigated. W ith 20 h exposure at 4 div, 
statistically significant increases in viability (P<0.01) were obtained for H202at6.25, 12.5,
25 and 50pM (112.33% ± 0.33, 112.08% ± 2.54, 113.71% ± 1.74 and 111.53% ±2.36, of 
the control, respectively; n = 4) while lOOpM resulted in a decrease in viability to 93.06%
±3.13 , which was not significant.
3.5.1.1, Effect o f  recovery duration
The influence of the length of recovery period after hydrogen peroxide insult on the 
eventual survival o f osteoblast cultures was examined. The recovery period was taken as 
the period between the end o f treatment with hydrogen peroxide and the reading of 
viability values with the plate reader. This period was, therefore, inclusive o f the 4 h gap 
for which the cultures were incubated with alamar blue before readings were taken. As 
shown in the left panel o f Fig. 3.9, cultures treated for 1 h with H202 200|uM had a 
significantly better suiwival with a recovery period of 24 h than with 4 h (P<0.05). In 
contrast, treatment for a longer period of 6 h resulted in reduced survival with 24 h
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compared to 4 h of recovery (P<0.05, n = 4). With a higher concentration of peroxide 
(500|liM ), there were no differences in survival outcomes for cultures treated for 1 or 6 h 
when recovery period was increased from 4 to 24 h (n = 4) (Fig. 3.9, right panel).
3.5.1.2, Cellular differentiation and sensitivity to oxidative damage by H 2 O2 
At this stage, the influence o f differentiation induced by ascorbate and (3-glycerol 
phosphate on the sensitivity o f MC3T3-E1 cells to hydrogen peroxide-mediated oxidative 
damage was assessed. Non-switch cultures were exposed to the same concentrations of 
hydrogen peroxide (lOOpM-SniM) at 10 div as were switch cultures, and the viability 
values obtained by alamar blue reduction compared with previous values for switch 
cultures as shown in Table 3.3. It appeared that sensitivity to H202-induced oxidative 
damage was enhanced by switching-induced differentiation, although the differences in 
sensitivities o f switch and non-switch cultures to the damage failed to reach statistical 
significance for most concentrations.
3.5.1.3, Catalase prevents the damaging effect o f  hydrogen peroxide
Catalase (CAT) is an antioxidant enzyme Icnown to destroy hydrogen peroxide by reducing 
it to water and molecular oxygen according to the equation:
CAT
2H 2O 2 2H 2O  +  O2
Catalase was therefore tested for its ability to prevent the reduction in osteoblastic viability 
caused by hydrogen peroxide at 10 div. Catalase at 1250U/ml had a mitogenic effect on its 
own which was statistically significant at 6 h and also completely abolished the damaging 
effects o f hydrogen peroxide SOOjuM, raising viability beyond control level at each time 
point (n = 4) (Fig. 3.10). A series o f consecutive half dilutions o f catalase, starting from 
1250U/ml, was also tested against H 2 O2 . Table 3.4 shows the results obtained when each 
o f these dilutions was added alone and when combined with H 2 O 2 . All o f the catalase 
concentrations showed some evidence of mitogenicity and were able to prevent damage by 
peroxide.
In order to confirm that the observed effect of catalase on hydrogen peroxide cytotoxicity 
was entirely due to its catalytic (enzymatic) activity and not attributable to some other 
protein that could be present in the “cocktail”, catalase was inactivated in a water bath at 
for 5-7 min and then the ability of this inactivated enzyme to prevent hydrogen 
peroxide cytotoxicity at the longest time point (6 h) was tested. The heat-inactivated
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catalase (250U/ml) at 6 h had no mitogenic effect when applied alone and also completely 
failed to prevent hydrogen peroxide cytotoxicity (n = 3) (Fig. 3.11).
3.5.1.4. Aspirin (acetylsalicylic acid, ASA) and hydrogen peroxide cytotoxicity 
The ability of catalase to induce cyclooxygenase (COX), especially COX-2, and the 
relevance of this induction to mitogenicity elicited by catalase has been reported in a 
number o f tissues (Chen et al., 1998; Choi et al., 2001; Litvinov &Turpaev, 2004; Jang et 
al., 2004; Jang et al., 2005). Therefore, the possible effect o f aspirin (acetylsalicylic acid), 
a COX inhibitor, on hydrogen peroxide cytotoxicity was examined (n = 3) (Fig. 3.12A). 
The results showed that aspirin increased basal viability to 112.96% ± 1.15 o f the control 
when applied alone for 1 h (P<0.01) but had no effect at 6 h. However, when tested for its 
potential to modulate hydrogen peroxide toxicity, it showed no ability to either prevent or 
exacerbate the deleterious effect, whether at 1 or 6 h.
3.5.1.5. Superoxide dismutase (SOD) and hydrogen peroxide  
Hydrogen peroxide is a dismutation product of the superoxide anion radical, the 
antioxidant enzyme superoxide dismutase (SOD) being responsible for catalyzing this 
reaction according to the equation:
SOD
20% - + 2Fr -> H2O2 + O2
The effect o f SOD on hydrogen peroxide-induced reduction in the viability of osteoblasts 
was therefore assessed. Hydrogen peroxide at 500pM reduced viability in a time- 
dependent manner, with significance at 1,3 and 6 h (n = 4) (Fig. 3.12B). When SOD 
250U/ml was added alone, there were increases in cell viability, reaching significance at 1 
h, although these data were largely fraught with significant variability between replicates. 
Co-administration of hydrogen peroxide and SOD resulted in marginal improvements in 
viability compared to hydrogen peroxide alone. After 3 h of treatment, SOD raised 
viability significantly from 15.19% ± 2.06 for peroxide alone to 33.80% ± 8.96 (P<0.05).
3.5.1.6. Hydrogen peroxide in the presence o f  copper (II) ion
Tlii'ough the Fenton reaction, hydrogen peroxide is able to combine with transition metal 
ions such as iron (Fe^^) or copper (Cu^^) to generate the hydroxyl radical (Mazzio & 
Soliman, 2003). The possibility of interactions between hydrogen peroxide and copper (II)
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ion (generated from CUSO4 ) in MC3T3-E1 cultures was therefore investigated with an 
PI2 O2  concentration of lOOgM. As shown in Fig. 3.13A, this concentration had no effect on 
osteoblast viability when applied alone for 1 h. The addition o f CUSO4  ImM alone for 1 h 
reduced osteoblast viability significantly to 77.85% ± 3.59 of the control (P<0.01, n = 4).
A co-administration o f H 2 O2  lOOpM and CUSO4  ImM for 1 h reduced viability to 48.72% 
± 6.08 o f the control (P<0.G01), a reduction significantly more than was obtained with 
CUSO4  alone (P<0.001). In order to detemrine whether any production of hydroxyl radical 
was involved in this phenomenon, the effect o f mannitol, a known scavenger o f the
hydroxyl radical, was assessed on the damage caused by a co-administration o f FI2 O2  and 
CUSO4  (Fig. 3.13B). At 1 h, mannitol 50mM had no effect on its own, but surprisingly, it 
significantly exacerbated the reduction in viability caused by a combination o f H 2 O2  and 
CUSO4 . Viability was significantly decreased 30.58% to 69.42% ± 6.37 of the control 
(P<0.001, n = 4) by a combination of H 2 O 2 and CUSO4 . hr the presence of mannitol, a 
greater (91.28%) reduction in viability was obtained, bringing this value down to 8.72% ±
1.48 o f the control (P<0.001). This reduction in the presence o f mannitol was more 
significant than the reduction caused when only H 2 O2  and CUSO4  were combined 
(P<0.001). The morphological effects of these treatments also confirmed that a 
combination of H2 O2 and copper (II) ion was more damaging in the presence than in the 
absence o f mannitol (Fig. 3.14).
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Figure 3.7. Histograms showing the effects of hydrogen peroxide (lOOpM -  5mM) 
applied for 0.25, 1, 3 and 6 h on the viability of MC3T3-E1 osteoblast-like cells at 10 
div. Each column represents the mean ± S.E.M for n = 4 cultures. *P < 0.05, ** P< 
0.01 compared to control.
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Figure 3.8. Photomicrographs showing the effects of H2O2 on the phenotype of MC3T3- 
E1 cells as shown by phase contrast microscopy, (a) Control cells maintained in switch 
medium for 10 div are confluent and closely adhered when compared to cultures treated for 
6 h with (b) 200pM, (c) 500pM, and (d) 1000pM H2O2 , where cells rounded up (arrows) 
and a progressive loss of cells was evident. Bar = 20 pm.
83
□  1 h treatment H 6 h treatment
coo
co
■D
&
m<
120
100
80
60
40
20
0
ns
4 h recovery 24 h recovery
200mM H202
ns
pÆia
1
4 h recovery 24 h recovery
500mM H202
Figure 3.9. Histograms showing the effects of duration of recovery period on the outcome 
of damage by 200pM (left panel) and 500pM (right panel) hydrogen peroxide. The 
recovery period is the period between the end of treatment with hydrogen peroxide and the 
reading of viability values with the plate reader, inclusive of the 4 h gap for which the 
cultures were incubated with alamar blue before readings were taken. Each column shows 
the mean ± SEM for n = 4 cultures. *P<0.05, **P<0.01, ***P<0.001 compared to control; 
#P<0.05, ns = non-significant for 4 h vs. 24 h recovery.
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AB REDUCTION (% OF CONTROL)
H2 O2 (pM) NON-SWITCH SWITCH
0.25 h
100 97.09 ± 3 .10 87.02 ± 8.25
200 97.50 ± 4 .87 92.59 ± 2 .60
500 92.50 ±9.55 82.64 ± 9 .75
1000 94.18 ±4.48 83.85 ± 8 .36
5000 80.76 ± 3 .06 78.69 ± 10.16
I h
100 94.30 ±2.15 93.18 ± 3 .67
200 91.11 ± 4.34 76.44 ±5 .77
500 88.01 ± 3 .54 60.30 ±3.30**
1000 75.96 ±4.93 71.14±7 .68
5000 54.57 ±4.49 58.08 ± 7.88
3 h
100 99.84 ± 3 .96 83.20 ±5.08*
200 82.48 ±7.38 40.97 ± 12.29*
500 41.91 ± 7 .37 26.57 ±8 .28
1000 37.36 ±3.23 21.93 ±2.40**
5000 24.13 ± 10.68 14.69 ±2 .29
6 h
100 106.40 ±3 .78 76.52 ± 13.25
200 78.61 ± 12.93 32.23 ± 7.27*
500 38.20 ±8 .17 24.29 ± 9.48
1000 12.05 ±5.76 16.83 ±3.49
5000 12.31 ±2.81 15.54 ±2.53
Table 3.3. Table showing the differential sensitivities of non-switch and switch cultures to 
hydrogen peroxide (lOOpM -  5mM) at 10 div. Each value indicates the mean ± SEM for n 
= 4 cultures. *P<0.05, **P<0.01 compared to non-switch cultures.
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Figure 3.10. Histograms showing the effects o f catalase (CAT) 1250U/ml on the viability 
of MC3T3-EI cultures and the hydrogen peroxide-mediated cytotoxicity in these cultures. 
Each column shows the mean ± SEM for n = 4 cultures. *P<0.05, ***P<0.001 compared to 
control; #P<0.05, ###P<0.001 compared to corresponding H 2 O 2  SOOpM.
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A B  R e d u c t i o n  ( %  o f  c o n t r o l )
0.25 h I h 3 h 6 h
C A T (U/ml)
39 12G.13± 14.62 114.92 ± 14.29 93.35 ± 11.14 109.82 ± 8 .44
78 1G6.98± 11.6G 108.50 ± 11.67 109.24 ± 10.12 87.19 ± 10.90
156 125.28 ±8.48 114.43 ± 13.21 105.43 ±  13.30 113.36 ±6.41
313 84.35 ± 22.77 127.89 ± 13.90 107.09 ± 10.16 118.69 ±3.97
625 115.45 ± 13.31 112.88 ±6.61 130.77 ±8.93 114.42 ±5 .76
H 2 O2
50GpM 74.43 ± 9.53 66.43 ± 10.30* 50.43 ± 13.00*** 30.01 ±6.19***
H 2 O2 
5GGpM + 
C4T(U/ml)
39 1G6.57±2.66" 104.14 ±4.20" 93.72 ± 10.87" 111.39± 10.31"
78 1G2.57±7.24 107.65 ±6.81" 102.73 ±2.31" 101.97 ±2.19"
156 124.43 ± 1 4 .4 9 '' 110.30 ±6.60" 108.10 ±3.06" 110.65 ±6.48"
313 99.97 ± 6.19 121.47 ± 16.98*' 107.25 ±3.20" 118.30 ± 10.47"
625 11G.1G±4.87" 115.16±  10.74" 115.82 ±7.00" 110.90 ±4.92"
Table 3.4. Table showing the effects of increasing catalase concentrations (39U/ml -  
625U/ml) on the viability of MC3T3-E1 cultures and the cytotoxicity mediated by 
hydrogen peroxide in these cultures at 10 div. Each value represents the mean ± SEM for n 
= 4 cultures. *P<0.05, ***P<0.001 compared to control; “P<0.05, *^P<G.G1, T<G.GG1 
compared to corresponding H 2 O2  5GGpM.
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Figure 3.11. Histogram showing lack of effect of heat-inactivated catalase (250U/ml) on 
the viability of MC3T3-E1 cultures and the cytotoxicity mediated by H202(500pM)in 
these cultures. The inactivation of 250U/ml catalase by heat treatment caused a complete 
loss of its mitogenic activity and its ability to prevent H202-mediated cytotoxicity after 6 h 
of exposure. Each column represents the mean ± SEM for n = 3 cultures. *** P<0.001 
compared to control; ns = non-significant compared to H2O2 - treated cultures.
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Figure 3.12. Histograms showing the effects of (A) aspirin (ASA, ImM) and (B) the 
antioxidant enzyme superoxide dismutase (SOD) 250U/ml on the viability of MC3T3-E1 
cultures when each was applied alone and in combination with hydrogen peroxide 
(500pM) for up to 6 h. Each column represents the mean ± SEM for (A) n = 3 or (B) n = 4 
cultures. *P<0.05, **P<0.01, *** P<0.001 compared to control; #P<0.05, ns = non­
significant compared to corresponding H2 O 2 500pM.
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Figure 3.13. Histograms showing (A) the effects o f CUSO4  ImM alone and in 
combination with hydrogen peroxide lOOpM for 1 h on the viability of MC3T3-E1 
cultures and (B) the effect of the hydroxyl radical scavenger mannitol 50mM on the 
reduction in viability o f MC3T3-E1 cells induced by a combination of hydrogen 
peroxide (lOOpM) and copper (II) ion (ImM ) for 1 h. Each column represents the 
mean ± SEM for n = 4 cultures. **P<0.01, ***P<0.001, ns = non-significant 
compared to control; ###P<0.001.
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Figure 3.14. Photomicrographs showing the morphological effect of 1 h combination of 
H2O2 lOOpM and ImM on the viability of MC3T3-E1 cells and the exacerbation of 
this effect by the hydroxyl radical scavenger, mannitol 50mM. (a) Control (b) H2O2 
lOOpM (c) Cu^^lmM (d) H2O2 lOOpM + ImM, and (e) H2O2 lOOpM + ImM + 
Mannitol 50mM. Cultures treated with hydrogen peroxide and copper (II) ion showed 
damaged phenotype (d), which was worse in the presence of mannitol (e). Bar = 50pm.
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3.5.2.2. Membrane permeability transition (MPT) in H202~induced cell death
A  critical requirement for caspase-mediated apoptosis is the release o f cytochr ome c from 
the mitochondria through the process of membrane permeability transition, leading to the 
opening o f the inner membrane permeability transition pore. The involvement of this 
phenomenon in H 2 O2 -induced osteoblastic cell death was therefore assessed by the use of 
cyclosporin A, an agent that blocks the opening of the transition pore. Cyclosporin A 
(CsA) at 0.5, 1 and lOpM had no effect on its own when applied for 1 or 6 h (n = 4) (Fig. 
3.16A). At 1 h, hydrogen peroxide (500pM) reduced osteoblast viability very significantly 
to 61.18% ± 3.32 (P<0.001 , 11 = 4) (Fig. 3.16B). CsA had no effect on this reduction. In 
contrast, however, while 6 h application o f H 2 O 2 500pM reduced viability very 
significantly to 18.82% ± 2.34 (P<0.001, n = 3), CsA significantly ameliorated this 
reduction in a concentration-dependent manner.
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3.5.2. Mechanisms o f H202-induced osteoblastic cell damage and death
With a view to having a clearer understanding o f the nature of cell death induced by 
hydrogen peroxide in MC3T3-E1 cells, the relative contributions o f the processes of 
apoptosis and necrosis to the eventual demise o f the cells after treatment with the oxidant 
were investigated.
3.5.2.1. Amelioration o f  cell death by caspase-3 inhibition
Caspases are known to be the predominant mediators of apoptotic cell death (Cohen,
1997). Caspase-3 is believed to be the major and most widely studied executive caspase 
(Du et al., 1997). The role of caspase-3 in cell death mediated by hydrogen peroxide in 
MC3T3-E1 cells was therefore examined using the compound Z-DEVD-fmk, a potent 
caspase-3 inhibitor, at a concentration that had no effect on basal viability when applied 
alone. Hydrogen peroxide at a concentration of 200pM  reduced viability significantly at 6 
h (P<0.001, n = 3) (Fig. 3.15A). Z-DEVD-fmk (40pM) was unable to protect significantly 
against this insult, only raising viability 6% from 77.60% ± 3.85 for H 2 O2 alone to 82.55% 
± 0.66. At a higher concentration o f 500pM, hydrogen peroxide reduced viabilities very 
significantly to 63.98% ±  2.85 and 8.11% ± 2.38 o f the control, for 1 and 6 h treatments, 
respectively (P<0.001, n = 3) (Fig. 3.15B). In the presence o f Z-DEVD-fmk, the damage 
by H2 O2  500pM was unaltered at 1 h, but was very significantly protected against at 6 h 
(P< 0.001).
:É
Î
3.5.2.3. Poly (ADP-rihose) polymerase (PARP) inhibition in H202-'mediated cell
death
Evidence now shows that overactivation of the nuclear protein PARP, especially PARP-1, 
is inextricably involved in the induction o f necrotic cell death (Ha & Snyder, 1999; Moroni 
et al., 2001). In this study, the level of necrotic death involved in hydrogen peroxide- 
mediated osteoblastic cell death was examined using PARP inhibitors. Nicotinamide 
(NAm) is known to have some potential to inhibit PARP while DPQ is a very potent 
inhibitor. When tested at 6 h, nicotinamide at a concentration of 30pM  had no effect on its 
own and also failed to modify the deleterious effect of PI2 O 2 which reduced viability 
significantly to 21.60% ± 7.01 of the control (P<0.001, n = 4) (Fig. 3.17A). At a higher 
concentration of ImM, nicotinamide still had no effect when applied alone, but 
significantly protected against H2 O2  damage, raising viability from 32.42% ± 2.39 for 
peroxide alone to 66.46% ± 3.14 (P<0.001, n = 3) (Fig. 3.17B). DPQ (lOpM) had no effect 
on the cultures when applied alone. It also failed to elicit any protection when tested 
against the cytotoxicity of H2 O2  200pM that reduced viabilities significantly to 85.08% ± 
4.21 at 1 h (P<0.01) and to 81.98% ± 3.43 at 6 h (P<0.001, n -  5) (Fig. 3.18A). When 
tested against H2 O2 500pM (n = 3) (Fig. 3.18B), DPQ (lOpM) did not improve viability 
significantly at 1 h (a 6.9% rise from 66.27% ± 4.77 to 73.17% ±3.11), but at 6 h, there 
was a very significant (33.22%) rise in viability from 7.98% ± 2.39 to 41.20% ± 3.65 
(P<0.001).
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Figure 3.15. Histograms showing (A) the lack of effect of a caspase-3 inhibitor, Z-DEVD- 
fmk 40pM, on the cytotoxicity mediated by H2 O2 200pM in MC3T3-E1 cells and (B) the 
protective effect o f the inhibitor on the cytotoxicity mediated by H2 O2  500pM in MC3T3- 
E1 cells. Each column represents the mean ± SEM for n = 3 cultures. ***P<0.001 
compared to control; ns = non-significant, ### P<0.001 for the protective effect o f the 
inhibitor vs. cultures treated with (A) 200pM H2 O2  or (B) 500pM H2 O2  in the absence o f 
the inhibitor.
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Figure 3.16. Histograms showing (A) the lack of effect o f the inner membrane 
permeability pore blocker, cyclosporin A (CsA), on the viability o f MC3T3-E1 cultures 
and (B) the effects o f the blocker on hydrogen peroxide-mediated cytotoxicity in MC3T3- 
E1 cultures, for 1 or 6 h o f exposure. Each column shows the mean ± SEM for (A) n = 4 
cultures and (B) n = 4 cultures (1 h treatments) or n = 3 cultures (6 h treatments). 
***P<0.001 compared to control; #P<0.05, ##P<0.01 compared to corresponding H2 O2  
500pM treatment.
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Figure 3.17. Histograms showing (A) the lack o f effect o f a low concentration o f the poly 
(ADP-ribose) polymerase (PARP) inhibitor, nicotinamide (NAm 30pM) and (B) the effect 
o f a high concentration o f the PARP inhibitor (NAm ImM) on hydrogen peroxide- 
mediated cytotoxicity in MC3T3-E1 cultures. Each column shows the mean ± SEM for (A) 
n = 4 or (B) n = 3 cultures. ***P<0.001 compared to control; ###P<0.001, ns = non­
significant compared to H2 O2 500pM.
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Figure 3.18. Histograms showing (A) the lack of effect o f the potent poly (ADP-ribose) 
polymerase (PARP) inhibitor, DPQ (lOpM), on the cytotoxicity mediated by H2 O2  200pM 
and (B) the effect of the PARP inhibitor on the cytotoxicity mediated by H2 O2  500pM in 
MC3T3-E1 cultures. Each column shows the mean ± SEM for (A) n = 5 or (B) n = 3 
cultures. **P<0.01, ***P<Q.G01 compared to control; ns = non-significant compared to 
H2 O2 alone; ###P<0.001 compared to corresponding H2 O2 500pM.
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3.5.3. Roles o f  ligands at glutamate and adenosine receptors in hydrogen peroxide-
mediated cytotoxicity
3.5.3.1. Glutamate and NMD A receptor ligands and H 2 O2 cytotoxicity
In view of the trophic effects of a number of glutamate receptor ligands tested earlier, their 
possible roles were investigated in modulating damage caused by H2 O 2 on switched 
osteoblasts at 10 div, a stage at which they are believed to express fimctional glutamate 
receptors (Quarles et al., 1992). Hydrogen peroxide at 500pM reduced osteoblast viability 
in a time-dependent manner compared to untreated controls, with values down to 95.26% ± 
2.29, 84.13% ± 1.94, 72.20% ±7.01 , and 57.84% ± 13.04, for 0.25, 1, 3 and 6 h of 
treatment, respectively (n = 4 - 5) (Table 3.5). The obseiwed reduction in viability was 
significant at 1,3 and 6 h. As shown in the table, both agonists and antagonists failed to 
protect against the damaging effect of H 2 O2 . hi fact, rather than elicit any protective effect, 
they all showed a substantial tendency to potentiate the effects o f peroxide. At 0.25 h, 
hydrogen peroxide had no significant effect (95.26% ± 2.29 of the control), but in the 
presence of either the non-competitive NMDA receptor antagonist MK-801 (20pM) or the 
selective antagonist D-AP5 (50pM), H 2 O2  was able to reduce significantly viability to 
86.81% ± 4.54 (P<0.05) and 77.36% ± 2,29 (P<0.001) of the control, respectively.
3.5.3.2. Interactions between adenosine receptor ligands and hydrogen peroxide
Adenosine receptor ligands were also tested for their potential ability to modify damage to 
osteoblasts caused by the reactive oxygen species hydrogen peroxide. The results are as 
shown in Table 3.6 (n = 4 - 5). In each case, hydrogen peroxide (500pM) reduced viability 
in a time-dependent manner. Adenosine had no significant effect on the damage caused by 
hydrogen peroxide. The selective A, receptor agonist CPA applied at 50iiM for 0.25 h 
increased viability significantly from 95.97% ± 1.58 for H 2 O2  alone to 105.82% ± 3.45 
when combined with H 2 O2 . However, it did not significantly improve H 2 O2 damage caused 
by longer treatments. The selective A 2 A agonist CGS21680 (20nM) did not improve 
damage at any time point. Caffeine, an adenosine receptor antagonist, at ImM ameliorated 
the H 2 O2  damage at 3 h, improving viability significantly to 62.19% ± 6.66 from 44.62% ± 
4.02 for H 2 O2 alone (P<0.05). There were no significant effects on H2 O2 damage when the 
selective A | antagonists, DPCPX (50nM) and 8-PT (20pM), and the selective A 2 A 
antagonists, ZM241385 (50nM) and SCH58261 (50nM), were used.
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Experiments were also performed to examine if  a more stable adenosine analogue, 2- 
chloroadenosine, and higher concentrations (lOOnM for each) o f the Aj and A2 A receptor 
ligands could modify damage caused by hydrogen peroxide, hi this regard, the selective 
agonists and antagonists were tested for 1 and 3 h. Interestingly, 2-chloroadenosine, even 
when applied at a concentration of 1 pM, protected against H 2 O2  damage, with viability 
significantly improved from 72.87% ± 2.83 to 92.27% ± 4.57 (P<0.01) after 3 h and 
enhanced from 50.00% ±  4.68 to 71.35% ± 5.72 (P<0.01) after 6 h o f treatment (n = 3)
(Fig. 3.19). CPA lOOnM when applied alone for 1 h caused a significant increase in 
viability, which was 108.58% ± 0.75 o f the control (P<0.001), and also afforded protection 
against oxidant injury when present for 3 h (P<0.05, n = 4) (Fig. 3.20). DPCPX applied for 
1 h at lOOnM increased the viability o f MC3T3-E1 cells significantly to 107.85% ± 1.25 
(P<0.001), but failed to modify H 2 O2  damage (Fig. 3.20). CGS21680 increased baseline 
viability significantly when applied alone for 1 h (P<0.05), and also improved viability in 
Fl2 Ü2 -treated cultures (P<0.01 for 1 h, n = 4; and P<0.001 for 3 h, n == 3) (Fig. 3.21). 
ZM241385 lOOnM increased viability to 106.77% ± 0.77 o f the control level (P<0.01) after 
1 h application, but did not modify the effect o f H 2 O2 either at 1 or 3 h (Fig. 3.21). The 
effects of these treatments on the morphology o f the MC3T3-E1 cells are as shown in Fig. 
3.22, where arrows point to damaged cells and the agonists only partially improved 
damage by peroxide.
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ALAMAR BLUE REDUCTION (% OF CONTROL)
LIGAND
(pM)
0.25 h 1 h 3 h 6 h
H 2 O2 500pM 95.26 ± 2.29 84.13 ± 1.94^'^' 72.20 ± 7 .01^ 57.84 ±13.04^
NMDA 10 
100
82.37 ± 8.19  
82.27 ±4.83
66.61 ±9.59* 
70.94 ±8.30*
47.82 ± 15.00*
49.82 ± 16.35*
45.34 ± 
46.67 ±
14.56*
14.52*
Glu 100 
1000
82.46 ±8 .28  
88.72 ± 0 .10
72.88 ± 5.60** 
70.98 ± 7.00**
52.69 ± 15.53* 
52 .89± 15.81*
47.73 ± 
47.70 ±
14.63*
14.23*
MK-801 20 86.81 ±4.54* 71.13 ±9.60* 56.18 ± 14.43* 43.02 ± 13.53**
D-AP5 50 77.36 ±2.29"*** 74.03 ±7.14** 46.27 ± 14.13** 46.84 ± 12.36** I
: |
■
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I
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S
I
'I
Table 3.5. Table showing the effects of some NMDA receptor ligands on hydrogen peroxide- 
mediated cytotoxicity in MC3T3-E1 cultures. Each value as shown, representing the 
mean ± SEM for n = 4 or 5 cultures, is for the indicated ligand in combination with 
H2 O 2 500pM. *P<0.05, **P<0.01, *** P<0.001 compared to control; ^P<0.001 compared to 
H2 O2 500pM.
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LIGAND 
(pM, except stated)
AB RED U CTIO N  (%  O F CON TROL)
0.25 h 1 h 3 h 6 h
H 2 O2 SOOjuM 104.27 ± 7.34 88.26 ± 7 .14 44.62 ±4.02*-^* 30.88 ±8.67**
Adenosine 10 
100 
1000
101.49 ± 7 .00  
107.92 ±8.71 
101.41 ±8.33
83.28 ± 5.08 
91.00 ±8.49 
88.47 ±5.52
55.84 ±5.59 
54.14 ±6 .26  
45.61 ± 10.41
23.61 ±4.78
19.71 ±4.67 
27.03 ± 7.56
Caffeine 1000 112.66 ±6.87 87.32 ±3 .39 62.19 ±6.66" 29.27 ±6.03
B 2 O2 SOOjuM 95.97 ± 1.58 66.30 ±4.70** 15.19 ±2.06*** 10.65 ±2.96***
CPA 50nM
CGS21680 20nM 
DPCPX 50nM 
8-PT 20
105.82 ±3.45"
102.34 ± 3 .36  
97.58 ± 3 .10  
101.76 ±3.88
71.37 ±5.48
75.30 ±4.35 
74.75 ±5.55 
74.53 ±2.98
21.98 ±5.75
21.02 ± 7 .26  
21.68 ± 4 .07  
22.33 ±8.51
12.24 ± 1.62 
15.50 ±2.65 
15.93 ± 5 .70  
15.69 ±0.84
H 2 O2 SOOjuM 81.34 ±8.05 67.34 ±7.27* 56.36 ± 16.39 46.64 ±20.08
ZM241385 50nM 80.69 ±8.24 73.50 ±9.57 54.30 ± 17.60 46.24 ± 19.28
SCH58261 50nM 83.18 ±6.25 68.06 ±9.41 57.89 ± 16.95 43.31 ± 18.64
Table 3.6. Table showing the effects o f some adenosine Ai and A 2 A receptor ligands on 
hydrogen peroxide-mediated reduction in viability of the MC3T3-E1 cultures. Each value 
as shown, representing the mean ± SEM for 11 = 4 or 5 cultures, is for the indicated 
adenosine receptor ligand in combination with H2 O2  500pM. *P<0.05, **P<0.01,
*** P<0.001 compared to control, "P<0.05 compared to H 2 O 2 500pM.
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Figure 3.19. Histograms showing the effects of a stable adenosine analogue, 2- 
chloroadenosine (2-ClA IpM), on hydrogen peroxide-mediated cytotoxicity in MC3T3-E1 
cells. Each column represents the mean ± SEM for n = 3 cultures. ***P<0.001 compared to 
untreated controls; ## P<0.01 compared to H2O2 500pM.
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Figure 3.20. Histograms showing the effects o f a selective adenosine A] receptor agonist, 
CPA (lOOnM), and a selective A| receptor antagonist, DPCPX (lOOnM), on hydrogen 
peroxide-mediated cytotoxicity in MC3T3-E1 cells. Each column represents the mean ± 
SEM for n = 4 cultures. *** P<0.001 compared to control; # P<0.05 compared to H 2 O 2 
500pM.
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Figure 3.21. Histograms showing the effects of a selective adenosine A2A receptor agonist, 
CGS21680 (lOOnM), and a selective A2A receptor antagonist, ZM241385 (lOOnM), on 
hydrogen peroxide-mediated cytotoxicity in MC3T3-E1 cells. Each column shows the 
mean ± SEM for n = 4 cultures for 1 h treatments or n = 3 cultures for 3 h treatments. 
*P<0.05, **P<0.01, *** P<0.001 compared to control; ## P<0.01, ### P<0.001 compared 
to corresponding H2O2 500pM.
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Figure 3.22. Morphological effects o f 3 h application of H2O2 500pM alone and in 
combination with specific A| and A%A adenosine receptor agonists and antagonists (each at 
1 OOnM). (a) Control (b) H2O2 (c) H2O2 + CPA (d) H2O2 + CGS21680 (e) H2O2 + DPCPX, 
and (f) H2O2 + ZM241385. Arrows indicate damaged cells that have rounded up to a 
shrunken phenotype. Bar = 50pm.
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3.5.4. Other generators o f  reactive oxygen species
3.5.4.1. Xanthine (X) and xanthine oxidase (XO)
The effect of the superoxide-generating system o f xanthine (X) and xanthine oxidase 
(XO) on osteoblast viability was also examined for 1, 6 and 24 h. Xanthine (lOOjuM) 
alone applied for 1 or 6 h had no effect on viability but at 24 h significantly increased 
baseline viability beyond control level to 108.01% ± 2.82 (P<0.01, n = 4 - 5) (Fig.
3.23). The application of xanthine oxidase at an activity of 0.02U/ml had no effect on 
osteoblast viability. Xanthine and xanthine oxidase when combined together produced 
no effect on osteoblast viability at I o rb  h, but increased viability significantly to 
108.38% ± 0.83 of the control at 24 h (P<0.05). There was no difference between this 
effect and that produced when xanthine was applied alone for 24 h.
3.5.4.2. Metabolites o f  the Itynurenine metabolic pathway
The kynurenine pathway is involved in the metabolism o f the amino acid tiyptophan. A 
number o f metabolites produced along this pathway are Icnown to be potent generators 
o f reactive oxygen species. They include 3-hydroxyanthranilic acid (3-HAA) and 3- 
hydroxykynurenine (3-HK). Osteoblast cells were therefore cultured with these 
metabolites to observe any potential effects on baseline viability. 3-HAA at 1 and 
lOnM had no effect when applied for up to 24 h. At I OOnM, 3-HAA induced a slight 
but significant increase in viability after 1 h exposure (P<0.05), but had no effect when 
treatment lasted for 6 or 24 h (n = 3) (Fig. 3.24A). Osteoblast cultures were exposed to 
3-HK for a period between 1 and 24 h. The application o f 10 and lOOpM 3-HK for up 
to 6 h had no effect (n = 5) (Fig. 3.24B). Even when cultures were treated for a longer 
period o f 24 h, 3-hydroxykynurenine at 1, 10 and lOOpM still had no effect, giving 
viability values of 99.80% ± 2.43, 105.73% ± 1.66 and 98.03% ± 0.97 o f the control, 
respectively. However, profound time-dependent reductions in viability were obtained 
with 3-HK at ImM. This concentration reduced osteoblastic viability significantly to 
85.44% ± 1.34 o f the control at 1 h, representing a 14.56% reduction (P<0.01) (Fig. 
3.24B). With a longer exposure period o f 6 h, viability in the presence o f 3-HK ImM 
was decreased to 39.13% ± 4.77 of the control (P<0.01), representing a significantly 
greater reduction of 60.87% (P<0.001). Morphologically, cultures treated with 3-FIK 
ImM  for 1 h showed some loss of intact cells while treatment with the same
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concentration of the kynurenine for a longer period of 6 h revealed greater loss of cells 
and the rounding up of remaining cells (Fig 3.25).
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Figure 3.23. Histograms showing the effects of xanthine lOOpM and xanthine oxidase 
0.02U/ml on the viability of MC3T3-E1 cultures when each of them was applied alone and 
when they were combined for 1, 6 or 24 h. Each column represents the mean ± SEM for n 
= 4 or 5 cultures. *P<0.05, **P<0.01 compared to control.
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Figure 3.24. Histograms showing the effects on the viability o f MC3T3-E1 osteoblast 
cultures of (A) a kynurenine pathway metabolite, 3-hydroxyanthranilic acid (3-HAA) 
applied for 1, 6 or 24 h and (B) another kynurenine pathway metabolite, 3- 
hydroxykynurenine (3-HK), applied for 1 or 6 h. Each column shows the mean ± SEM 
for (A) n = 3 or (B) n = 5 cultures. *P<0.05, **P<0.01 compared to control; 
###P<0.001 for comparison of effects o f 3-HK ImM at 1 and 6 h (SNK).
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Fig. 3.25. Effects on the morphology of MC3T3-E1 cells of 3-hydroxykynurenine (3-HK). 
(a) Control (b) ImM (1 h) (c) ImM (6 h). Treatment with 3-HK ImM for 1 h showed 
initiation of damage to previously intact cells (b), which was more pronounced with the 
longer treatment (6 h) (c). Bar = 50pm.
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3,5.5. Nitrosative stress and osteoblastic viability
We investigated whether the effects elicited by reactive oxygen species in MC3T3-E1 
cells are shared by reactive nitrogen species like nitric oxide by using the nitric oxide 
donor S-nitroso-Wacetyl penicillamine (SNAP). Baseline viability was unchanged with 
1 or 6 h exposure to SNAP lOpM, but a 24 h exposure resulted in a significantly 
increased viability that was 109.13% ± 3.50 of the control (P<0.05, n = 4) (Fig. 3.26A). 
SNAP lOOpM elicited no effect at any time point examined. Cultures were 
subsequently exposed to higher SNAP concentrations for 24 h. SNAP ImM  failed to 
produce a significant effect, reducing viability less than 7% to 93.08% ± 6.57 o f the 
control (n = 4) (Fig. 3.26B). However, SNAP at 5mM was profoundly toxic to the 
osteoblasts, with almost 94% reduction o f viability to 6.10% ± 0.72 o f the control 
(P<0.01), an effect that suggested that complete cell death was induced with this SNAP 
concentration.
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Figure 3.26. Histograms showing (A) the lack of effect o f low concentrations (10, 
lOOpM) o f a nitric oxide donor, S-nitroso-V-acetyl penicillamine (SNAP) applied for 1, 
6, or 24 h and (B) the effects o f high concentrations (1, 5mM) o f the donor, applied for 
24 h, on the viability of MC3T3-E1 cultures. Each column represents the mean ± SEM 
for n = 4 cultures. *P<0.05, **P<0.01, ns = non-significant compared to control.
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3.5.6. Mitochondrial poisoning and osteoblastic viability
Considering the observed relative resistance o f MC3T3-E1 cultures to both oxidative and 
nitrosative stress - evidenced by a requirement for prolonged exposure to high 
concentrations of inducers o f oxidative and nitrosative stress to elicit significant reduction 
of viability - the degree of their sensitivity to mitochondrial damage was established. Two 
known potent mitochondrial poisons were used: potassium cyanide (KCN) and 3- 
nitropropionic acid (3-NPA). Interestingly, exposures of MC3T3-E1 cultures to both low 
and high concentrations of KCN (lOpM -  lOmM) were unable to produce any statistically 
significant damage with treatments lasting for up to 24 h, although lOOpM and ImM 
applications were potentially toxic at 24 h, reducing viabilities to 85.06% ± 4.74 and 
85.33% ± 7.02 o f the control (n = 4 - 5) (Fig. 3.27A). Similarly, exposure to 3-NPA at 10, 
100 and lOOOpM for up to 6 h produced no effect on osteoblast viability. However, with 
24 h of exposure, 3-NPA lOOpM significantly reduced osteoblast viability 33.36% to 
66.64% ± 15.62 o f the control (P<0.05, n = 4) (Fig. 3.27B), while 3-NPA ImM  elicited a 
greater reduction (57%) to 42.86% ± 7.04 o f the control (P<0.01).
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Figure 3.27. Histograms showing (A) lack o f effect of the mitochondrial poison, 
potassium cyanide (KCN) and (B) the effects of another mitochondrial poison, 3- 
nitropropionic acid (3-NPA), each applied for up to 24 h, on the viability o f MC3T3-E1 
cultures. Each column represents the mean ± SEM for (A) n = 4 or 5 or (B) n = 4 cultures, 
*P<0.05, **P<0.01 compared to control. No statistically significant effect was produced by 
KCN.
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4. RESULTS -  EFFECTS OF GLUTAMATE AND OXIDATIVE STRESS ON THE 
VIABILITY OF CEREBELLAR GRANULE NEURONES (CGNs) 
4.1. Immuiiocytochemical labelling for neuronal tubnlin
In order to determine their purity, the cultured cerebellar granule neurones were 
immunolabelled with an antibody specific for the p-III isoform o f neuronal tubulin. This 
isoform o f the cytoskeletal protein tubulin is found tlu'oughout the cytoplasm, but not 
nucleus, o f the perikarya and extends into the neurite processes; it is specific for neurones 
(Geisert & Frankfurter, 1989; Farina et al., 1999). The results are as shown in Fig. 4.1. At 8 
div, the cultures showed strong immunoreactivity against the mouse anti-human p-III 
isoform of tubulin monoclonal antibody (Fig. 4.1b), while control cultures that were not 
treated with the (primary) antibody lacked such staining (Fig. 4. Id). The corresponding 
bright field appearances have been included (Fig. 4.1a and Fig. 4.1c).
4.2. Alamar Blue (AB) standardization
The routine alamar blue determination of viability in cerebellar granule neurones (CGNs) 
was standardized with regard to seeding density and duration of incubation with the dye, as 
was the case with the M C3T3-EI cells. Seeding densities were in the range 2.5 x 10  ^to 2 x 
10^ cells per ml, in consecutive, two-fold increases, incubated for 2, 4, 6, and 8 h. For a 
given incubation period (6 h), AB reduction increased linearly (R^ = 0.9002) with 
increasing densities (Fig. 4.2A). Similarly, for a given seeding density (1 x 10  ^cells per 
ml), AB reduction increased linearly (R^ = 0.9739) with time (Fig. 4.2B). In all 
experiments therefore, a seeding density of 1 x 10  ^cells per ml and an incubation period of 
6 h were chosen as standard.
The non-toxicity o f AB to CGNs was also confirmed. Two sets o f cultures were pretreated 
for 6 h with either AB (10%v/v) or an equal amount (10% v/v) o f vehicle. No disruption or 
lysis of neuronal cells was obseiwed. Cultures were then restored to the culture medium for 
at least 16 h before viability was determined. When quantified with AB itself, there was no 
difference in the viability of cultures pretreated with AB and that of cultures pretreated 
with vehicle dilution (0.120 ± 0.003 vs. 0.124 ± 0.004, for AB- and vehicle-treated 
(control) cultures, respectively; n = 6). The use o f the trypan blue exclusion test also 
confirmed no difference in the viabilities o f the two sets of cultures (92.93% ± 3.17 vs. 
90.55% ± 0.40, n - 4).
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Figure 4.1. CGN cells cultured for 
8 div to identify positively the 
neuronal phenotype by 
immunocytochemical labelling with 
antibody against P-III isoform of 
tubulin, which is a specific marker 
for the neuronal cytoskeleton.
(a) bright field and (b) fluorescent 
micrographs o f neurones with 
extensive neurite outgrowth 
evident.
(c) bright field and (d) fluorescent 
micrographs o f neurones when 
primary antibody was omitted as a 
staining control (note only faint 
background outline o f neuronal cell 
bodies and no staining into the 
neurite processes).
Bar = 50pm.
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Figure 4.2. Graphs showing the linear correlation between alamar blue (AB) 
reduction and (A) the initial seeding density when duration o f incubation was 6 h 
and (B) the duration of AB incubation for a given seeding density of 1 x 10  ^cells 
per ml in cerebellar granule neuronal (CGN) cultures. Each data point represents the 
mean ± SEM for n = 4 cultures.
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4.3. Serum and high potassium concentration withdrawals (deprivation)
Serum and raised potassium ion concentrations are two culture supplements whose 
inclusions in the culture medium are known to significantly promote the survival o f CGN 
cultures (Hopp et al., 1987; Hetman et al., 1999; Gallo et al., 1987; Balazs et al., 1988; 
Lindholm et a l , 1993). The degree o f sensitivity of the CGN cultures to the absence of 
these supplements was therefore assessed. Cerebellar granule cultures gi'own in 10% PCS 
were serum-deprived for 1 and 6 h at 8 div. This was followed by a recovery period of 20 h 
before viability determination. While 1 h o f serum deprivation had no effect on neuronal 
survival, cultures without serum for 6 h showed a very significant (32.42%) reduction 
(P<0.01, n = 6) in survival when compared with non serum-deprived control (67.58% ± 
2.21 o f the control) (Fig. 4.3). Cultures that underwent semm withdrawal especially at 6 h 
showed a grossly slmmken morphology with extensive damage to their neurite processes 
(Fig. 4.4a-c) compared to control cultures with robust appearance and intact neurite 
processes. Withdrawal of high potassium concentration was achieved by reducing the 
concentration o f potassium in the culture medium from 25mM to 5mM for 2 days from 6 
to 8 div. This reduction took into account the level of potassium in the basal medium 
(MEM) used, which was approximately 5mM. The potassium withdrawal protocol was 
therefore essentially the withdrawal of the potassium added at plating. The full medium 
was restored for at least 20 h at the end of the 2 days o f high potassium withdrawal, after 
which viability was determined. As shown in Fig. 4.3, a very significant (31.44%) 
reduction (P<0.01) in viability compared to control cultures that were maintained in high 
potassium concentration was obseiwed (68.56% ± 5.74 o f the control) and this was well 
correlated with morphological effects, as low-potassium cultures contained slirivelled 
neurones with damaged processes as opposed to high-potassium (control) cultures that 
retained intact cell bodies and neurite interconnections (Fig. 4.4d-e). The results from 
semm withdrawal experiments determined the subsequent protocol throughout, which 
subjected CGNs for no longer than 1 h without semm in Hanks’ Balanced Salt Solution 
(HBSS) when undertaking excitotoxicity studies.
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Figure 4.3. The effects of withdrawing PCS and high potassium concentration on 
the viability of CGNs. Serum was withdrawn at 8 div for the indicated duration, 
while high potassium concentration (25mM) was withdrawn for 2 days from 6 to 8 
div. High potassium concentration withdrawal implies removal of the extra 
potassium added to the culture medium when cultures were set up. This was 
achieved by restoring the cultures to MEM supplemented with PCS, without adding 
extra potassium. Basal potassium level in the MEM used was approximately 5mM. 
Each column represents the mean ± SEM for n = 6 cultures. **P<0.01, ns = non­
significant compared to control.
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Figure 4.4. Effects on cerebellar granule neurones of (a-c) withdrawing serum for 1 or 6 h 
and (d-e) reducing potassium concentration for 2 days from 25mM (high K^) to 5mM (low 
K^). Cultures were supplemented with or without 10% PCS.
(a) Control (no serum withdrawal) (b) 1 h serum withdrawal (c) 6 h serum withdrawal, and
(d) Control (25mM K ) (e) 2 days of low (6 - 8 div). Note the gross shrunken 
appearance of cultures that were serum-deprived for 6 h (c) and those that were maintained 
in low potassium concentration (e), in comparison to their respective control cultures (a 
and d), which showed intact neurite processes. Bar = 50pm.
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4.4. Excitotoxicity in the cerebellar granule neurones
Excitotoxicity studies were carried out at 9 div in Hanks’ Balanced Salt Solution without 
serum, due to the earlier observations that serum may significantly compensate for and 
thus occlude the neurotoxic effect o f glutamate.
4.4.1. Glutamate and NMDA-induced excitotoxicity
The effects o f glutamate and the selective agonist NMDA on the viability of cerebellar 
granule neurones were examined using two different post-treatment protocols. One 
restored the cultures, after 1 h treatment, to semm-free MEM enriched with D-glucose 
21mM (MEM + glucose) and the other restored cultures to MEM supplemented with 10% 
PCS (MEM + semm). Cultures were allowed to recover for at least 18 h. With both 
protocols, glutamate (lOpM - IniM) reduced the viability o f CGNs significantly in a 
concentration-dependent manner, compared to the control (P<0.01, n == 4 - 6) (Pig. 4.5). 
However, there were greater reductions in viability when cultures were restored to MEM + 
glucose than when restored to MEM + semm, which was significant for lOpM and lOOpM 
of glutamate. NMDA (lOpM - ImM) also induced a concentration-dependent reduction in 
CGN viability with both conditions (n = 4 - 6) (Pig. 4.6). NMDA was less potent in 
reducing CGN viability than glutamate at comparable concentrations, and no difference 
was observed between the effects o f the two restoration protocols for any given 
concentration o f NMDA. Morphologically, there was severe damage to the cell bodies and 
neurites o f cultures treated with glutamate or NMDA, and at high concentrations, cell loss 
was evident (Fig. 4.7). The loss o f cells following treatment with lOOpM glutamate was 
significantly greater when cultures were restored to MEM + glucose than when restored to 
MEM + serum. For all subsequent excitotoxicity experiments, cultures were restored after 
1 h o f treatment to serum-containing MEM, as this favoured baseline survival significantly 
more than restoration to serum-free, glucose-enriched MEM.
4.4.1.1. Blockade hy antagonists o f  glutamate-induced excitotoxicity
By employing both non-competitive and selective antagonists at the NMDA receptor, the 
involvement of the NMDA receptor in the observed reduction in CGN viability induced by 
either glutamate or NMDA was clarified. The non-competitive NMDA antagonist 
dizocilpine (MK-801) (lOpM) and the selective antagonist D-AP5 (50pM) had no 
significant effects on the CGN cultures when applied alone, giving viability values of 
107.30% ± 2.04 and 105.83% ± 2.96 of the control, respectively (n = 3). For glutamate or
120
:NMDA, a working concentration o f 300|liM  was chosen, as this concentration produced 
approximately 50% reduction in viability, thus allowing increases or decreases induced by 
other agents to be clearly observed. Glutamate 300pM reduced the viability o f CGN 
cultures to 62.44% ± 1.22 o f the control (P<0.01, n = 3) (Fig. 4.8A). MK-801 (lOpM) 
significantly attenuated this effect o f glutamate (P<0.05), raising viability to 79.94% ±
6.78, a level that was still significantly lower than the control (P<0.05 compared to 
control), while the application o f D-AP5 at 50pM restored viability to 91.03% ± 6.58 
(P<0.01), a level comparable with the control. This restoration o f viability by D-AP5 
correlated with morphological improvement in which damage to cell bodies was improved 
as shown in Fig. 4.11 a-c. The involvement o f the AMPA/kainate receptors in the reduction 
of viability by glutamate was examined using the AMPA/kainate receptor blocker, CNQX, 
at lOjuM. CNQX had no significant effect on its own and also failed to attenuate the effect 
of glutamate that reduced CGN viability to 58.73% ± 8.31 o f the control (P<0.001, n = 4) 
(Fig. 4.8B). Kynurenic acid (KYA), a product o f the kynurenine pathway of tryptophan 
metabolism (Stone & Darlington, 2002), blocks NMDA receptor activation by acting as an 
antagonist at the glycine-sensitive co-agonist site (Perkins & Stone, 1982). Its effect on 
glutamate-induced reduction in viability o f CGNs was therefore investigated. At ImM, 
KYA completely blocked the significant (23.92%) reduction (P<0.01) in viability induced 
by glutamate 300 |liM  (n = 4) (Fig. 4.9A). Complete blockade of glutamate effect was also 
obtained with KYA lOOpM (n = 4) (Fig. 4.9B). These concentrations of KYA elicited no 
significant changes in viability when applied alone (107.92% ± 5.36 and 112.45% ± 3.28, 
for lOOpM and ImM KYA, respectively; P>0.05, n = 3). However, with regards to 
morphological outcomes, KYA when applied with glutamate preserved neuronal cell 
number but not neurite outgrowth (Fig. 4.1 la, b, d).
4.4.1.2. Antagonists and NMDA-induced excitotoxicity
Application of NMDA 300pM resulted in a significant decrease in the viability of CGNs to 
61.89% ± 2.87 (P<0.001) (Fig. 4.10A). This effect was completely abolished by both MK- 
801 (lOpM) and D-AP5 (50pM) (P<0.001, n = 3). Interestingly, in the presence of D-AP5, 
NMDA-treated cultures retained a morphology that was almost identical to that of control 
cultures (Fig. 4.11a, e, f). hr Fig. 4 .1 OB, NMDA reduced viability to 67.63% ± o f the 
control (P<0.001, n = 3). Kynurenic acid at lOOpM totally blocked this NMDA effect, 
while at ImM, it raised viability in the presence of NMDA significantly beyond the control 
level (P<0.01).
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Figure 4.5. The effects o f 1 h application o f glutamate on the viability of cerebellar 
granule neuronal cultures at 9 div. Treatments were carried out in Hanks’ Balanced Salt 
Solution (HBSS) without serum. At the end o f the treatment period, cultures were either 
restored to serum-free MEM containing D-glucose 2 ImM (MEM + glucose), or to medium 
containing 10% PCS without glucose (MEM + serum). Each column shows the mean ± 
SEM for n = 4 or 6 cultures. **P<0.01 compared to control; #P<0.05, ##P<0.01 for 
comparison between MEM + glucose and MEM + serum cultures.
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Figure 4.6. Histograms showing the effects of 1 h application of NMDA on the viability of 
cerebellar granule neuronal cultures at 9 div. Treatments were done in Hanks’ Balanced 
Salt Solution without serum. At the end of the treatment period, cultures were either 
restored to serum-free MEM containing D-glucose 2 ImM (MEM + glucose), or to medium 
containing 10% PCS without glucose (MEM + serum). Each column shows the mean ± 
SEM for n = 4 or 6 cultures. *P<0.05, **P<0.01 compared to control.
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Fig. 4.7. Morphological effects of increasing concentrations of glutamate and NMDA on 
cerebellar granule neuronal cultures at 9 div that were restored to MEM + serum (except 
otherwise stated), (a) Control (b) Glutamate lOOpM (c) Glutamate lOOpM (MEM + 
glucose) (d) Glutamate ImM (e) NMDA lOOpM (d) NMDA ImM. Glutamate-treated (b, 
c, d) or NMDA-treated (e, f) cultures suffered damage to their cell bodies and neurites. 
There was greater cell loss with restoration to MEM + glucose (c) than with restoration to 
MEM + serum (b) for glutamate lOOpM. Bar = 50pm.
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Figure 4.8. Histograms showing the blockade of the excitotoxic effects on CGNs o f 1 h 
application of glutamate (Glu BOOpM) by (A) the non-competitive NMDA receptor 
antagonist, MK-801 (lOpM), and the selective NMDA receptor antagonist, D-AP5 
(50pM), but not by (B) the AMPA/kainate receptor antagonist, CNQX (lOpM). Each 
column shows the mean ± SEM for (A) n = 3 or (B) n = 4 cultures. *P<0.05, **P<0.01, 
***P<0.001, a = non-significant compared to control; #P<0.05, ##P<0.01, ns = non­
significant compared to Glu 300pM.
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Figure 4.9. Histograms showing the blockade o f the excitotoxic effects o f glutamate (Glu 
300pM) by the broad-spectrum glutamate receptor antagonist, kynurenic acid (KYA), at 
(A) ImM, and (B) lOOpM. Each column shows the mean ± SEM for n = 4 cultures. 
**P<0.01, ***P<0.001 compared to control; ###P<0.001 compared to Glu 300pM.
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Figure 4.10. Histograms showing the blockade of the excitotoxic effects on CGNs of 1 h 
application of NMDA (300pM) by (A) the non-competitive NMDA receptor antagonist, 
MK-801 (lOpM), and the selective NMDA receptor antagonist, D-AP5 (50pM) and (B) 
the broad-spectrum glutamate receptor antagonist, kynurenic acid (KYA) lOOpM, ImM. 
Each column shows the mean ± SEM for n = 3 cultures. **P<0.01, ***P<0.001 compared 
to control; ###P<0.001 compared to NMDA 300pM; ++P<0.01 for comparison between 
the effects of KYA lOOpM and KYA ImM on excitotoxicity induced by NMDA 300pM.
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Fig. 4.11. Photomicrographs showing glutamate- and NMDA-induced morphological 
damage in cerebellar granule neurones and protection by some NMDA receptor 
antagonists, (a) Control (b) Glu 300pM (c) Glu 300pM + D-AP5 50pM (d) Glu 300pM + 
KYA lOOpM (e) NMDA 300pM (f) NMDA 300pM + D-AP5 50pM. D-AP5 significantly 
improved glutamate-induced damage to both cell bodies and neurite outgrowth, while 
kynurenic acid reduced the damage by preserving cell number but not neurite outgrowth. 
Cultures that were treated with NMDA in the presence of D-AP5 retained a morphology 
that was identical to that of control cultures. Bar = 50pm.
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4.4,2, Mitochondrial poisoning and NMDA receptor activation
In order to verify the extent o f mitochondrial involvement in the damage and death of 
CGNs, the degree of sensitivity of these cultures to mitochondrial impairment was 
examined using the mitochondrial poison 3-nitropropionic acid (3-NPA). Following 1 or 6 
h exposures, 3-NPA reduced CGN viability in a concentration-dependent manner, 
compared to the control (P<0.01, n = 3) (Fig. 4.12). While 3-NPA lOpM applied for 1 or 6 
h had no effect, the damaging effects produced by each of the higher 3-NPA 
concentrations (lOOpM, ImM) at 1 and 6 h were comparable. An examination o f CGN 
morphology following these treatments showed profound loss o f neurones and in some 
cases some pathological clumping together of cells (Fig. 4.13a-d). In an attempt to 
understand the potential niechanism(s) of 3-NPA-induced damage, the prospect o f a 
possible involvement of NMDA receptor activation was investigated by testing the 
selective NMDA antagonist D-AP5 at 50pM against the damaging effect o f 3-NPA. This 
concentration o f D-AP5 had no effect on its own on basal viability (102.69% ± TOO of the 
control, n = 4). As shown in Fig. 4.14A, 3-NPA ImM  applied for 6 h reduced viability 
significantly to 59.58% ± 3.01 (P<0.001, n = 3). In the presence o f D-AP5, this effect was 
completely abolished. Similarly, when tested against damage by another mitochondrial 
poison, potassium cyanide (KCN), D-AP5 raised viability from 62.85% ± 3.97 for KCN 
ImM alone applied for 6 h (P<0.001, compared to control, n = 4) (Fig. 4.14B) to 89.75% ±
4.79, a level not significantly different from the control. The profound cell loss and 
damage to neurite outgrowths induced by this KCN concentration are as shown in Fig. 4.13 
(a, e).
129
□ 1 h 16 h
1 2 0
Oiz 100 c  O o't- 80
cg
o3T3
üè,
CD
<
60
40
20
0
** **
10 100 1000 
3-nitropropionic acid [pM]
Figure 4.12. Histograms showing the dose-dependent effects on the viability of CGN 
cultures at 8 div of 1 and 6 h exposures to the mitochondrial poison, 3-nitropropionic acid 
(3-NPA). Each column shows the mean ± SEM for n = 3 cultures. **P<0.01 compared to 
control.
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Figure 4.13. Concentration-dependent damaging effects of the mitochondrial poison 3- 
nitropropionic acid (3-NPA) and the damaging effect of another mitochondrial poison, 
potassium cyanide (KCN) at ImM on the morphology of cerebellar granule neurones, (a) 
Control (b) 3-NPA lOOpM (1 h) (c) 3-NPA lOOpM (6 h) (d) 3-NPA ImM (6 h) (e) KCN 
1 mM (6 h). Cells that were treated with the poisons (b-e) showed massive loss of cells, 
degeneration of neurite connections, and in some cases pathological clumping together of 
cells, in contrast to control cultures (a) with intact cell bodies and neurite connections. Bar 
= 50pm.
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Figure 4.14. Histograms showing the effects of the selective NMDA receptor antagonist, 
D-AP5 (50pM), on the reduction in CGN viability induced by 6 h of exposures to the 
mitochondrial poisons (A) 3-nitropropionic acid (3-NPA) ImM and (B) Potassium cyanide 
(KCN) ImM. Each column shows the mean ± SEM for (A) n = 3 or (B) n = 4 cultures. 
***P<0.001, ns = non-significant compared to control; ###P<0.001 compared to (A) 3- 
NPA ImM or (B) KCN ImM.
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4.4.3. Mechanisms o f glutamate-induced excitotoxic damage
The relative involvements o f the induction of caspase-3, poly (ADP-ribose polymerase) 
and the process of membrane permeability transition in glutamate-mediated excitotoxicity 
were examined.
4.4.3.1. Role o f  caspase-3-mediated apoptosis
The caspase-3 inhibitor Z-DEVD at 40pM had no effect on its own on CGN viability. 
Exposure to glutamate 300pM  for 1 h reduced viability significantly to 66.95% ±3.15 of 
the control (P<0.01, n = 4) (Fig. 4.15). This glutamate effect was significantly attenuated 
(24.34%) in the presence of Z-DEVD 40pM  to a viability level o f 91.29% ± 7.57 (P<0.01 
compared to glutamate alone), which was comparable to the untreated control.
4.4.3.2. Induction o f  membrane permeability transition (MPT)
The ability of the membrane permeability transition pore blocker cyclosporin A at 0.5, 1 
and lOpM in preventing excitotoxic damage by glutamate was verified. When added alone, 
these concentrations gave viability values o f 94.87% ± 6.92, 99.57% ± 11.24 and 97.63% ± 
3.66, respectively (n = 3), which were not statistically different from the control. CsA at 
0.5 and 1 pM completely blocked the significantly reduced neuronal viability (69.97% ± 
2.08, P<0.001, n = 4) (Fig. 4.16) resulting from Glu 300pM treatment, restoring levels to 
control values. Interestingly, CsA at lOpM also completely blocked the glutamate effect, 
but in this case improving viability to 131.35% ± 3.88, a level significantly higher than the 
control (P<0.001). When CsA at IpM  was tested against NMDA-induced reduction in 
CGN viability, it was equally capable o f protecting the neurones against NMDA, raising 
this value to mateh the control at 103.48% ± 4.35 (P<0.001 vs. NMDA alone, n = 3), in 
contrast to NMDA 300pM alone which reduced viability to 64.44% ± 4.05 of the control 
(P<0.001).
4.4.3.3. Involvement o f  poly (ADP-ribose) polymerase (PARP)
Nicotinamide ImM  (a PARP inhibitor), while having no effect on its own, raised viability 
signifieantly (P<0.01) from 65.36% ± 1.50 for glutamate alone to 75.73% ± 2.38 when co­
administered with glutamate for 1 h (n = 3) (Fig. 4.17A). The very potent PARP inhibitor 
DPQ at lOpM had no effect on basal neuronal viability when applied alone (n = 5) (Fig. 
4.17B). Glu 300pM reduced viability to 60.76% ± 6.65 of the control (P<0.01). In the
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presence of DPQ lOpM, this glutamate effect was significantly (P<0.01) attenuated 
(27.52%) to 88.28% ± 8.22, a level comparable to the control.
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Figure 4.15. Histogram showing the effect of the caspase-3 inhibitor, Z-DEVD-fmk 
40pM, on the neurotoxicity mediated by Glu 300pM in CGN cultures. Each column 
represents the mean ± SEM (n = 4 cultures). **P< 0.01, ns = non-significant compared to 
untreated control; ## P<0.01 for the protective effect of the inhibitor vs. cultures treated 
with Glu 300pM in the absence of the inhibitor.
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Figure 4.16. Histogram showing the effects o f cyclosporin A (0.5, 1, lOpM), a membrane 
permeability transition pore blocker, on glutamate-mediated neurotoxicity in CGN 
cultures. Each column shows the mean ± SEM for n = 4 cultures. ***P<0.001 compared to 
control; ###P<0.001 compared to Glu 300pM.
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Figure 4.17. Histograms showing the effects on glutamate-mediated neurotoxicity in CGN 
cultures o f the poly (ADP-ribose) polymerase (PARP) inhibitors (A) nicotinamide (NAm) 
ImM and (B) DPQ lOpM. Each column shows the mean ± SEM for (A) n = 3 or (B) n = 5 
cultures. **P< O.Ol, ***P<0.001, ns = non-significant compared to control; ##P<0.01 
compared to Glu 300pM.
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4.4.4. Adenosine receptors and protection against glutamate-induced excitotoxicity 
The roles o f adenosine Ai and A 2 A receptor ligands in the modulation o f glutamate-induced 
excitotoxic damage in the cerebellar granule neurones were examined.
4.4.4.1. A 1 receptor ligands and modulation o f  excitotoxic damage
The selective Ai receptor agonist CPA at lOOnM had no effect on basal viability. 
Application of glutamate 300pM reduced viability significantly to 66.02% ± 1.23 
(P<0.001, n = 4) (Fig. 4 .18A). Complete protection was afforded by CPA against this 
damage, raising viability to 95.16% ± 1.78 o f the control. While the selective Ai receptor 
antagonist DPCPX (lOOnM) did not have any effect on its own, it tended to exacerbate the 
neuronal damage induced by glutamate (n = 3) (Fig. 4.18B). Addition o f glutamate 300pM 
alone decreased viability to 74.48% ± 4.59 (P<0.001). In the presence of DPCPX, the 
addition of glutamate lowered viability a further 8.34% to 66.14% ±2.76 , although the 
difference was not statistically significant.
4.4.4.2. À 2A receptor ligands and excitotoxic damage
Exposure to glutamate 300pM lowered neuronal viability significantly to 73.06% ± 3.99 
(P<0.05, n = 4) (Fig. 4.19A). The selective A2 A receptor agonist, CGS21680 at lOOnM 
neither had any significant effect on its own nor modified the damage caused by glutamate. 
On the other hand, although without effect on its own, the selective A 2 A antagonist 
ZM241385 at lOOnM significantly attenuated the damage caused by glutamate (P<0.05, n 
= 3) (Fig. 4.19B), restoring viability to 86.08% ± 8.02 from 62.19% ± 4.11 obtained in the 
presence of glutamate alone.
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Figure 4.18. Histograms showing (A) the protective effect o f the A; receptor agonist, CPA 
(lOOnM) and (B) the lack o f significant effect of the Ai receptor antagonist, DPCPX 
(lOOnM) against glutamate-induced reduction in the viability o f CGN cultures. Each 
column represents the mean ± SEM for (A) n = 4 or (B) n = 3 cultures. ***P< 0.001, a = 
non-significant compared to control; ### P<0.001, ns = non-significant compared to Glu 
300pM.
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Figure 4.19. Histograms showing (A) the lack of significant effect o f the A2 A receptor 
agonist, CGS21680 (lOOnM) and (B) the protective effect o f the A 2 A receptor antagonist, 
ZM241385 (lOOnM) against glutamate-induced reduction in the viability o f CGN cultures. 
Each column represents the mean ± SEM for (A) n = 4 or (B) n = 3 cultures. *P< 0.05, 
**P< 0.01, a = non-significant compared to control; #P<0.05, ns = non-significant 
compared to Glu 300pM.
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4.5. Reactive oxygen species (ROS) and neuronal viability
4.5.1. Hydrogen peroxide and the viability o f cerebellar granule neurones 
Cerebellar granule neurones were exposed to concentrations o f H 2 O 2  ranging from 10 to 
400pM  in full (serum-containing) medium for 0.25, 1, 3 and 6 h. In order to verify whether 
the duration o f recovery could influence treatment outcomes, recovery durations of 6 and 
24 h were employed. Cultures were all restored after treatment to full culture medium. 6 h 
of recovery was taken as the period immediately after treatment with H2 O2 for which 
cultures were incubated with alamar blue (AB) before determining viability by plate 
reading. Recovery for 24 h was for the period allowed between the end of treatment and 
the determination of viability, including the last 6 h for which cultures were incubated with 
AB before plate reading. Fig. 4.20A shows the results obtained for 6 h of recovery while 
Fig. 4.20B illustrates the outcomes for 24 h o f recovery. With a recovery period of 6 h, 
H2 O2  reduced the viability o f cerebellar granule neurones in a concentration- and time- 
dependent manner, compared to the controls and all effects were significant (P<0.01, n == 4 
- 7). It was striking that even H 2 O2 iOpM applied for as brief as 0.25 h induced a very 
significant (nearly 31%) reduction in viability to 69.45% ±  3.09 o f the control. With a 
longer recovery period o f 24 h, neuronal survival was significantly poorer (P<0.05 or 
P<0.01, n = 4 - 7). After short (0.25 h) exposures to H 2 O2  10 and 30pM, viability was still 
greater than 50%. However, following longer treatments - at all concentrations - the 
cultures showed practically no viability. Hydrogen peroxide caused progressive loss of 
cells and elimination of neurite processes (Fig. 4.21a-e), an effect that was more extensive 
with the longer (24 h) period of recovery (cf. 4.21a, b and c). The 24 h recovery inteiwal 
was adopted for all subsequent experiments.
4.5.1 J .  Prevention by catalase o f  H 2 O2 <2ffects
The antioxidant enzyme catalase, at an activity of lOOU/ml, was able to prevent completely 
the profound deleterious effects of H 2 O2 (30pM) when tested for 1 or 6 h (n = 4) (Fig.
4.22). At 1 h, it improved viability from 13.86% ± 3.04 for peroxide alone to 109.66% ± 
7.61 (P<0.001) when combined with peroxide, and at 6 h from 11.98% ± 2.34 to 108.52% 
± 5.17 (P<0.001). Catalase was able to improve significantly the loss of cells and neurite 
outgrowth induced by H 2 O2  (Fig. 4,21a, e and f), so that the morphology of H202-treated 
cultures in the presence o f catalase was more similar to the control than to the H2 O2 - 
challenged phenotype. In addition to its protective action against peroxide, catalase was
140
141
also able to enhance significantly on its own the basal viability o f CGN cultures to 
130.73% ± 3.02 (P<0.001) and 125.00% ± 4.92 (P<0.01) of the control, for 1 and 6  h, 
respectively.
4.5.1.2. Aspirin (acetylsalicylic acid, ASAJ and hydrogen peroxide
Catalase has been reported to induce cyclooxygenase-2 (COX-2) (Litvinov and Turpaev,
2004). Since aspirin blocks cyclooxygenases, its ability to modify the effect o f H2 O2 was 
examined. As shown in Fig. 4.23, aspirin at ImM had no effect on basal viability. H 2 O2 ]■;
(30pM) applied for 6  h lowered viability to 50.95% ± 7.68 o f the control (P<0.001, n = 4). f 
In the presence o f ASA ImM, H 2 O2 induced-damage improved nearly 11% to 61.82% ±
2.90 of the control, but this difference was not statistically significant.
4.5.1.3. Hydrogen peroxide (HjOt), copper and mannitol
Interactions between H2 O2 , copper (II) ion and mannitol were investigated for 1 and 6  h. 
Surprisingly, H 2 O2 (5pM) induced a significant (P<0.05) reduction in viability at 1, but not 
at 6  h (n = 8 ) (Fig. 4.24A). Copper (II) ion, generated from CUSO4  (0.5mM), induced a 
time-dependent reduction of CGN viability, lowering it significantly at 6  h to 48.42% ±
9.23 o f the control (P<0.001). Co-administration o f H2 O2 (5pM) and CUSO4  (0.5mM) 
resulted in significant reduction o f viability at 1 and 6  h to 59.63% ± 9.26 (P<0.01) and 
44.63% ± 8.98 (P<0.001) o f the control. The reduction in the presence o f the two agents at 
1 h was not statistically different from the reduction in the presence of either of them 
alone, but at 6  h, reduction in viability by the two agents combined was significantly more 
than the reduction caused by H 2 O2  alone (P<0.001), though still not different from the 
effect obtained in the presence o f CUSO4  alone. The cultures became shrunken after 
treatments with the two agents, with extensive loss of outgrowths (Fig. 4.25a-c).
Through the Fenton reaction, the hydroxyl radical is generated by H 2 O2  in the presence of 
a transition metal like copper or iron. Mannitol is known to scavenge the formed hydroxyl 
radical, thus preventing its damaging effect. However, the current results contrasted with 
this expectation, as mannitol manifested a tendency to potentiate rather than alleviate the 
effect o f co-administration of peroxide and copper. Mannitol at 50mM had no effect on its |  
own on neuronal viability (n = 4) (Fig. 4.24B). Hydrogen peroxide and C11SO4 when added 
together reduced viabilities at 1 and 6  h to 78.13% ± 2.47 (P>0.05) and 48.39% ±  10.79 
(P<0.001), respectively. In the presence o f mannitol, these values were further reduced to 
59.21% ± 12.40 and 28.99% ± 7.29 (P>0.05 compared to damage by a combination of
H2 O2  and CUSO4  in the absence of mannitol). This further decrease in viability induced by 
mannitol was consistent with its exacerbation of morphological damage by H 2 O2 and 
copper (II) ion in these cultures (Fig. 4.25a, c, d).
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Figure 4.20. Histograms showing the effects of hydrogen peroxide (lOpM - 400pM) on 
CGN cultures for 0.25, 1, 3 and 6 h exposures at 8 div when viability determination was 
done (A) 6 h and (B) 24 h after the end o f treatment period. The 6 h recovery period was 
the duration immediately following treatment for which alamar blue was incubated with 
the cultures before determination of viability, while the 24 h recovery period was the 
duration between the end of treatment and the determination o f viability, inclusive o f the 
final 6 h during which alamar blue was incubated with the cultures before plate reading. 
Each column represents the mean ± SEM for n = 4 - 7 cultures. *P<0.05, **?< 0.01 
compared to untreated control.
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Figure 4.21. Photomicrographs showing the concentration- and time-dependent neurotoxic 
effects of hydrogen peroxide (H2O2) on the morphology of cerebellar granule cells when 
recovery duration was 24 h (except otherwise stated), and the protection by catalase. (a) 
Control (b) H2O2 lOpM (3 h) with 6 h recovery (c) H2O2 lOpM (3 h) (d) H2O2 30pM (1 h)
(e) H2O2 30pM (6 h) (f) H2O2 30pM + CAT lOOU/ml (6 h). Progressive loss of cells and 
neurite processes was evident in H202-treated cultures (b-f). Damage was more 
pronounced with 24 h of recovery (c) than with 6 h (b) In the presence of catalase, the 
phenotype of H202-treated cultures (f) was more similar to that of control cultures (a) than 
to that of cultures treated with H2O2 alone (e). Bar = 50pm.
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Figure 4.22. Histograms showing the effects of catalase lOOU/ml on the viability of CGN 
cultures and the hydrogen peroxide-induced cytotoxicity in these cultures. Each column 
shows the mean ± SEM for n = 4 cultures. **P<0.01, ***P<0.001 compared to control; 
###P<0.001 compared to corresponding H2O2 30pM.
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Figure 4.23. Histograms showing the effects of aspirin (ASA) ImM on hydrogen 
peroxide-induced cytotoxicity in CGN cultures. Each column shows the mean ± SEM for 
n = 4 cultures. ***P<0.001, a = non-significant compared to control; ns = non-significant 
compared to H2O2 30pM.
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Figure 4.24. Histograms showing the effects on the viability o f CGN cultures o f (A) 
hydrogen peroxide (5pM) and copper (II) ion (O.SmM), and (B) hydrogen peroxide (5pM) 
and copper (II) ion (O.SmM) in the presence o f mannitol SOmM. Each column shows the 
mean ± SEM for (A) n = 8 or (B) n = 4 cultures. *P<0.05, **P<0.01, ***P<0.001 
compared to control; ###P<0.001 compared to H2 O2 SpM, ns = non-significant.
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Figure 4.25. Morphological effects of simultaneous addition of hydrogen peroxide and 
copper (II) ion for 1 or 6 h on the cerebellar granule neurones and the exacerbation of this 
damage in the presence of the hydroxyl radical scavenger mannitol. (a) Control (b) H2O2 
5^M + O.SmM (1 h) (c) H2O2 S^M + O.SmM (6 h) (d) H2O2 SuM + O.SmM 
+ Mannitol 50mM (6 h). Hydrogen peroxide and copper (II) ion caused significant damage 
to neuronal morphology when applied together for 6 h (c), but the damage was more 
profound in the presence of mannitol (d). Bar = 50pm.
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4.5.2. Mechanisms o f  H202~induced neuronal damage in the CGNs
The involvements o f caspase-3, PARP and the event of membrane permeability transition 
(MPT) in the H202-mediated damage and death o f CGNs were examined.
4.5.2. L  Induction o f  caspase-3 and PARP
Basal CGN viability in the presence o f the caspase-3 inhibitor Z-DEVD-fmk (40 pM) did 
not differ from the control at 0.25 or 1 h, with values o f 96.63% ± 2.59 and 103.17% ± 
1.58, respectively (n = 4). Similarly, the PARP inhibitor DPQ (lOpM) had no effect when 
applied on its own, giving viability values of 102.57% ± 4.51 and 103.53% ± 4.47 (n = 4) 
at 0.25 and 1 h. At H2 O2  lOpM, 0.25 and 1 h exposures reduced viability significantly to 
77.89% ± 3.45 and 73.09% ± 7.72 of the control, respectively (P<0.01, n = 4) (Fig. 4.26A). 
While Z-DEVD-fmk failed to alleviate these effects, DPQ elicited significant 
improvements (comparable with the controls) to 91.88% ± 4.13 (P<0.05) and 101.57% ± 
3.42 (P<0.01) of the control. A higher H2 O2  concentration o f lOOpM decreased viability to 
32.57% ± 3.33 (P<0.001) at 0.25 h and to 6.07% ± 1.59 (P<0.001) at 1 h (n == 4) (Fig. 
4.26B). Z-DEVD alleviated the peroxide damage at 0.25 h to 55.81% ± 1.61 (P<0.001) 
whereas with DPQ, the damage was improved to 58.85% ± 3.16 (P<0.001). However, 
neither of these agents was able to improve the damage caused by 1 h exposure to H 2 O2  
lOOpM.
4.5.2.2. Alleviation o f  H 2 O2 damage by cyclosporin A
Cyclosporin A (CsA) when added to the CGN cultures at 0.5 and lOpM for 1 h had no 
significant effects (92.29% ± 5.03 and 93.97% ± 3.05 of the control, respectively; n = 3). 
At 1 h, the H202-mediated reduction of CGN viability to 67.35% ± 3.77 of the control 
(P<0.001, n =3) (Fig. 4.27A) was potentiated in the presence o f CsA 0.5pM to 55.62% ± 
2.37 (P<0.05), but improved in the presence o f CsA lOpM to 88.05% ± 5.32 (P<0.01). 
Exposure to lOOpM of peroxide for 1 h lowered viability very significantly to 12.04% ± 
0.63 o f the control (P<0.001, n = 3) (Fig. 4.27B). Cyclosporin A at 0.5pM had no effect on 
this damage but at lOpM ameliorated it to 28.51% ± 5.87 o f the control (P<0.01).
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Figure 4.26. Histograms showing the effects of the caspase-3 inhibitor, Z-DEVD-fmk 
(40pM), and the PARP inhibitor, DPQ (lOpM), on the neurotoxicity mediated by (A) H2 O2  
lOpM and (B) H2 O2 lOOpM in CGN cultures. Each column represents the mean ± SEM for 
n = 4 cultures. **P< 0.01, ***P< 0.001 compared to control; #P<0.05, ##P<0.01, 
###P<0.001, ns = non-significant compared to corresponding H 2 O 2 .
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Figure 4.27. Histograms showing the effects of the membrane permeability transition pore 
blocker, cyclosporin A (0.5, lOpM), on the neurotoxicity mediated by 1 h application of 
(A) H2 O2  lOpM and (B) H2 O2  lOOpM in CGN cultures. Each column represents the mean 
± SEM for n = 3 cultures. ***?< 0.001 compared to untreated control; #P<0.05, ##P<0.01, 
ns = non-significant.
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4.5.3. Adenosine receptor-mediated protection against oxidative damage by H2O2
The roles of Ai and A 2 A adenosine receptors in modulating oxidative damage by hydrogen 
peroxide in the CGNs were verified using ligands at these receptors. None of the ligands 
had any significant effect on viability when applied alone and each of them was tested 
against H 2 O2  for 1 h. 2-chloroadenosine (2-ClA) 1 pM failed to modify the effect of 
hydrogen peroxide (30pM) that reduced viability to 31.22% ± 9.72 of the control 
(P<0.001,n = 3) (Fig. 4.28).
4.5.3.1. AI receptor ligands
Hydrogen peroxide 30pM  decreased viability significantly to 36.02% ± 1.68 o f the control 
(P<0.001, n = 3) (Fig. 4.29A). In the presence o f the selective Ai receptor agonist CPA 
(lOOnM), this damage was significantly attenuated (P<0.G01) to 73.34% ± 3.53. On the 
other hand, the significant lowering o f viability by H 2 O2  lOpM to 60.09% ± 10.03 of the 
control (P<0.01) was unaltered in the presence o f the selective Ai receptor antagonist 
DPCPX (lOOnM) (n = 3) (Fig. 4.29B).
4.5.3.2. A 2A receptor ligands
A reduction in CGN viability to 51.67% ± 6.89 of the control (P<0.001) was induced by 
H 2 O2  lOpM (n = 3) (Fig. 4.30A), which remained unchanged in the presence of the 
selective A 2 A receptor agonist CGS21680 lOOnM. The selective A 2 A receptor antagonist 
ZM241385 improved viability significantly (P<0.05) to 57.69% ± 13.42 of the control 
when present with H 2 O2  30pM  (n = 3) (Fig. 4.30B), compared to a value of 34.10% ± 0.53 
of the control (P<0.001) in the presence of H 2 O2 30pM alone.
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Figure 4.28. Histogram showing the lack o f effect of 2-chloroadenosine (2-ClA) 1 pM on 
the neurotoxicity mediated by H2 O2 30pM in CGN cultures. Each column represents the 
mean ± SEM for n = 3 cultures. ***?< 0.001, a =non-significant compared to control; ns = 
non-significant compared to H2 O 2 30pM.
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Figure 4.29. Histograms showing (A) the protective effect o f the selective Ai adenosine 
receptor agonist, CPA (lOOnM) and (B) the lack o f effect o f the selective A, adenosine 
receptor antagonist, DPCPX (lOOnM) against the neurotoxicity mediated by H 2 O2 in CGN 
cultures. Each column represents the mean ± SEM for n = 3 cultures. **P< 0.01, ***P< 
0.001, a = non-significant compared to control; ###P<0.001, ns = non-significant 
compared to H2 O2 alone.
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Figure 4.30. Histograms showing (A) lack o f effect of the selective À 2 a adenosine receptor 
agonist, CGS21680 (lOOnM) and (B) the protective effect o f the selective A2 A adenosine 
receptor antagonist, ZM241385 (lOOnM) against the neurotoxicity mediated by H2 O2  in 
CGN cultures. Each column represents the mean ± SEM for n = 3 cultures. ***?< 0.001, a 
= non-significant compared to control; #P<0.05, ns = non-significant compared to H2 O2  
alone.
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4.5.4. Effects o f some other inducers o f oxidative stress
The kynurenine pathway metabolite 3-hydroxykynurenine (3-HK) is known to be a potent 
inducer of oxidative sti'ess. Its effect on the viability of CGNs was therefore examined. The 
effect of the superoxide-generating system of xanthine (X) and xanthine oxidase (XO) was 
also investigated.
4.5.4.1. 3-hydroxykynurenine (3-HK) and neuronal viability
3-hydroxykynurenine reduced the viability o f CGNs in a concentration-dependent manner 
(P<0.01, n = 4) (Fig. 4.31). At IpM , 3-HK had no effect. Reduction following 6 h of 
exposure to 3-HK lOpM was significantly more than was obtained after 1 h o f exposure to 
the same concentration (51.20% ± 2.96 vs. 88.71% ± 5.47; P<0.001), whereas exposure to 
lOOpM or ImM of the kynurenine elicited comparable reductions in viability at 1 and 6 h. 
The effects of 3-HK on CGN viability were consistent with the damage it inflicted on the 
morphology o f the cultures (Fig. 4.32). The number of cells and neurites progressively 
dwindled with increasing concentrations o f 3-HK or durations o f exposure to it.
4.5.4.2. Mixture o f  xanthine (X) and xanthine oxidase (XO)
Exposure to xanthine (X) lOOpM alone for 1 or 6 h had no significant effect on CGN 
viability (n = 3) (Fig. 4.33A). In contrast, the application of xanthine oxidase (XO)
0.02U/ml alone produced a time-dependent reduction in viability. At 6 h, XO lowered 
viability significantly to 47.51% ± 6.24 of the control (P<0.001). The mixture of X and XO 
further reduced viabilities at 1 and 6 h to 20.07% ± 8.59 and 13.58% ± 0.96 o f the control, 
respectively (P<0.001). The reduction by X/XO mixture was significantly more than the 
reduction by XO alone, whether at 1 or 6 h (P<0.001). The mixture also damaged 
significantly the cell bodies and neurite outgrowths of the neuronal cultures (Fig. 4.34a, e, 
f). In order to confirm that the observed effect o f XO was solely due to its enzymatic 
activity, the effect of combining X and heat-inactivated XO was determined. Heat 
inactivation was achieved by heating in a water bath at 60°C for 5-7 min. The results (Fig. 
4.33B) showed that following heat inactivation, XO was no longer able to elicit any 
reduction in CGN viability, whether on its own or when combined with xanthine for 6 h (n 
= 4).
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4.5.4.3. Effects o f  superoxide dismutase (SOD) and catalase (CAT) on damage by X/XO  
The nature o f the reactive oxygen species (ROS) produced by the mixture of X and XO in 
our experimental system was verified using the antioxidant enzymes superoxide dismutase 
(SOD) and catalase (CAT). Cultures were exposed for 6 h. Xanthine lOOpM induced an 
increase in CGN viability to 116.93% ± 1.23 of the control (P<0.05, n = 4) (Fig. 4.35A), 
whereas xanthine oxidase 0.02U/ml lowered viability to 45.41% ± 10.25 (P<0.001). When 
combined, xanthine and xanthine oxidase induced a significant lowering of viability to 
15.18% ± 1.24 (P<0.001), which was significantly more than the damaging effect of XO 
alone (P<0.001). Superoxide dismutase SOD 250U/ml had no effect on its own on basal 
viability. In the presence of SOD, the damaging effect of the mixture of xanthine and 
xanthine oxidase was unaltered.
The effects o f catalase on the X/XO system are detailed in Fig. 4.35B (n = 4). Xanthine 
lOOpM alone had no effect, xanthine oxidase reduced viability to 55.04% ± 3.04 
(P<0.001), and the mixture of X and XO lowered viability to 29.76% ± 11.51 (P<0.001). 
The effect of X/XO was significantly more than the effect of XO alone (P<0.01). In the 
presence of catalase - which showed no effect on its own - the reduction in viability 
induced by a mixture of xanthine and xanthine oxidase was abolished, with viability 
restored to a level comparable to the control (114.87% ± 0.75).
4.5.4.4. Xanthine oxidase alone
In view o f the observation that exposure to xanthine oxidase alone produced a significant 
reduction in the viability of CGNs, the possible mediation o f this damage by ROS was 
examined (Fig. 4.36). Exposure o f CGNs to xanthine oxidase 0.02U/ml alone reduced 
viability significantly to 54.56% ± 2.81 of the control (P<0.001, n = 4), while its 
morphological effects included extensive degeneration of neuronal cell bodies and neurite 
extensions (Fig. 4.34a, c, d). The xanthine oxidase inhibitor, allopurinol (AP) at lOOpM, 
while having no effect on its own (99.66% ± 2.78 of the control), was able to attenuate 
very significantly (P<0.001) the effect o f xanthine oxidase, improving viability to 89.43% 
± 3.16, a level not significantly different from the control. When tested against XO, SOD 
at 250U/ml produced no significant improvement. However, catalase at 250U/ml 
completely prevented the damaging effect o f XO (P<0.001), improving viability 
significantly beyond the control level to 120.11% ± 1.20 (P<0.001 compared to control).
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Figure 4.31. The effects of the kynurenine pathway metabolite, 3-hydroxykynurenine (3- 
HK) (IpM  - ImM), applied for 1 or 6 h, on the viability of cerebellar granule neurones at 
div. Each column represents the mean ± SEM for n = 4 cultures. **?< 0.01 compared to 
control; ###P<0.001 for comparison of the effects of 3-HK lOpM at 1 and 6 h.
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Figure 4.32. Photomicrographs showing concentration- and time-dependent damage to 
CGN morphology induced by 3-hydroxykynurenine (3-HK). (a) Control (b) 3-HK lOpM 
(1 h) (c) 3-HK lOpM (6 h) (d) 3-HK lOOpM (1 h) (e) 3-HK lOOpM (6 h) (f) 3-HK ImM (6 
h). There was greater damage (loss of cells and neurite outgrowth) with increasing 
concentrations of 3-HK (c, e, f) or with longer exposures (b and c; d and e). Bar = 50pm.
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Figure 4.33. Histograms showing (A) the effects of xanthine (X) lOOpM and xanthine 
oxidase (XO) 0.02U/ml and (B) the lack of effects of xanthine (X) lOOpM and heat- 
inactivated xanthine oxidase (XO) 0.02U/ml on the viability of CGNs when each of them 
was applied alone or in combination for 1 or 6 h at 8 div. Each column represents the mean 
± SEM for (A) n = 3 or (B) n = 4 cultures. ***?< 0.001, a = non-significant compared to 
control; ###P<0.001, ns = non-significant.
160
j  1
K > 'V
A
:m  r u \i
‘.Ï •*■
• r
p.
c** . ' M l# #
d  \  * -Ar" 'I
Figure 4.34. Photomicrographs showing the effects of xanthine (X), xanthine oxidase 
(XO) and their combination (X/XO) on the morphology of cerebellar granule neurones, (a) 
Control (b) X lOOpM (6 h) (c) XO 0.02U/ml (1 h) (d) XO 0.02U/ml (6 h) (e) X/XO (1 h)
(f) X/XO (6 h). Note the damage to cell bodies and neurite outgrowth in cultures treated 
with xanthine oxidase alone (6 h) (d) or with xanthine and xanthine oxidase (X/XO) for 1 
or 6 h (e, f), compared to control cultures (a). Bar = 50pm.
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Figure 4.35. Histograms showing (A) the inability of the antioxidant enzyme superoxide 
dismutase, SOD 250U/ml and (B) the ability o f the antioxidant enzyme catalase, CAT 
250U/ml to prevent the damaging effect on CGN cultures o f the mixture of xanthine (X) 
lOOpM and xanthine oxidase (XO) 0.02U/ml. Each column represents the mean ± SEM for 
n = 4 cultures. *P<0.05, ***P<0.001, a = non-significant compared to control; ##P<0.01, 
###P<0.001, ns = non-significant.
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Figure 4.36. The effects of the xanthine oxidase inhibitor, allopurinol (AP) lOOpM, and 
the antioxidant enzymes superoxide dismutase (SOD) 250U/ml and catalase (CAT) 
250U/ml on the damage to CGN cultures induced by xanthine oxidase (XO) 0.02U/ml. 
Each column represents the mean ± SEM for n = 4 cultures. ***P<0.001 compared to 
control; ###P<0.001, ns = non-significant compared to XO 0.02U/ml.
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4.5.5, Nitrosative stress and the viability o f  cerebellar granule neurones
In order to determine whether the effects o f ROS such as hydrogen peroxide on the 
viability o f CGNs are shared by reactive nitrogen species (RNS) such as nitric oxide at 
comparable concentrations, the extent o f nitrosative stress-induced damage achievable with 
the nitric oxide (NO) donor, S-nitroso-A-acetyl-penicillamine (SNAP), was assessed (Fig. 
4.37). At lOpM, SNAP induced no change in viability with up to 6 h o f exposure, but with 
24 h o f exposure, it elicited a significant increase in viability to 116.29% ± 7.80 of the 
control (P<0.05). In contrast, at lOOpM or above, SNAP produced a concentration- and 
time-dependent damaging effect on CGN viability (P<0.01, n = 4), which correlated with 
progressive loss o f cells and extensive degeneration of neurite processes (Fig. 4.38a-d).
The influences of the nitric oxide synthase (NOS) inhibitor L-NAME and the guanylate 
cyclase inhibitor ODQ on the damage induced by SNAP were examined. When added 
alone, L-NAME at 1 and lOmM produced no statistically significant effect, with values of 
100.55% ± 2.13 and 113.80% ± 8.43 of the control, respectively (n = 4). Similarly, ODQ at 
10 and lOOpM had no effect, giving values o f 99.29% ± 3.25 and 100.41% ± 3.24 of the 
control (n = 4). Exposure to SNAP lOOpM for 24 h reduced viability significantly to 
45.80% ± 4.28 o f the control (P<0.001, n = 4) (Fig. 4.39A). In the presence of L-NAME 
ImM , there was no improvement of the SNAP-induced damage (49.98% ± 5.43 of the 
control). However, in the presence of L-NAME lOmM, the SNAP-induced damage was 
significantly improved to 93.47% ± 0.82 (P<0.001), a level comparable with the control. 
The guanylate cyclase inhibitor ODQ, whether at 10 or lOOpM, produced no significant 
effect on SNAP-induced damage of the CGNs that lowered viability to 40.90% ± 4.60 of 
the control after 24 h of exposure (P<0.001, n = 4) (Fig. 4.39B). Morphological assessment 
showed that L-NAME (lOmM) significantly improved SNAP-induced damage to neuronal 
cell bodies and neurite extensions (Fig. 4.38a, b, e), while ODQ (lOOpM) lacked such 
restorative effect (Fig 4.38a, b, f).
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Figure 4.37. Histograms showing the effects of the nitric oxide (NO) donor, S-nitroso-A- 
acetylpenicillamine (SNAP) (lOpM - ImM), on the viability o f cerebellar granule 
neurones for 1,6 or 24 h o f exposure. Each column shows the mean ± SEM for n = 4 
cultures. *P<0.05, **P<0.01 compared to control.
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Figure 4.38. Photomicrographs showing the concentration- and time-dependent damaging 
effects of the nitric oxide-releasing compound, S-nitroso-A-acetylpenicillamine (SNAP), 
on the morphology of cerebellar granule neurones and the influences on this damage of the 
nitric oxide synthase (NOS) inhibitor, L-NAME, and the soluble guanylate cyclase 
inhibitor, ODQ. (a) Control (b) SNAP lOOpM (24 h) (c) SNAP ImM (6 h) (d) SNAP 
ImM (24 h) (e) SNAP lOOpM + L-NAME lOmM (24 h) (f) SNAP lOOpM + ODQ lOOpM 
(24 h). SNAP induced cell loss and extensive degeneration of neurite processes. In the 
presence of L-NAME, SNAP-induced morphological damage was significantly reduced (a, 
b, e), restoring neuronal cultures to a phenotype closer to that of control cultures. ODQ had 
no effect on SNAP-induced damage to CGN morphology (a, b, f). Bar = 50pm.
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Figure 4.39. Histograms showing (A) the effect o f the nitric oxide synthase (NOS) 
inhibitor, L-NAME (ImM , lOmM) and (B) the lack of effect o f the guanylate cyclase 
inhibitor, ODQ (lOjaM, 10G|aM) on the SNAP-induced reduction in viability o f CGNs. 
Each column shows the mean ± SEM for n = 4 cultures. ***P<0.001 compared to control; 
###P<0.001, ns = non-significant compared to SNAP lOOpM.
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5. DISCUSSION
5.1. Culture purity and immunolabelling
Cerebellar granule neurones (CGNs) are frequently used in the study of mechanisms involved 
in apoptosis (Kalda & Zharkovsky, 1999) and in neuropharmacology for studying pathways of 
drug"induced apoptosis. They are easier to handle in microdissection, produce many more 
testable cultures (Cambray-Deakin, 1995), and have been used to assess the neurotoxic effects 
of glutamate (Slagsvold et al., 2000; Vaudry et al., 2003, Hou et al., 2006), kainic acid 
(Verdaguer et al., 2002; Smith et al., 2003), MPP^ and colchicine (Gorman et al., 1999), which 
is why they have been chosen for neuronal investigations in this study. Cerebellar interneuron- 
enriched primary cultures are laiown to provide an almost pure population of a single type of
live neurones (granule cells) (Levi et al., 1989). These cells are the most numerous neuronal
'■population in the cerebellum. The CGN cultures used in this study were obtained from 8-day 
old Sprague-Dawley rat pups. This is a developmental stage at which cerebellar neurones have 
reached the differentiating (postmitotic) stage (Hertz et al., 1985). Cytosine arabinoside (Aia 
C) is an antimitotic agent for dividing cells that competitively inhibits the incorporation of 2' 
deoxycytidine into DNA (Smith & Orr, 1987; Wallace & Jolmson, 1989). Cultures in this 
study were treated with Ara C (lOpM) 20-24 h after passaging, as the addition o f this 
compound to CGN cultures at such concentration and culture stage eliminates glial population 
of cells, since the glial cells are still in the mitotic phase. Other cerebellar neurones are 
eliminated by the process of differential centrifugation during the setting up of the cultures.
With this standard procedure, the investigator is left with a homogeneous population 
(containing > 90% of granule cells), characterized as glutamatergic neurones (Schousboe et 
al., 1985). The concentration of Ara C used is established to be non-toxic to neurones, 
although Daniels & Brown (2002) reported that it may be toxic to CGNs after potassium 
withdrawal tlirough p53-dependent apoptosis. Our study, however, maintained the cultures 
routinely in a high potassium concentration (25mM). Using the technique of 
immunocytochemistry, it was found that these cerebellar granule neuronal cultures showed 
strong immunoreactivity against the mouse anti-human beta-III isoform of tubulin monoclonal 
antibody, which is specific for neurones (cytoskeleton-staining) (Geisert & Frankfurter, 1989;
Farina et al., 1999), thus confirming that the cultures were predominantly neuronal.
5.2. Alamar Blue reduction assay for the determination of cell viability
In this study, the relatively new Alamar Blue (AB) reduction method was used for the 
quantification of cell viability. Several methods are available for determining cell viability, 
including the trypan blue exclusion, neutral red uptake, crystal violet inclusion, Clrromium-51 
(^^Cr) release and the MTT (or XTT) assay (Nociari et al., 1998). As well as the MTT, trypan 
blue, calcein-AM, ethidium bromide, propidium iodide, fluorescein diacetate and lactate 
dehydrogenase (LDH) assays are also employed in excitotoxic studies (Lustig et a l, 1992a; 
1992b; White et ai., 1996). However, there are several obvious advantages of the AB method 
over many o f the other methods as follows:
1. AB assay allows the choice of detection method, as it can be read either 
fluorometrically or colorimetrically. Measurements in this study have been made 
colorimetrically (dual-wavelength) using the ELISA plate reader (DYNEX 
Technologies, USA). The chosen wavelengths were 540 and 595nm.
2. The dye is soluble, thus making any subsequent process o f extraction unnecessary, 
unlike the MTT assay in which the generated formazan has to be solubilized before 
plate reading is possible.
3. No centrifugation is required, because the method is appropriate for either suspension 
or attached (monolayer) cells.
4. Fewer steps are required. Therefore, it is time saving and easily adaptable to 
automation.
5. AB is stable over a long period of time and could be stored (in the dark, as it is light- 
sensitive) for 12 months at room temperature and 20 months at 2 - 8°C. AB dye is also 
stable in culture medium, which is highly desirable for investigations involving 
continuous cell growth monitoring, kinetic studies, and incubation time of days.
6. It is relatively non-toxic to cells and is therefore less likely to interfere with normal 
metabolism, thereby allowing precious cells to be reused for further investigations (as 
the assay is performed under sterile conditions). This has the economic benefit of 
saving cost, unlike methods such as the MTT, which necessitate killing the cells 
(O’Brien et al., 2000).
7. It is non-radioactive and non-toxic to personnel and therefore considered safe and 
disposable with less regulation.
169
170
The claim that AB is non-toxic to cells in culture was confimied in this study. Whether in 
MC3T3-E1 or cerebellar granule cultures, the viability of cultures previously treated with AB 
was not different from the viability of AB-naive cultures when quantification was done using 
trypan blue exclusion or even the dye itself.
The active ingredient in this dye is 7-hydroxy-3H-phenoxazin-3-one-10-oxide (O’Brien et al., 
2000). These authors showed that the identity o f AB is resazurin (blue and non-fluorescent), 
which is reduced to resomfin (pinlc and fluorescent) and further reduced to hydroresorufin 
(uncoloured and non-fluorescent). Cellular activity (likely to be by oxygen consumption 
thi’ough metabolism) reduces the oxidized alamar blue. The dye works on the basis that the 
internal environment o f proliferating or metabolically active cells is more reduced than that of 
non-proliferating or metabolically inactive cells. Specifically, the ratios o f NADPH/NADP, 
FADH/FAD, FMNH/FMN, and NADH/NAD increase during proliferation and AB can be 
reduced by all of these intermediates. The reduction is accompanied by a measurable shift in 
colour (Nociari et al., 1998). Because it can be reduced by cytochromes, AB substitutes for 
molecular oxygen as an electron acceptor while tétrazolium salts such as MTT are reduced by 
the above-mentioned intermediates but not by cytoehiomes (O’Brien et ah, 2000). Acceptance 
o f electrons from these compounds changes AB from the original, oxidized, indigo blue, non- 
fluorescent state to the reduced, pinlc, fluorescent state. In order to measure AB reduction 
colorimetrically, the absorbance is usually measured at two wavelengths because the 
absorption spectra of the oxidized (blue) form and the reduced (red) form overlap. The 
standard wavelengths ai'e 570 and 600nm, where the reduced and oxidized fonns absorb, 
respectively, but filter combinations at wavelengths other than these have been confirmed to 
be equally acceptable (e.g., 540 and 630nm; 565 and 610nm), as long as the necessary 
corrections are made, based on a foimula given by the manufaeturers (as explained in section 
2.4 o f this thesis). However, a second approach to the measurement of AB reduction is by 
fluorescence, which appears to be more sensitive than dual-wavelength colorimetry. In this 
case, excitation is made at 530-560nm and emission measured at 590nm. Several authors have 
cited the use of AB (see Aluned et a l, 1994; Stephen et a l, 1999; Marcelo et a l, 1998;
Melissa et a l, 1996; Page et a l, 1993; Mershon et a l , 1994; Harvey et a l , 1995; Squatrito et 
a l , 1995; White et a l, 1996). While they are equally specific, the AB method has been found 
to require fewer cells and is more sensitive than the ^'Cr assay in evaluating cell-mediated
Î
cytotoxicity (Nociari et a l , 1998). There are also very small inter- and intra-assay variations 
with AB cytotoxicity assays, an observation that was confimied in this study by the relatively 
small error bars in most of the data. In comparison with the LDH assay, AB is able to quantify 
cell death predominantly involving apoptosis more accurately than the LDH assay, as the loss 
of membrane integrity, which the LDH assay relies upon, is a late feature of apoptotic death 
(Wliite et a l, 1996). Another benefit of the AB assay in relation to the MTT assay arises from 
the fact that tétrazolium salts (MTT assay) could be reduced by superoxide that is generated 
during excitotoxic or other forms of cell death and thus give an erroneous indication of normal 
cell viability while cell death is occurring. This is because the reaction in which tétrazolium 
salts are reduced to their intensely coloured formazans occurs via the formation of a free 
radical intermediate, tetrazolinyl, in which only one election has been transferred to the 
tetrazole ring. In fact, the reduction of nitroblue tétrazolium is the basis for a well-established 
indirect assay for superoxide dismutase (Marshall et a l, 1995). The AB assay effectively does 
not harbour these potential artefacts.
In order to obtain the best results, however, factors such as cell density, incubation times, 
media composition and concentrations of the agents under investigation should be 
standardized or carefully selected. This process would avoid potential pitfalls such as over­
reduction of AB to the colourless and non-fluorescent hydroresomfin. In this study, AB 
reduction varied directly and was well correlated with both cell density and the incubation 
period for the osteoblast and neuronal cultures used. Guided by these data, MC3T3-E1 
cultures were therefore routinely seeded at a density of 1 x 10  ^cells/ml and incubated with AB 
for 4 h while CGN cultures were seeded at 1 x 10  ^cells/ml and incubated with AB for 6 h.
A possibility that the AB assay is sensitive to protein conditions in culture media has been 
raised (Goegan et a l, 1995). However, the manufacturers of the AB used in this study 
(alamarBlue™ from Biosource, Belgium) stated explicitly that the presence of 10% PCS in the 
culture medium has no effect on the results obtained with this AB when reduction is measured 
colorimetrically (as done in this study), whereas this level of seium causes some quenching of 
fluorescence. Assays were therefore carried out, either in serum-free medium or, as it was in 
most cases, in medium containing the same amount of PCS, especially for neuronal cultures 
whose viability could be significantly impaired with prolonged (> 1 h) culturing in seium-free 
medium, hi addition, our use of the dye was for an endpoint measurement o f cytotoxicity,
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.which has been observed as more valuable than its use as a kinetic measure for monitoring cell 
growth (O’Brien et al., 2000).
5.3. MC3T3-E1 cell line; a suitable in vitro model for osteoblastic development
The MC3T3-E1 cell line has been used in this work. It was derived from newborn calvariae
and has been previously shown to exhibit osteoblast-like characteristics after repeated
passages (Quarles et al., 1992). Parameters o f the osteoblast phenotype which this cell line
expresses include type 1 collagen synthesis, alkaline phosphatase (ALP) activity and nodular
extracellular matrix mineralization resembling woven bone (Sudo et al., 1983). This evidence
was further strengthened by Quarles et al, (1992) when they showed that these cells in culture
display a temporal sequence of development that was characterized by distinct proliferative
and differentiated stages. Alkaline phosphatase is a common marker of differentiation in bone
and has been hypothesized to be involved in the process of mineralization, though its precise
physiological role has not been delineated (Henthorn, 1996). To characterize the cells,
therefore, a developmental profile of ALP activity from 4 div to 17 div was obtained in this
study by measuring the conversion by ALP of the colourless p-nitrophenylphosphate to the
yellow p-nitrophenol in alkaline solution at 405nm wavelength. The effects of a combination
.of ascorbate and p-glycerol phosphate (switching) on the proliferation and differentiation of 
these cells were also examined. In this regard, these supplements were added after tluee days 
in culture, which implied that a developmental stage of N day(s) post-switch corresponded to 
(N + 3) days in vitro (div). The addition o f these supplements increased proliferation 
significantly. Similarly, the supplements induced increased differentiation in the MC3T3-E1 
osteoblast cultures that reached significance 7 days after switching (days post-switch) (10 div)
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and onwards, as measured by ALP activity. In fact, at 11 days post-switch, ALP activity was ■more than four-fold higher in switch than in non-switch cultures. Interestingly, this 
phenomenon was not cell density-dependent, as a similar pattern of changes in ALP activity 
was obtained with a three-fold higher density. Our observations are consistent with earlier 
reports (Quarles et al., 1992). The initial stage of development o f the cells is characterized by 
cell proliferation and high levels o f type 1 collagen expression, biosynthesis and secretion, but 
the cells remain undifferentiated as evidenced by low levels of alkaline phosphatase activity.
There is also an inability to assimilate effectively newly synthesized collagen into extracellular
..    ./ill
matrix and mineralization is absent (Stein et al., 1996). In fact, it has been suggested that 
ascorbic acid stimulates osteoblast proliferation tlu ough its effects on the synthesis of collagen 
or some related matrix protein that interacts with cell surface adhesion receptors to cause the 
stimulation of proliferation (Harada et ah, 1991). Another report by Franceschi & Iyer (1992) 
showed that the earliest effects of ascorbic acid were to stimulate type 1 procollagen inRNA 
and collagen synthesis (24 h after ascorbate addition), followed by induction of ALP (48-72 h) 
and osteocalcin (96-144 h) niRNAs. However, in their work, Quarles et al. (1992) argued that 
ascorbate does not stimulate type I collagen gene expression in MC3T3-E1 cells but is 
absolutely required for deposition of collagen in the extracellular matrix. During days 1-9 in 
vitro, subconfluent cultures are seen displaying rapid increases in cell number and high rates 
o f DNA synthesis (Quarles et al., 1992). The next developmental stage, which occurs 10 days 
after plating, is characterised by downregulation of replication and expression of differentiated 
osteoblast functions. Growth rates reach a plateau and DNA synthesis becomes negligible. At 
this time, increases in alkaline phosphatase activity- a characteristic of the osteoblast 
phenotype- and acquisition of specialized bone fiinction consisting of collagen deposition into 
an extracellular matrix occur. This was the same stage from when the switch cultures in this 
study began to exhibit a significantly gieater level o f ALP activity than their non-switch 
counterparts. With regard to ascorbate and p-glycerol phosphate, Quarles et al. (1992) 
observed that when these agents are absent, MC3T3-E1 cells attain gi'owth arrest and express 
low levels of alkaline phosphatase at day 10 (as was the case with our non-switch cultures) but 
fail to express a fully differentiated osteoblast phenotype as revealed by the inability to form 
and mineralize extracellular matrix. They noted that ascorbate facilitates the expression of 
osteoblast phenotype in these cells without affecting the timing o f maturation. When ascorbate 
is added to the culture medium, significant increases occur in cellular ALP activity in 
differentiated cells, but the time course of osteoblast phenotype development as defined by 
cessation of mitogenic growth and the onset of ALP expression is unaffected. P-glycerol 
phosphate acts synergistically with ascorbate to stimulate further collagen accumulation and 
ALP activity in post-mitotic, differentiated osteoblast-like cells. Quarles et al. (1992) also 
found, as did this study, that the expression of ALP was time- but not density-dependent. This 
expression was evident only at the onset of growth arrest at about day 9 and was enlianced 2- 
fold by ascorbate and p-glycerol phosphate. The current work, however, has shown the
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possibility of a greater than 2-fold enhancement of ALP activity by the switching supplements. 
Many agents having a trophic influence on the MC3T3-E1 cell development are laiown to 
increase the expression of ALP, as measured by the extent to which the enzyme can release 
free p-nitrophenol (4-nitrophenol) from p-nitrophenylphosphate (4- nitrophenylphosphate) 
(Yada et al., 1994; Suzuki et al., 1998; Genever & Skerry, 2001). This shows ALP is involved 
in mineralization by MC3T3-E1 cells. There is now evidence for a role of p38 MAP kinase in 
the regulation of ALP expression during osteoblastic cell differentiation (Suzuki et al., 2002). 
A final phase o f MC3T3-E1 maturation starts about day 20, characterized by matrix 
calcification linked with progressive increases in extracellular matrix accumulation and ALP 
activity (Stein et al., 1996). These cells are therefore representative of immature osteoblasts 
which undergo a temporal program consistent with osteoblast differentiation in stages 
analogous to in vivo bone fomiation, thus making the MC3T3-E1 cell line as used in this and 
other studies a suitable model of osteogenic development in vitro.
5.4, Differential responses of osteoblast and neuronal cultures to culture conditions
Responses of MC3T3-E1 cultures that have or have not been exposed to a number of culture 
conditions including levels of serum, serum withdrawal and supplementation with potassium 
or glutamine were examined in this study. The process of switching by the addition of 
ascorbate and p-glycerol phosphate initiated differences in responsiveness to serum, which 
varied depending on the concentration of serum in the culture medium. In culture medium 
containing a low PCS concentration (1%), non-switch cultures exhibited a higher level of 
viability compared to switch cultures. The reverse was the case at the highest PCS 
concentration used (20%). No such differences in viability were found at 10% PCS, which 
justifies the usual concentration for culturing these and most other cells. In general, serum at 
10 or 20% concentration (v/v) promoted suiwival better than at 1%. However, complete 
withdrawal of serum from these cells for up to 1 day in culture did not provoke any significant 
impairment in their viability and even with longer days of withdrawal (2 or 3 days), reduction 
in viability, though significant, was no more than 18%, and the process of switching did not 
influence this outcome. In fact, the hardy nature o f these cultures was further revealed by an 
insignificant (6.8%) reduction in viability obtained when they were maintained for 10 div 
without changing the medium, compared with parallel cultures replenished every 2-3 days
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until 10 div. No difference was found when cultures were fed every 2-3 days by replacing half 
of the culture medium as opposed to replacing the complete medium. It is possible that the 
mild but significant reduction in viability after 3 days of seium withdrawal was due to 
apoptosis, as it has been reported that MC3T3-E1 cells undergo apoptosis in response to serum 
withdrawal or addition of TNF-a. This effect was shown by TUNEL labelling and DNA 
fragmentation (Jilka et al., 1998). A readily observed feature o f serum deprivation in cultures 
is an increase in the level of lipid peroxidation, possibly partly due to the absence of serum 
components that might provide an anti-oxidant function, e.g., ascorbate, urate, caeruloplasmin, 
etc. Acute serum deprivation is also known to lead to profound effects on the penneability of 
the cell membrane to Na^ and IC^  which may be related to increased levels o f lipid 
peroxidation (Hopp et al., 1987). Chang et al. (2004) observed that in postnatal cortical 
neurones, transfected semm response factor (SRF) exerted a dose-dependent protection against 
the effect of trophic withdiuwal downstream of extracellular signal-regulated kinases 1/2 
(ERKl/2) and phosphatidylinositol-3 kinase (PI3 K) signalling, which are Imown to be 
activated by brain-derived neurotrophic factor (BDNF) (Hetman et al., 1999).
With regard to potassium supplementation, lOmM for 10 div elicited a trophic effect, 
especially in the switch cultures; 25mM was without effect, while 50mM was potentially 
toxic. The addition o f glutamine to a final concentration o f 2mM induced significant and 
comparable trophic effects in the switch and non-switch cultures. A continued depolarization 
with 30-60mM KCl inhibits glutamate release in MG63 cells (in the presence of extracellular 
Ca^^) and in MC3T3-E1 cells grown for at least 7 div in osteogenic conditions. However, it 
does not have any effect on MC3T3-E1 cultures grown without osteogenic ascorbate or p- 
glyeerol phosphate or on these cultures when grown with the osteogenic supplements for up to 
5 div (Genever & Skerry, 2001). Therefore, high potassium could impair osteoblastic viability 
of well-differentiated MC3T3-E1 cultures by reducing the trophic effect o f glutamate. Overall, 
our data are consistent with these previous findings and additionally have frirnished culture 
standards that could be adopted in the routine culture of this and possibly other osteoblastic 
cell lines.
Further to this, the relevance of this research was again emphasized by considering the relative 
fastidiousness of cerebellar granule cultmes in comparison with MC3T3-E1 cultures when the 
former were grown under similar conditions. While 1 h of serum withdrawal had no effect on
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CGN viability, 6 h of serum withdrawal was profoundly detrimental to their smwival, quite 
unlike the case with MC3T3-E1 cultines. This reinforces the previous realization that the 
suiwival of neuronal cultures depends critically on trophic factors including antioxidants 
present in serum that could prevent the induction of lipid peroxidation. Equally damaging to 
CGN viability was the lowering of the potassium concentration from 25mM to 5mM for 2 
days (6 to 8 div). This is most likely due to apoptotic cell death, as cultured CGNs are Imown 
to undergo spontaneous apoptosis if  grown in physiological KCl concentrations (5mM) but 
survive in the presence of depolarizing concentrations of KCl (25mM) (Xifro et al., 2005). 
The authors found that neuroprotection mediated by this high KCl concentration was BDNF- 
independent but mediated by a mitogen-activated protein kinase- (MAPK) and 
phosphatidylinositol-3 (PI3) kinase-dependent inhibition of caspase-3. During their postnatal 
migration from the external to the internal gianule cell layer, cerebellar neurones require 
excitatory inputs from mossy fibres. Consequently, neurones which receive the excitatory 
inputs survive and differentiate, while those which fail to do so die by apoptosis (Williams & 
Herrup, 1988; Wood et al., 1993). This requirement is mimicked in vitro by maintaining CGN 
cultures in the presence of a depolarizing concentration of KCl (e.g., 25niM) (Gallo et al., 
1987), providing a reason why these cultures are routinely cultured in a high concentration of 
KCl, often 25mM. Alternatively, the CGN cultures could be maintained in the presence of 
exogenous trophic agents such as NMDA (Gallo et a l, 1987; Balazs et al., 1988), or BDNF 
(Lindholra et al., 1993). The presence of 25niM potassium or NMDA in CGNs does induce a 
trophic effect, which includes a specific regulation at the mRNA level of the enzymes 
involved in the glutamate neurotransmitter synthesis, such as aspartate aminotransferase 
(AAT) and phosphate-activated glutaminase (PAG) (Caballero-Benitez, 2004). The protection 
by NMDA against caspase-mediated apoptosis o f cultured CGN is dependent on activation of 
tyi'osine kinases and PI3 kinase but, unlike the protection by high KCl concentration, is also 
BDNF-dependent (Xifro et a l , 2005). In contrast, however, some other authors have argued 
that it is caspase-independent mechanisms that are involved, as caspase inhibitors do not 
inhibit apoptotic death of cerebellar neurones induced by low concentrations, although they 
block caspase activity and DNA fragmentation (Miller et al., 1997). These discrepancies are 
easily resolved in the light of current evidence that the process of apoptosis involves both 
caspase-dependent and -independent mechanisms. Furthermore, apoptosis induced by low K^
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in CGNs is associated with reduced interaction between CREB-binding protein (CREB is 
cAMP/calcium response element-binding protein) and the ubiquitously expressed transcription 
factor, NF-kB. There are five NF-tcB proteins in mammalian cells, namely p50, p52, p65 
(RelA), RelB and c-Rel Yalcin et al. (2003) showed that in normal nemones, p65 interacts 
with the transcriptional co-activator, CREB-binding protein (CBP). However, the decrease in 
transcriptional activity o f NF-kB caused by low K’*' is accompanied by a reduction in the 
interaction between p65 and CBP, which causes hyperphosphorylation of CBP. It has also 
been suggested that neuronal apoptosis following serum and potassium deprivation in CGNs 
may be due to inappropriate control of the cell cycle, as roscovitine, an antitumour drug that 
inhibits cyclin-dependent kinases Cdkl, Cdlc2 and Cdk5, showed a significant neuroprotective 
effect in CGNs deprived of these supplements (Verdaguer et al., 2004). Another Cdk inhibitor, 
flavopiridol, at therapeutie dosage almost completely prevented colchicine-induced apoptosis 
in CGNs (Jorda et al., 2003). One other possible mechanism by which the reduction of 
could trigger apoptosis in the CGNs is by partial closure o f L-type Ca^^ channels with a 
consequent di'op of intracellular concentrations of this cation (Vitolo et al., 1998). Valencia & 
Moran (2001) suggested that the superoxide anion could also be responsible for the apoptotic 
death of CGNs induced by potassium deprivation. Interestingly, adenosine and ADP were 
shown to prevent apoptosis caused by lowering the IC*" concentration from 25mM to 5mM in 
cultured rat CGNs (Vitolo et al., 1998).
5.5. Glutamate and NMDA receptors
5.5.7. Glutamate and the viability of neurones
The neurotoxic actions of glutamate and NMDA were demonstrated in this study in a dose- 
dependent manner. The absence of serum from the culture medium during post-treatment 
recovery, which lasted for at least 20 h, enhanced the neurotoxicity of glutamate, but not of 
NMDA. This enhancement was best demonstrated with glutamate at 10 and lOOpM. The 
presence of a high level o f glucose in culture medium during post-treatment recovery was 
unable to compensate for the absence of serum. It is possible that the absence of serum 
imposed additional stress on the cultures, thus potentiating the excitotoxic effect of glutamate, 
since it was shown earlier in this study that serum withdrawal from CGN cultures for just 6 h
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resulted in more than 30% reduction in basal viability. However, the reason why a similar 
occurrence of seium deprivation-induced potentiation of neurotoxicity was not found with 
NMDA is not clear. Again, at comparable concentrations, glutamate induced greater damage 
to the viability o f CGNs than did NMDA. One possibility is that glutamate was able to 
activate both the NMDA and non-NMDA receptors - all of which may contribute to cell death 
- to cumulatively induce a higher level of death, whereas NMDA was a specific agonist 
activating only the NMDA population of glutamate receptors. This, however, may not be the 
case, as blockade of the non-NMDA receptors by CNQX completely failed to attenuate the 
damaging effect o f glutamate, whereas both the non-competitive and competitive NMDA 
receptor agonists, MK-801 and D-AP5, respectively, were able to protect significantly against 
this effect o f glutamate, with D-AP5 restoring viability to a level comparable to that o f control 
cultures without glutamate. This suggests that the neurotoxic action of glutamate in the CGNs, 
at least in our culture system, is attributable mainly and most clearly to the overactivation of 
NMDA receptors. The NMDA receptor has several modulatory sites sensitive to a variety of 
agents (Watkins et al., 1990; Stone & Addae, 2002), including those with redox properties.
For example, the receptor is known to require glycine for its activation (Johnson & Ascher, 
1987) and of late, the critical role of the amino acid D-serine to the activation of NMDA 
receptor has also been espoused (Mustafa et al., 2004). All these may add to the complexity of 
the NMDA receptor in mediating nemotoxicity. The likelihood o f NMDA receptor 
desensitization in this paradigm is also suspect, as lOOpM and ImM NMDA each caused less 
damage than a mid-way concentration o f 300pM. It is therefore possible that while lOOpM 
NMDA was not sufficient to significantly overactivate the receptor in order to mediate 
toxicity, ImM was so high a concentration that it desensitized the receptor. Should this be the 
case, a concentration of 300pM would then just be adequate to overactivate the receptor and 
lead to significant neurotoxicity- without inducing desensitization- in a way that shows it is 
equipotent with a comparable concentration of glutamate at this receptor.
Glutamate receptor-mediated neurodegeneration can now be separated into two distinct forms, 
acute and delayed, which can be distinguished from each other based on the time course and 
ionic dependence of neuronal degeneration (Kato et al., 1991; Choi et al., 1987). Acute 
neurotoxicity is typified by neuronal swelling in the presence o f agonist, leading to osmotic 
lysis. Removing from the medium Na^ and Cf, two ions responsible for the massive influx of
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water into the cell tlii'ough the open Gin-gated channels, can prevent this. On the other hand, 
delayed neurotoxicity which is caused by NMDA (and, in most cases, KA receptor agonists) 
occurs over hours after a brief exposure to a high concentration of agonist or prolonged 
exposure to a low concentration of agonist (Kato et al., 1991; Choi et al., 1987; Rotlunan et 
al., 1987). Blockade of acute neurotoxicity does not prevent delayed NMDA- or KA-induced 
neurotoxicity, indicating that this form o f glutamate receptor-mediated neurodegeneration 
does not depend on acute toxicity. In fact, delayed neurotoxicity in vitro, which more closely 
resembles glutamate receptor-mediated neurodegeneration in vivo, has been successfiilly 
dissociated from neuronal excitation (Choi et al., 1987; Rothman et al., 1987). Calcium 
elevation may not need to be prolonged to elicit neuronal damage (Michaels & Rothman,
1990) and, depending on the type of neurone, increase in intracellular calcium may be 
mediated by both voltage-dependent calcium channels and NMDA receptor-gated Ca^ "*" influx 
(Frandsen & Schousboe, 1993). In our case, since the quantification of viability following 1 h 
exposure to glutamate or NMDA was carried out at least 20 h post-treatment, it is reasonable 
to conclude that the data reflect contributions to neuronal cell death from both events of acute 
and delayed neurotoxicity. In the event of a stroke, it is laiown that excitotoxic brain lesions 
initially cause primary destruction of brain parenchyma, but subsequently result in secondary 
damage of neurones several hours after the insult. It is this secondary damage that is 
responsible for most o f the volume o f the infarcted area and the loss of brain fiinction (Skaper,
2003). In secondary neuronal damage, a major component is the migration o f macrophages 
and microglial cells towards the sites of injury, where they are laiown to produce massive 
quantities of toxic cytokines and oxygen radicals (Skaper, 2003).
In relation to neuroprotection, the role of kynurenic acid (KYA) as a glutamate receptor 
antagonist was confiimed in this study. Even at a low concentration of lOOpM, it completely 
abolished the neurotoxic effects of glutamate and NMDA. Kynurenic acid is an antagonist at 
both the NMDA and non-NMDA receptors, acting at the stryclmine-resistant glycine-sensitive 
site of the former. It is able to antagonise glutamate receptor activation in rodents and primates 
(Stone & Perkins, 1984). Endogenously, it is produced in the brain, though synthesized more 
effectively in the periphery (Scharfman & Goodman, 1998). Research over the last decade has 
furnished massive evidence that changes in the levels of endogenous KYA can affect NMDA 
receptor fiinction in vivo, thus modifying excitotoxic vulnerability, neurophysiological activity
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and behaviour (Coyle, 2006). Kynurenic acid is able to cross the blood-brain barrier 
(Scharfman & Goodman, 1998, Salvati et a l, 1999) and has been used as a lead compound in 
the development of compounds with potential therapeutic use (Stone & Darlington, 2002) in 
the treatment of strokes, epilepsy (Rowley et a l, 1993; Nichols & Yielding, 1993) and 
neurodegenerative disorders, following observations that its glutamate antagonist property is 
responsible for its ability to prevent brain damage from anoxia (Simon et a l, 1986) and 
ischaemia (Germano et a l , 1987, Salvati et a l , 1999).
5.5.2. Glutamate and osteoblast viability
In contrast to the highlighted obseiwations of glutamate neurotoxicity, no toxicity resulting 
from glutamate or NMDA exposure was demonstrated in the osteoblast cultures, even at 
concentrations as high as ImM, which are profoundly neurotoxic. It is now Imown that 
osteoblasts express the whole range of glutamate receptors that display the same 
electrophysiological characteristics as their neuronal counterparts. In fact, the NMDA-type 
glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological 
characteristics as neuronal receptors (Gu et a l, 2002). They also express glutamate 
transporters and the exocytotic machinery required for complete glutamate release. In 
addition, there is evidence for targeted vesicular glutamate exocytosis in osteoblasts (Bhangu 
et a l, 2001) and the mechanisms of calcium handling are similar to those in neurones (Skerry 
& Genever, 2001). Therefore, the presence of glutamate release, together with functional 
receptors on bone cells, raises the possibility that excessive glutamate could also induce 
damage in bone tissue. However, results from this study render this rationalization largely 
improbable. Significant increases in cell numbers were obseiwed when lOOpM and ImM 
glutamate were applied to osteoblast cultures for 1 h and 15 min respectively. Similarly, 
NMDA lOOpM and ImM induced increases in cell proliferation when applied for up to 3 h. In 
fact, 20 h exposure to glutamate or NMDA at 4 div resulted in significant trophic effects for 
concentrations up to lOmM. These findings demonstrate a trophic rather than a toxic role for 
glutamate in bone. Our data are consistent with previous reports using either cell lines or 
primary cultures o f osteoblasts. Excitotoxic effects have not been demonstrated to date in bone 
cells. The observation that glutamate release parallels ALP activity (Bhangu et a l, 2001) 
suggests that, once MC3T3-E1 cells differentiate, they express a phenotype resembling that of
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glutamate-releasing neurones. The anticonvulsant drug, riluzole, has been reported to inhibit 
glutamate release and ALP activity and to induce, at higher concentrations, apoptosis in 
MC3T3-E1 cells, suggesting a trophic role for glutamate in development. In addition, it has 
been shown that addition of exogenous glutamate (50pM-lmM ) promoted osteoblast survival 
under semm-free conditions and increased the survival rates of human osteoblasts exposed to 
TNF-a and IFN-y, providing an evidence for an intrinsic synaptic-like glutamatergic 
signalling network in bone (Genever & Skerry, 2001). However, according to these authors, 
lOmM glutamate significantly reduced viable osteoblast numbers. This study exposed the 
osteoblast cultures to glutamate lOmM only at 4 div and found no toxic but trophic effect. 
Unlike in the CNS, glutamate release is negatively regulated by voltage-dependent calcium 
entry, since a continued depolarization with 30-60mM KCl inhibits glutamate release in 
osteoblastic cells (Genever & Skerry, 2001). The finding in our study that 50mM, but not 10 
or 25mM K^, had a tendency to be toxic to the osteoblast cells is therefore consistent with this 
report, finther supporting the evidence o f a trophic role for glutamate, the inhibition (by high 
potassium) of which removes the effect, resulting in decreased viability.
However, with regard to the action o f glutamate in osteoblast cells, our data point to a 
fundamental line of research that is worth investigating further. This arises from the finding 
that the application o f glutamate, NMDA, or the antagonists MK-801 and D-AP5 in 
combination with hydrogen peroxide (H2 O2 ) tended to be more toxic than the application of 
peroxide alone. The role of glutamate in disease states in bone characterized by elevated levels 
o f free radicals or ROS such as H 2 O2 therefore demands clarification. In support of these 
identified concerns, it has been reported that a similar glutamatergic (NMDA) receptor ligand, 
quinolinic acid, can be excitotoxic to hippocampal neurones at concentrations not injurious to 
neurones by itself in the presence of donors of nitrosative and oxidative stress (Behan &
Stone, 2002). It is therefore possible that, in the presence of oxidative or nitrosative stress, 
these mechanisms occur in osteoblasts too, thus causing glutamatergic ligands to have a toxic 
action on MC3T3-EI cells.
5.5.3. Downstream effectors of glutamate toxicity
It is now known that the neuronal damage that occurs following conditions like stroke is due 
to the massive release of glutamate from neurones and glia, rather than to the immediate
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hypoxia or ischaemia itself (Obrenovitch & Urenjak, 1997), a role that has also been 
demonstrated for glutamate in neiirodegenerative diseases like Alzheimer’s, Parkinson’s and 
Huntington’s diseases (Coyle & Puttfarcken, 1993). Excessive accumulation of glutamate in 
the synaptic cleft or the overactivation of its receptors, especially the NMDA receptors, leads 
to increased intracellular concentration o f free calcium, which is able to activate several 
pathways, including the calcium-dependent nitric oxide synthase (NOS), which generates the 
free radical nitric oxide (NO) from the amino acid L-arginine. The calcium-dependent 
activation of phospholipase A j (PLA2 ) also results in the production o f arachidonic acid (AA), 
which yields superoxide radical thimigh its subsequent metabolism by lipoxygenases and 
cyclooxygenases to form eicosanoids (Chan & Fisliman, 1980). Amchidonic acid and oxygen 
radicals enhance the release of glutamate and inliibit its inactivation by uptake through glial 
transporter processes, thus promoting a vicious cycle (Pellegrini-Giampietro et ah, 1988; 
Williams et ah, 1989). In addition, under conditions of energy failure and elevated calcium 
levels, xanthine dehydrogenase could be converted by proteases such as calpains to xanthine 
oxidase (McCord, 1985), which can in turn yield superoxide radical tluough its conversion of 
accumulated hypoxanthine and xanthine to uric acid (Halliwell & Gutteridge, 1989). The 
dismutation o f superoxide radical by superoxide dismutase (SOD) yields H 2 O2 . Tlirough the 
Fenton reaction, H2 O2 in the presence of transition metals like iron or copper could yield the 
very reactive hydroxyl radical (Halliwell & Gutteridge, 1989). Besides, NMDA receptor 
agonists can cause ATP depletion and elevation of AMP within hours, and a concuiTent 
increase in lactic acid (Retz & Coyle, 1982) causes the resulting acidic conditions to promote 
the release of Fe^ "^  from its cellular stores, thus yielding the hydroxyl radical from H2 O2 
tlirough the Fenton reaction (Halliwell & Gutteridge, 1989). Reaction between NO and 
superoxide produces peroxynitrite anion which is also a very toxic ROS and can decompose to 
"OH (Beckman et al., 1990).
The mitochondria act as low-affmity, high-capacity “sinks” to sequester excess calcium in 
order to maintain its homeostasis (Sapolsky, 2001). However, after a while, a combination of 
excessive levels of calcium and generated ROS (oxidative stress) overwhelms the capacity of 
the mitochondria, leading to calcium deregulation and subsequently neuronal damage and 
death tluough apoptotic or necrotic pathways involving mediators such as caspases, apoptosis 
inducing factor (AIF) and the nuclear enzyme, poly (ADP-ribose) polymerase (PARP). The
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mediation of glutamate-induced neuronal damage by oxidative stress is now a subject of 
intensive research and it is now widely accepted that oxidative stress is a causal, or at least an 
ancillary, factor in the neuropathology of several adult neurodegenerative disorders and 
conditions such as stroke, trauma and seizures (Coyle & Puttfarcken, 1993) in which excessive 
extracellular levels of glutamate or the overstimulation o f its receptors has been implicated. 
Our study therefore set out to investigate the effects of oxidative stress induced by ROS and 
glutamate on CGNs and MC3T3-E1 cells, using the parameter of cell viability as end-point.
5,6. Oxidative stress-induced modulation of cellular viability
The effects of oxidative stress on the viability of MC3T3-E1 osteoblast and CGN cultures 
were examined using H2 O2 , xanthine/xanthine oxidase (X/XO) mixture and ROS-generating 
kynurenines- 3-hydroxyantlnanilic acid (3-HAA) and 3-hydroxykynurenine (3-HK).
5.6.1. Hydrogen peroxide-induced oxidative stress
Oxidative stress results from excessive production of ROS to a degree that overwhelms the 
antioxidant defence capacity of a cell (Sapolsky, 2001). It induces significant damage by 
altering cellular structure and function of biomolecules, including proteins, lipids, and nucleic 
acids. In neurones, oxidative stress induced by ROS mediates cellular damage by glutamate. 
Since glutamate is equally released in osteoblasts where its receptors are functionally 
expressed, the effects of ROS on MC3T3-E1 osteoblast-like cells and cerebellar granule 
neurones were investigated. Hydrogen peroxide was the main ROS used in this study, even 
though the effects of free radicals generated by the X/XO mixture and kynurenines (3-HAA, 
3-HK) were also investigated at a later stage. Even though H2 O2 is not very reactive unless its 
concentration builds up significantly in living tissues, it is very important to the elucidation of 
pathologies associated with elevated levels of ROS for a number o f reasons. It is Imown that 
H2 O2  is produced by almost all cell types and has the profound ability to diffuse within and 
across cells, unlike superoxide, which is unable to traverse membranes. This ability results 
from its stable nature, causing H2 O2 to target a wide range of intracellular and extracellular 
sites. In addition, in the presence of a transition metal like iron or copper, H2 O2 produces the 
hydroxyl radical, which is the most reactive and toxic of the ROS. hi the present study, H2 O2 
applied to the 10 div cultures at concentrations up to lOOpM showed no deleterious effect on
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the osteoblast cultures. In fact, when these cultures were exposed to H 2 O2 concentrations up to 
50pM at an earlier developmental stage o f 4 div, significant increases in viability, suggesting 
increased proliferation, were obtained. It is Imown that exogenously added superoxide and 
H2 O2 , as active oxygen species, stimulate the expression of early growth-regulated genes such 
as Q-fos and o-jun, and activate protein kinases distinct from protein kinase C, which suggests 
that these ROS might function as niitogenic stimuli thi’ough signalling pathways common to 
natural growth factors (Burdon, 1995). The observation that superoxide (or its dismutation 
product, H 2 O2 ) are released by cells either constitutively, in the case of tumour cells, or 
following cytokine stimulation has led to speculation that they serve as an autocrine growth 
stimulation system or as a means of intercellular communication (Burdon, 1995).
However, in this study, the application of 200pM or above of peroxide for at least 1 h at 10 
div elicited significant reduction in osteoblast viability, which was both concentration- and 
time- dependent. Morphological changes as assessed by phase contrast microscopy correlated 
well with degrees of reduction in viability, with progressive loss o f cells and the rounding up 
of the remaining cells as peroxide concentrations or durations of exposure were increased. 
These observations led us to the conclusion that low concentrations of H 2 O2 are generally 
stimulatory to the giowth of MC3T3-E1 cells, while higher concentrations (>200pM) have 
deleterious effects leading to cell death. This is consistent with previous studies which 
reported inhibited differentiation of MC3T3-E1 cells (Mody et al., 2001), and with studies of 
other cell types where H2 O2 proved toxic (Burdon, 1995; Li et al., 2003; Demelash et al.,
2004).
When bone cultures were treated with 200pM of peroxide for 1 h, increasing their recovery 
duration from 4 to 24 h resulted in a slightly improved viability while treatment for 6  h with 
the same concentration and lengthening of recovery duration led to a worsening of survival. 
On the other hand, with a higher concentration o f 500pM, raising the duration of recovery 
after treatment for 1 or 6  h did not affect viability outcome. This observation justified our 
choice of 4 h recovery duration and a working concentration of 500pM for most subsequent 
experiments.
Whether H2 O2 elicited damage directly or indirectly in the MC3T3-E1 cultures was examined. 
Catalase (CAT) is an enzyiue Imown to catalyse the breakdown o f H2 O 2 to water and oxygen, 
while superoxide dismutase (SOD) converts the superoxide anion to hydrogen peroxide and
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oxygen. They are both naturally occurring antioxidant enzymes. Catalase completely 
prevented the deleterious effects of H2 O2  at all the concentrations used, while SOD was unable 
to modulate significantly H2 O2 effects. The heat-inactivated catalase also completely failed to 
prevent damage due to peroxide. Taken together, these observations suggest that the obseiwed 
damage inflicted on the osteoblast cells was due to a direct action by H 2 O2 and that the 
prevention of this damage was entirely due to the enzymatic action o f catalase and not 
attributable to some other protein that may be present in the “cocktail.”
Interestingly, both CAT and SOD induced some mitogenic effect when applied alone. This 
could imply that MC3T3-E1 cells generate a continuous level o f ROS sufficient to restrain cell 
proliferation. This seems unlikely however, in view of the stimulatory effects of low 
concentrations of exogenous peroxide. An alternative explanation may be due to effects of 
CAT and SOD that are not dependent on their metabolism of ROS, for example, the depletion 
of local metal concentrations below the levels which limit cellular proliferation.
Catalase has been reported to induce COX-2 expression in smooth muscle cells (Chen et al., 
1998), macrophages (Jang et al., 2004), microglia (Jang et a l, 2005), and hippocampal 
neuronal cells (Choi et a l , 2001), but the mechanisms of induction o f COX-2 expression by 
catalase in osteoblast and neuronal cells are not clear. Extracellular catalase also induced 
COX-2, IL-8 , and stromelysin in primary human chondrocytes (Litvinov &Turpaev, 2004). 
Whereas COX-1 is constitutive in most cells, COX-2 is inducible by various cytokines, 
endotoxins, growth factors, or tumour promoters (Baigent & Patrono, 2003), thus 
demonstrating its prime importance in inflammation and cell proliferation. A new 
acetaminophen-sensitive isoform, COX-3, has recently been identified mainly in the brain 
(Chandraseklraran et a l, 2002; Shaftel et a l , 2003). Constitutively expressed COX-2 has been 
reported in certain regions of the brain, reproductive tissues, kidney, and thymus (Baigent & 
Patrono, 2003; Rocca et a l, 1999). The possibility that the induction of COX-2 modulates the 
prevention by catalase of H2 0 2 -induced damage was therefore examined using acetylsalicylic 
acid (aspirin, ASA), a non-specific COX inhibitor. Aspirin had no effect on H 2 0 2 -mediated 
osteoblastic damage, indicating that catalase cytoprotection against oxidative damage by 
peroxide may not be related to its COX-2-inducing potential. However, in contrast to our 
observation, Petersen et al. (2005) found that low concentrations of NSAIDs or ASA caused a 
significant protection against H 2 0 2 ~induced apoptosis in human lens epithelial cells whereas
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higher concentrations were toxic. This could imply a substantial degree of tissue specificity in 
AS A-mediated protection against oxidant injury.
Our work and that of others have shown that a combination o f ascorbate and p-glycerol 
phosphate (which we have referred to as switching) increases the proliferation and 
differentiation o f MC3T3-E1 osteoblast cells (Quarles et al., 1992; Harada et al., 1991;
increased from 6  to 24 h, suggesting the initiation of secondary damage to cells that might 
have previously escaped the oxidative insult and a gradual progression towards complete 
demise of cells that were initially only partially buffeted. As was the case with osteoblast cells, 
catalase completely abolished the toxic effect of H2 O2 on CGNs. Although not statistically 
significant, aspirin showed a tendency to improve damage caused by H2 O2 , which may imply 
a possible contributory role for the induction of COX-2 in the event o f oxidative damage. This
186
I
Fatokun et al., 2006). Since the more differentiated osteoblast cultures manifest a phenotype 
resembling the in vivo situation more closely, the sensitivities o f switch (i.e., the more 
differentiated) and non-switch (i.e., the less differentiated) cultures to oxidative damage by 
H2 O 2 were compared. Switch cultures generally tended to be more sensitive to peroxide 
damage than non-switch cultures, implying that differentiation in osteoblasts may increase 
sensitivity to oxidative damage. Whether this is related to a developmental change in the level 
or nature of antioxidant defence systems is not clear and is therefore worth investigating. A 
similar observation was reported in motor neuronal cell lines: the fully differentiated forms 
(NSC34D) were more sensitive to low and high concentrations of nitric oxide than the less 
differentiated (NSC34) cells (Chodimella et a l , 2005).
In comparison to the degree o f MC3T3-E1 sensitivity to peroxide-mediated damage, 
cerebellar granule neurones (CGNs) were much more sensitive to this oxidant, to an extent 
that even lOpM H2 O2  applied for just 15 min caused a significant reduction in the viability of 
CGNs, even though we are very cautious here of making conclusive generalizations, as 
immortal and stem cells could show intrinsic resistance to oxidative stress (Kondoh et a l,
2005). The effects o f peroxide on CGNs were both concentration- and time-dependent and 
morphological assessment showed that the degree of peroxide-induced phenotypic changes 
coiTclated positively with increasing concentrations of, or the durations of exposure to, the 
oxidant. Cells were grossly slminken in appearance with their neuronal processes severely
damaged after treatment with H2 O2 . Suiwival was poorer when the recovery duration was
I
may also serve to support the oxidative stress theory of glutamate excitotoxicity, as COX-2 
contributes to NMDA-mediated neuronal cell death in primary cortical cell culture (Hewett et 
al., 2 0 0 0 ), possibly through its induction of significant oxidative stress following 
overactivation o f glutamate receptors sensitive to NMDA. Agents that are able to block COX- 
2 would therefore prevent intracellular accumulation of ROS and thus protect against NMDA 
receptor-mediated excitotoxicity. In fact, COX-2 inhibition has been found to protect cultured 
CGNs from glutamate-mediated cell death (Strauss & Marini, 2002). However, inhibition of 
PLA2 or the subsequent metabolism of arachidonic acid by lipoxygenases, but not by 
cyclooxygenases, provides protection against glutamate toxicity (see Coyle & Puttfarcken, 
1993). This may suggest that the lipoxygenase pathway compared to the cyclooxygenase 
pathway generates a substantially higher level of oxidants. Overall, the profound sensitivity of 
CGN cultures to H2 O2 in this study strongly suggests that ROS are a major effector of 
glutamate-induced excitotoxicity in the CNS. The use of H2 O2 as an inducer of damage could 
be a clinically important model o f oxidative stress in neurodegenerative diseases. For example, 
in Alzheimer’s disease, ^-amyloid plaque builds up in the brain and causes intracellular 
accumulation of H2 O2 (Behl et al., 1995). This work is therefore very relevant to investigation 
o f mechanisms underlying neurodegeneration, with the ultimate aim of finding novel therapies 
for the associated conditions.
5.6.2. Effects o f hydrogen peroxide in the presence of copper (II) ion 
The generation of toxic hydroxyl radical by H2 O2 in the presence o f a transition metal like 
copper or iron tluough the Fenton reaction is well known (Mazzio & Soliman, 2003). In the 
MC3T3-B1 cells used in this study, a combination of H2 O2 and Cu^^ (generated from CUSO4 ) 
for 1 h resulted in significant reduction in viability, an effect that was more significant than the 
reduction obtained in the presence o f either H 2 O2 or Cu^^ alone, suggesting that the hydroxyl 
radical may be involved in this further lowering of viability. In CGNs, a similar pattern was 
obtained, although this did not reach significance and so was less clear-cut. A puzzling 
conundmm, however, was the observation in both MC3T3-E1 and CGN cultures that, in the 
presence of mannitol, a known scavenger of hydroxyl radical (Klian et ah, 2005) and which 
had no effect on its own on either culture, a combination of H2 0 2 and Cu^^ induced a 
considerably greater reduction in viability than was the ease when these two agents were
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1combined without the scavenger. This phenomenon reached statistical significance with data 
from osteoblast cultures. A possible explanation of this strange effect is that the addition of 
mannitol at a concentration of 50mM could disturb ionic homeostasis, thus toppling isotonic 
balance in the cultures, which could have a net effect o f further damaging cellular viability, 
especially in cells whose integrity has already been compromised thi'ough oxidative stress 
inflicted by the high level o f reactive oxygen species such as hydrogen peroxide or even the 
hydroxyl radical, if  it was at all produced through the reaction of hydrogen peroxide with 
copper.
5.6.3. Xanthine (X) and xanthine oxidase (XO)
The xanthine and xanthine oxidase (X/XO) system represents another free radical-generating 
system which has been used in many experimental studies as a source o f superoxide radical. 
As explained earlier, XO is able to act on xanthine to produce superoxide radical through its 
conversion o f accumulated hypoxanthine and xanthine to uric acid (Halliwell & Gutteridge, 
1989). The ability o f the X/XO mixture to modify osteoblastic and neuronal viability was 
therefore investigated.
No damaging effect was found after co-administration of neurotoxic concentrations of X 
(lOOpM) and XO (0.02U/ml) to MC3T3-E1 cells for up to 24 h. histead, the application of X 
or X/XO for 24 li produced a significant increase in viability, while XO had no effect at any 
tiiue point. This seems to conflict with an earlier report of significant induction of oxidative 
stress in these cells by X/XO (25pM/25mU/ml) (Mody et a l, 2001), although it was 
intracellular ROS production that these authors measured and not the direct effect of the 
generated ROS on MC3T3-E1 viability. In view of their resistance to oxidative damage, 
increased levels of ROS in these cells may be difficult to interpret as correlating directly with 
damage to their viability. The same report showed a significant decrease in ALP activity by 
X/XO in these cells.
In a striking contrast to what was found with the MC3T3-E1 cultures, the application of
.similar concentrations of X and XO to CGNs resulted in a profound reduction in viability. 
Xanthine alone had no effect in most cases, while the application o f xanthine oxidase alone 
resulted in a significant time-dependent lowering of viability. Application of X and XO 
produced a time-dependent reduetion in CGN viability significantly greater than was found
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with XO alone. Heat-inactivation of XO led to a complete loss of its enzymatic activity, as the 
inactivated enzyme had no effect when applied alone or in combination with xanthine, 
implying that the xanthine oxidase-induced effects were solely due to its enzymatic activity. 
The nature o f the ROS generated by the X/XO mixture was examined using superoxide 
dismutase (SOD) and catalase (CAT). Surprisingly, SOD completely failed to rescue the 
lowering o f viability induced by X/XO while CAT offered complete protection against the 
viability-lowering effect of X/XO on CGNs. These data strongly suggest that the damage to
189
neuronal viability by the X/XO mixture, at least in CGNs, could be entirely mediated by 
hydrogen peroxide under certain experimental conditions and not by the superoxide radical as 
is commonly the case. Further to this, in view of the ability of XO to impair CGN viability on 
its own, mediation of this damage by ROS was also examined. The lowering effect of XO on 
CGN viability was significantly blocked by the XO inhibitor, allopurinol, which restored 
viability to a level comparable to the control, suggesting that the effect was initiated by XO 
itself. An attempt to establish whether ROS generation was involved in this phenomenon and 
if so, the nature of the ROS, revealed that, similar to what was found with the X/XO mixture,
H 2 O2 , but not superoxide radical, mediated the damage by XO, as CAT was effective in 
completely preventing this damage, restoring viability to beyond control level, while SOD was 
entirely incapable of modulating the damage. It is therefore reasonable to conclude that 
sufficient levels of xanthine are present in the cerebellar granule neurones for exogenously 
added xanthine oxidase to act upon, resulting in the production of ROS such as hydrogen 
peroxide, which are capable of eliciting significant neuronal damage. Earlier works have 
implicated XO as a source of free radicals mediating damage by kainate in mouse CGNs, 
because allopurinol as well as a combination o f SOD and CAT protected against kainic acid-
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induced toxicity in these cells (Dykens et al., 1987). In this context, protein kinase C (PKC) is 
thought to be a possible modulator thi'ough its effects on intracellular Ca^^, as treatments with 
gangliosides which can inhibit PKC translocation attenuated KA-induced neurotoxicity in 
primary cultures of CGNs (Favaron et al., 1988).
5.6,4. Modulation of viability by kynurenines
The effects of two ROS-generating kynurenines on osteoblastic and neuronal viability were 
examined. 3-hydroxyanthi'anilic acid (3-HAA) generally had no significant effect on MC3T3-
tI
E l cultures with up to 24 h of exposure, except for a slight enhancement of viability when 
lOOnM was applied for 1 h. On the other hand, 3-hydroxykynurenine (3-HK) at ImM 
significantly and time-dependently damaged osteoblastic viability with 1 and 6 h of exposure, 
while lower concentrations had no effect. In view of this, the possible effects o f 3-HK on the 
viability of CGNs were also investigated at the same time points. In this case, a significant 
damage to viability was evident with a much lower concentration o f lOpM and the trend of 
damage was concentration- and time-dependent. 3-hydroxykynurenine is known to generate 
substantial levels of H 2 O2 and the nature o f cell death by this kynurenine is essentially 
apoptotic whereas its metabolite, 3-HAA, is a far weaker neurotoxin (Okuda et al., 1998). It is 
therefore possible that the damage inflicted on MC3T3-E1 or CGNs by 3-HK in this study was 
due to the generation in either of these cell types of hydrogen peroxide, which we have shown 
to be toxic to these cells on its own. There is a general awareness o f the intrinsically higher 
resistance to cytotoxic agents of cell lines compared to primary cultures. This seems to explain 
the reason for the lower sensitivity of MC3T3-E1 cultures to 3-HK, in view of the 
consideration that the differential sensitivities of these and CGN cultures to 3-HK-induced 
damage could be due to the previously established less vulnerability of MC3T3-E1 cells to 
hydrogen peroxide, which primarily mediates 3-HK toxicity. Our more extensive work on the 
toxicity of ROS has been focussed mainly on the effects of exogenously added H2 O2 , but it 
would be very interesting to confimi whether other ROS are involved in 3-HK toxicity in 
osteoblasts. This future investigation may further our understanding of this paradigm, 
especially in the light of the fact that most of the earlier reports have investigated the effects of 
3-HK in the CNS and even so, articles such as that of Okuda et al. (1998), which examined the 
possible brain regional selectivity of 3-HK toxicity, have reported that, while the cortical and 
striatal neurones were the most vulnerable to 1-lOpM concentration o f 3-HK, hippocampal 
neurones were less sensitive and CGNs (whether from embryonic or postnatal rat brains) were 
totally resistant to these concentrations of 3-HK. It is notable that while the CGNs used in this 
study also proved completely insensitive to 1 pM 3-HK, they succumbed to damage by lOpM, 
the upper limit o f the concentration range tested by Okuda et al. (1998). However, 
intermediate concentrations between 1 and lOpM have not been examined in this study. There 
is evidence that neurotoxicity of lower concentrations of 3-HK (lOpM or below) is entirely 
dependent on cellular uptake processes involving Na^-dependent amino acid transporters that
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recognise as substrates large neutral amino acids like tryptophan, phenylalanine and leucine, 
but not acidic or basic amino acids. Pretreatment of striatal neurones with xanthine oxidase 
inhibitors such as allopurinol prevented intracellular accumulation of peroxide as well as cell 
death induced by these concentrations o f 3-HK, indicating that the generation of ROS by 3- 
HK (1-lOpM) occurs intracellulaiiy tluough 3-HK interaction with xanthine oxidase. On the 
other hand, neurotoxicity of a higher concentration of 3-HK (lOOpM) is not dependent on 
uptake processes and does not show brain region selectivity, possibly because this high 
concentration undergoes non-enzymatic autoxidation in the extracellular compartment (Okuda 
et al., 1996; 1998).
The neuronal death processes activated by 3-HK and another kynurenine, quinolinic acid (QA)
i
were compared by Chiamgi et al. (2001). NMDA receptor antagonists and NOS or PARP 
inhibitors reduced QA, but not 3-HK toxicity. On the other hand, scavengers of free radicals, 
caspase inhibitors and cyclosporin preferentially decreased 3-HK neurotoxicity.
The significance of 3-HK-induced damage to the pathology o f Huntington’s disease (HD) has 
been variously reported, hicreased levels of 3-HK have been shown in the brain with several 
neurodegenerative disorders including HD (Pearson & Reynolds, 1992) and acquired 
immunodeficiency syndrome dementia (Sardar et al., 1995). When 3-HK at comparable 
concentrations in the brains with these disorders was applied to primary neuronal cultures, 
pronounced cell death was found (Olciida et al., 1996), which was attributable to H2 O2 
generated by 3-HK autoxidation. It is interesting to note that NADPH diaphorase-positive 
neurones are spared 3-HK toxicity, which mimicks the pathological features of HD brain. 
Therefore, taken together with earlier reports, the results o f this current study of 3-HK flirther 
lend credence to its critical role in neurodegenerative pathologies, and argues that 3-HK- 
induced neurotoxicity may represent a suitable experimental model for the elucidation of ?■
mechanisms o f neurodegeneration, with the potential benefit o f aiding the discovery of novel
.therapies for the treatment of debilitating neurodegenerative conditions.
5.7. SNAP-induced nitrosative stress
The primary interest o f this work was on oxidative stress. However, as nitric oxide (NO) is a 
member o f the free radical family with diverse biological functions, both in the CNS and the 
periphery, its effects on the viability of MC3T3-E1 and CGN cultures were examined, in order
T-
R
to determine whether NO induced damage tlu'ough nitrosative stress in a way similar to the 
oxidative damage induced by H2 O2 , X/XO, or 3-HK. Endogenously, NO is generated through 
the action of nitric oxide synthase (NOS), of which there are tln*ee isoforms (nNOS, iNOS, and 
eNOS), on the amino acid L-arginine. However, experimental studies investigating the actions 
o f NO use a number o f NO donors including sodium nitroprusside (SNP), S-nitroso-A^- 
acetylpenicillamine (SNAP), S-nitroso-A-acetylcysteine (SNAC), S-nitrosoglutathione 
(GSNO), nitroglycerine (NTG), the NONOates and 3-morpholinosydnoniniine (SIN-1) (Nara 
et ah, 1999; Volbracht et al., 2001; Shishido et al., 2003, Kennedy et a l ,  2006). The NO 
donor SNAP, a nitrosothiol derivative, has been used in this study. It is stable in storage (with 
BDTA added) and yields NO under physiological conditions, with reproducible results. 
Denitrosation of SNAP and the subsequent release of NO may also be due to catalysis by 
specific enzymes located at external vascular cell membranes (Kowaluk & Fung, 1990). 
Exposure of MC3T3-E1 cultures to SNAP at a concentration range of lOpM - ImM for up to 
24 h did not affect viability. When applied for 24 h, SNAP at lOpM resulted in a significant 
enhancement of baseline viability, possibly indicating NO-mediated cell proliferation. 
However, a very high concentration of SNAP (5mM) led to a complete demise of the 
osteoblast cultures. In an earlier study, osteoblast apoptosis resulted when NOS activity was 
induced and this was enhanced by pretreatment with TNF-a (Damoulis & Hauschka, 1997), 
suggesting NO-mediated cell death. A study by Chen et al. (2005) using SNP as the NO donor 
showed that the viability o f MC3T3-E1 cells was only significantly affected when the donor 
was applied at 1.5mM for 16 h or more, or at 2mM for at least 8 h. They concluded that NO 
released from SNP can induce osteoblast insults and apoptosis, and the mechanism may 
involve the modulation of mitochondrial functions, intracellular ROS, and Bcl-2 protein. The 
study was an extension o f an earlier one by the same gi'oup which showed that NO induces 
osteoblast apoptosis tlu'ough the de novo synthesis of Bax protein (Chen et a l, 2002). With 
regard to the CGNs, SNAP at lOpM (24 h) enlianced viability, similar to its effects on 
MC3T3-E1 osteoblast cultures, but significant lowering of viability began to be observed with 
SNAP at lOOpM applied for 6 h. The toxic effects o f SNAP were both concentration- and 
time-dependent. To investigate the possible involvements of NOS and NO-activated soluble 
guanylate cyclase (sGC) in the observed effects of SNAP, the NOS inhibitor L-NAME and the 
sGC inhibitor ODQ were employed. At ImM, L-NAME had no effect on SNAP-induced
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lowering of neuronal viability, but at a very high concentration o f 1 OmM, L-NAME 
significantly protected against SNAP-induced damage, restoring viability to a level 
comparable to the control, indicating that the activation of endogenous NOS could be a critical 
factor in the event o f neuronal damage elicited by exogenously added SNAP. However, since 
ODQ at 10 or lOOpM completely failed to modulate this SNAP-induced damage, activation of 
sGC may not be critical to the damage, at least in CGNs. It has been observed that in CGNs, 
nitric oxide donors elicit apoptosis by a mechanism involving excitotoxic mediators, Ca^ '*' #
overload, and subsequent activation of caspases (Leist et al., 1997), though hippocampal 
neurones in organotypic slice culture have been reported to be highly resistant to damage by 
endogenous and exogenous nitric oxide (Keynes et al., 2004). Calpain inhibitors are known to f
prevent NO-mediated apoptotic death of CGNs exposed to nitric oxide donors (Volbracht et 
a l , 2001). I
To date, controversies remain as to whether this unstable diatomic radical NO causes 
neurodegeneration on its own. For example, whereas Dawson and co-workers (1992) 
demonstrated protection against NMDA neurotoxicity in tissue culture by treatment with NOS :
inhibitors or with reduced haemoglobin (indicating that NO could contribute to neurotoxicity), ï
other investigators have not confirmed protection against NMDA- or glutamate-induced 
neurotoxicity by inhibition o f NOS (Demerle-Pallardy et a l, 1991; Pauwells & Leys en, 1992;
Hewett et a l, 1993). In addition, systemic treatment with NOS inhibitors was found to reduce |
(Nowicki et a l, 1991) or exacerbate (Yamamoto et a l , 1992) brain damage resulting from 
middle cerebral artery ligation, a lesion mediated by NMDA receptors, and NOS-expressing 
neurones are Imown to be resistant to both NMDA-mediated and NO-induced 
neurodegeneration, a phenomenon that could be explained by the protective effect of high 
concentrations o f MnSOD in these cells (Inagaki et a l, 1991).
According to Lipton and colleagues (1993), these disparities in the reported roles of NO in 
neurodegeneration could stem from the profound sensitivity of the NMDA receptor to redox 
changes: elevated levels o f superoxide anion favour its reaction with NO to form the toxic |
peroxynitrite leading to neurotoxicity, while reducing conditions may support S-nitrosylation 
o f the NMDA receptor thiol, thus downregulating the receptor and conferring protection 
against neurotoxicity. It is interesting to note that NO has recently been recognised as a novel 
and potent inhibitor of apoptosis (Figueroa et a l , 2005). The nitric oxide donor SNAP was
j
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;:'ïable to oppose caspase-mediated apoptosis induced by serum deprivation in cortical neurones, 
although in a normally serum-supplemented medium, high doses o f SNAP were neurotoxic in 
a caspase-3-dependent manner (Figueroa et ah, 2005). Another mechanism by which NO 
could be toxic is tlrrough its enzyme inhibition in the mitochondrial respiratory chain (Beltran 
et al., 2000).
5.8. Effects of mitochondrial poisons
In view of the realisation that the MC3T3-E1 osteoblast cultures were substantially less 
sensitive to oxidative or nitrosative damage than the CGN cultures, an attempt to compare the 
sensitivities of these two cultures to mitochondrial poisoning was made. Potassium cyanide 
(KCN) and 3-nitropropionic acid (3-NPA) are two agents that are known to severely impair 
mitoehondrial functioning in cells. Cyanide is a mitochondrial poison that inhibits cytoclirome 
oxidase. 3-NPA inhibits irreversibly succinic dehydrogenase localized in the mitochondrial 
inner membrane (Alexi et ah, 1998) and is also a respiratory inhibitor of mitochondrial 
electron transport chain complexes II and III and the tricarboxylic acid cycle (Alexi et al.,
1998; Cavalière et al., 2001). In addition, 3-NPA is an excitotoxin that has been shown to 
cause brain lesions similar to those of Huntington’s disease. The results o f this study showed 
that MC3T3-E1 cells were insensitive to KCN to an extent that even lOmM of the poison 
applied for up to 24 h produced no effect. The cultures were also insensitive to 3-NPA at 
lOpM applied for up to 24 h, or at lOOpM and ImM applied for up to 6 h. However, when 3- 
NPA was applied for 24 h at lOOpM and ImM, viability was reduced significantly by 33% 
and 57%, respectively.
In CGN cultures, 3-NPA at lOpM for up to 6 h had no effect on viability, but significant 
reductions in viability were obtained with lOOpM applied for 6 h or ImM applied for 1 or 6 h.
This effect was concentration-dependent. Interestingly, the toxic effect o f 3-NPA on the CGNs 
was abolished in the presence of the competitive NMDA receptor antagonist D-AP5, 
suggesting that the toxic effect of 3-NPA occurs tlrrough NMDA receptor activation. This is 
consistent with earlier observations. Wulhier et al. (1994) and Lee et al, (2000) showed that 3- 
NPA toxicity in the striatum was mediated by NMDA receptor activation, possibly through the 
removal of the Mg^ "^  blockade commonly associated with the receptor. Similai'ly, Riepe et al.
(1994) showed that the non-competitive NMDA receptor antagonist MK-801 mitigated
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morphological lesions caused by 3-NPA. It has been confirmed that oxygen free radicals and 
peroxynitrite play an important role in the pathogenesis of 3-NPA neurotoxicity, as this 
deleterious effect was attenuated in copper/zinc superoxide dismutase transgenic mice (Beal et 
ah, 1995). In fact, 3-NPA-induced lesion is used as a suitable model o f Huntington’s disease 
and there is evidence that NMDA receptor activation is involved in the degeneration of striatal 
neurones in Hungtington’s disease (Beal et al., 1986; Albin et ah, 1990). Agents that improve 
mitochondrial hinction or inhibit membrane permeability transition may eliminate increased 
caspase activation and cell death associated with enhanced NMDAR activity in HD (Zeron et 
ah, 2004). In a related observation, KCN applied at ImM caused profound damage to the 
viability of CGNs, and this was also prevented by D-AP5. A report by Patel et ah (1993) 
showed that the NMDA receptor mediated cyanide-induced cytotoxicity in hippocampal 
cultures, while Sturm et ah (1993) confirmed that adenosine attenuated KCN-mediated 
neuronal cell death tlrrough Ai-specific mechanisms. It is therefore possible that the protective 
effect of adenosine is due to inhibition of NMDA receptor activation. In CGNs, cyanide 
produces a Ca^^-dependent generation o f NO and ROS, which is initiated by NMDA receptor 
activation (Gunasekar et ah, 1996). Cyanide-induced toxicity is therefore prevented by NMDA 
receptor blockade or inhibition of PKC (Rathinavelu et ah, 1994; Pavlakovic et ah, 1995). 
Pretreatment of granule cells with NS398, a COX-2 inlribitor, attenuated ROS generation by 
KCN, suggesting that the COX-2 pathway is an important route for AA metabolism and the 
production of ROS during cyanide exposure (Gunasekar et ah, 1998). The overall results 
suggest that, while the MC3T3-E1 osteoblast cultures are largely insensitive to the 
mitochondrial poisons at concentrations that are known to elicit mitochondrial dysfunction, the 
CGNs do succumb to these mitochondrial poisons in a manner that critically involves a potent 
activation of the NMDA receptor. Based on this evidence, it could be hypothesized that 
osteoblast cultures may more likely follow the glycolytic pathway of metabolism, making 
them less reliant on mitochondrial oxidative phosphorylation for the generation of ATP, 
whereas neurones such as the CGNs depend mainly on mitochondrial oxidative 
phosphorylation for ATP production.
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5.9. Mechanisms of oxidative and excitotoxic damage: apoptosis and necrosis
The contributions of apoptosis and necrosis to osteoblastic cell death resulting from H2 O2 - 
induced oxidative damage and to neuronal cell death following both glutamate-induced 
excitotoxic and H202-induced oxidative damage were examined. Investigation of apoptotic 
mechanisms focussed on caspase-3, the executive caspase in apoptosis, and the event of 
membrane permeability transition (MPT), which allows the release of cytoclirome c from the 
mitochondria for the formation of the apoptosome that subsequently activates caspase-3. Even 
though it has been shown that staurosporine and hypoxia both cause activation of the protease 
in these cells (Chae et ah, 2000; 2001), there is yet a paucity of studies addressing the role of 
caspase-3 induction in apoptosis in MC3T3-E1 osteoblast-like cell line. Demonstrating the 
critical and central role of caspase-3 in excitotoxic cell death of many neuronal cell types, Du 
et al. (1997) noted that activation of a caspase-3-related cysteine protease is required for 
glutamate-mediated apoptosis of cultured cerebellar granule neurones. Both in vivo and in 
vitro data suggest that glutamate stimulates caspase-3 induction in neurones (Gottron et ah, 
1997; Tenneti et ah, 1998; Tenneti & Lipton, 2000; Hirashima et ah, 1999; Thomas & Mayle, 
2000; Han et ah, 2002; Lok & Martin, 2002; Zhang et al., 2002). Furtheimore, caspase-3- 
deficient mice show doubling of brain size, correlated with decreased apoptosis and premature 
death (Kuida et ah, 1996) and pro-caspase-3 is cleaved into its active form during apoptosis in 
many cells, including cerebellar gianule neurones (Du et ah, 1997).
On the other hand, investigation of contributions from necrosis in this study was mainly 
concerned with poly (ADP-ribose) polymerase 1 (PARP-1), the nuclear enzyme that is laiown 
to be activated by necrosis-inducing stimuli and which may, in some cases, also be implicated 
in the non-caspase type of apoptotic cell death involving the apoptosis inducing factor (AIF).
5.9.1. Induction o f caspase-3, membrane permeability transition (MPT) and 
poly(ADP- ribose) polymerase (PARP)
The agent Z-DEVD-fmk used in this study is an irreversible, cell-permeable caspase-3- 
selective inhibitor. Even though there have been reports that it is also capable of inhibiting 
caspases-6, -7, -8 and -10, this only occurs at much higher concentrations and the rank 
(decreasing) order of binding affinity is caspase-3 »  caspase-8 > caspase-7 > caspase-10 > 
caspase-6 (Bravarenko et a l, 2006). Furthermore, while most earlier works using this agent as
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a caspase-3 inhibitor were carried out at a concentration of around lOOpM, the concentration 
used to achieve caspase-3 inhibition in this study was 40pM, less than one-half of what is 
commonly used. Cultures were pretreated with Z-DEVD-fmk for 1 h and maintained in culture 
medium containing the inhibitor for the entire period of recovery.
It was clear from the results that inhibition by Z-DEVD-fmk of caspase-3 activation protected, 
though partially, against oxidative damage in MC3T3-E1 cultures and also against oxidative 
and excitotoxic damage in CGN cultures. For the MC3T3-B1 cultures, the protective effect of 
caspase-3 inlribition was most clear-cut with H2 O2 concentration o f 500pM applied for at least 
6 h. This suggests the involvement of caspase-dependent apoptosis in cell damage and death 
mediated by hydrogen peroxide in MC3T3-E1 osteoblast cultures. In CGN cultures, Z-DEVD- 
fmk did not protect against damage by lOpM H2 O2 applied for up to 1 h. While it protected 
partially against damage by a higher concentration of H2 O2 (lOOpM), it lacked any effect on 
damage by this same concentration when treatment was prolonged to 6 h. Interestingly, when 
tested for its ability to prevent excitotoxic cell death by glutamate, the inhibitor completely 
protected CGN cultures against cell death resulting from 1 h application of 300pM of 
glutamate. This most clearly indicates that glutamate-induced excitotoxic cell death occurs 
tlrrough caspase-mediated apoptosis and could be effectively prevented by inhibiting the
induction of caspase-3. A number of studies using the glutamate analogue kainic acid (KA), 
however, concluded that caspase-3 may not play a major role in CGN death following high 
KA doses (Verdaguer et ah, 2002; Smith et ah, 2003). This could mean that the NMDA
'receptor-mediated death of CGNs could involve distinct death pathways different from the 
ones involved when other ionotropic receptors such as kainate receptors are the major targets 
of excitotoxicity-inducing ligands.
A critical step that precedes the induction o f caspase-3, which has been investigated in this 
study, is the release of cytochrome c from the mitochondrial inner membrane. This occurs 
when a pore (membrane permeability transition pore) becomes opened through the process of 
membrane permeability transition (MPT). The released cytoclu’ome c combines with Apaf-1 
and procaspase-9 to form the apoptosome through which the processing of caspase-3 into its 
active form occurs. However, the release of cytoclirome c is preceded by its dissociation from 
its binding to cardiolipin in the inner mitochondrial membrane, which is stimulated by ROS- 
mediated cardiolipin peroxidation (Fariss et ah, 2005). Blocking permeability transition pore
.1:
■
I'
?
should therefore prevent the release of cytoclirome c and consequently the processing and 
induction of active caspase-3, thus preventing caspase-mediated apoptotic cell death. 
Cyclosporin A (CsA) is an immunosuppressant agent that is loiowii to block the permeability 
transition pore. Its immunosuppressive action results from binding to mitochondrial 
cyclophilin, an intracellular imniunophilin. The cyclosporin/immunophilin complex then 
inhibits the activity of the calcium-calmodulin-regulated phosphatase, calcineurin (protein 
phosphatase 2B), resulting in the accumulation o f phosphorylated calcineurin substrates in the 
cell, including the transcription factor, nuclear factor of activated T cells (NF-AT), which is 
active only in the non-phosphorylated state (Ruiz et ah, 2000; Canudas et ah, 2004). This 
results in the blockade of interleukin-2 (IL-2) transcription (Liu, 1993). When used in this 
study at a range of 0.5 - lOjiM, CsA dose-dependently blocked the viability-lowering effect of 
6 h (but not 1 h) application of H2 O2 (500pM) on MC3T3-E1 osteoblast cultures, but the 
blockade could not totally account for this damaging effect o f peroxide. In CGN cultures, CsA 
at lOpM significantly blocked cell damage by H2 O2 (lOpM) applied for 1 h, although at 
0.5pM, it paradoxically tended to potentiate damage by this concentration of H2 O2 . When 
tested against a higher concentration o f H2 O2 (lOOpM) applied for 1 h, CsA at 0.5pM had no 
effect, but at lOpM showed slight protection. On the other hand, the neuronal damage 
mediated by 300pM of glutamate was completely abolished by 0.5, 1, or lOpM of CsA, with 
viability rising significantly beyond control levels for CsA lOpM. These data further support 
the evidence for the involvement of apoptosis in oxidative death o f osteoblasts and neurones 
and in neuronal excitotoxicity, indicating that, while the process of MPT may not fully explain 
cell death mediated by ROS such as H2 O2 , it (MPT) may be highly critical to the initiation of 
the cascade of events leading to delayed excitotoxicity by apoptotic mechanisms. Glutamate- 
induced apoptotic changes involve various mechanisms and biochemical events and it has 
been shown that mitochondria are central to glutamate-induced cell death (Montai, 1998). This 
could also be linked to the complete protection afforded by CsA against glutamate 
neurotoxicity in this study, as previous studies have shown that inhibition of calcineurin 
prevents the collapse of mitochondrial membrane potential and apoptotic cell death 
(Ankarcrona et al., 1995; Wang et al., 1999) and that CsA protects against glutamate 
neurotoxicity tlrrough calcineurin-dependent and -independent mechanisms (Bnitovetsky & 
Dubinsky, 2000; Dawson et ah, 1993; Ruiz et al., 2000). Nevertheless, data on the effects of
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CsA in neuronal preparations are controversial. For example, it has been reported that CsA 
enhances rather than inhibits MPP'^-induced apoptosis in SH-SY5Y neuroblastoma cells (Fall 
& Bennett, 1998) and also increases the neurotoxic effect of NMDA in cortical cultures 
(McDonald et ah, 1997). It can also induce apoptosis in mixed neuronal/glial cultures 
(McDonald et al., 1996). According to Canudas et al. (2004), CsA did not decrease the 
viability of primary cultures o f rat CGN or induce apoptotic features but specifically enhanced 
the cytotoxicity and apoptosis induced by colchicine, through mechanisms possibly involving 
Cdk5. Chang & Joluison (2002) showed that the antiapoptotic effects of CsA are more 
pronounced in the presence of caspase inhibitors.
The release of cytoclirome c from the mitochondria prior to the activation of caspases could be 
induced in a series of steps critically involving calcineurin. Calcineurin does dephosphorylate 
Bcl-XL/Bcl-2-associated death promoter (BAD), a pro-apoptotic gene product that is then 
translocated to the mitochondria to dimerize with B-cell lymphoma/leukaemia-XL (B c 1- X l ) ,  a 
process that initiates apoptosis (Wang et al., 1996; 1999). It is this dimerization that induces 
the release of cytochrome c from mitochondria, and cytochi'ome c combines with apoptotic 
protease-activating factor-1 (Apaf-1) and pro-proteases to form the apoptosome, leading the 
way to cell death by apoptosis (Neame et al., 1998). Besides, the activator protein-1 (AP-1) 
transcription factor and the cellular counterpart of v-Jun (c-Jun) activation by its N-terminal 
kinase Jnlc, especially Jnk-3 (selectively expressed in the CNS), have been found to be critical, 
as Jnk-3 laiockout protects mice from excitotoxic apoptosis (Tabuchi et al., 1996; Yang et al., 
1997a; 1997b). Glutamate-induced apoptosis can also activate the tumour suppressor gene p53 
pathway and this can lead to cell death by activating a Bax-related pathway in neurones 
(Uberti et al., 1998). It therefore means that glutamate induces apoptosis by activating a 
number o f processes that possibly converge into caspase activation. While the gene products 
that constitute all the targets for caspases may not yet be Imown, it is clear from the foregoing 
that caspases play a crucial role in activating cell death by apoptosis during excitotoxicity.
The level of activation of the nuclear enzyme poly (ADP-ribose) polymerase (PARP-1) was 
also examined. Under normal conditions, PARP, especially PARP-1, is involved in the repair 
o f DNA strands and breaks. However, overactivation of PARP-1, which mostly occurs 
following cellular insults, could adequately precipitate necrosis, characterized by large DNA 
fragmentation. It therefore means that prevention of PARP-1 overactivation should be a viable
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protective strategy against necrotic cell death. There are a number o f PARP inhibitors
currently in use, one o f which is the very potent DPQ (Takahashi et ah, 1997), which has been
used in this study at lOpM. It is recognised as a specific PARP-1 inhibitor (Czapski et al.,
2004). Cultures were pretreated with DPQ for 1 h and maintained in culture medium
containing the inhibitor for the entire period of recovery. Because nicotinamide (NAm) has
also been reported to have some PARP-inhibiting potential (Tronov et ah, 2002), its effects on
oxidative and excitotoxic damage and death were equally examined. As was the case with
.caspase-3 inlribition, the significant but partial protective effects o f DPQ inhibition of PARP-1
in MC3T3-E1 cultures were most clearly observed against 500pM of hydrogen peroxide 
applied for 6  h. Similarly, nicotinamide at ImM displayed a significant but partial protection
1against the damaging effect o f H 2 O2 (500pM) applied for 6  h, while its lower concentration (30pM) had no effect on this damage. With regards to CGN cultures, DPQ protected against 
damage by lOpM H2 O2 applied for up to 1 h and lOOpM applied for up to 15 niin. The 
excitotoxic effect of glutamate (300pM) in CGN cultiues was prevented by DPQ to the extent 
of restoring viability to a level comparable to the control. Nicotinamide at ImM was also able 
to confer significant protection against this excitotoxic damage by glutamate. It is possible that 
nicotinamide rescued the cells in our study only from the necrotic component of the overall 
H2 0 2 -induced cell death, as a report by Tronov et al. (2002) showed that nicotinamide 
protected resting lymphocytes exposed to hydrogen peroxide from necrosis but not from 
apoptosis. They argued that the inhibition o f DNA repair by NAm (possibly by inliibiting 
PARP) inhibits the necrotic pathway, thereby enhancing H2 0 2 -induced apoptotic death of
lymphocytes. However, the protective effect of nicotinamide may be tissue- or insult-specific, 
as Lin and co-workers (2004) found no protective effect when the compound was tested 
against glutamate/NMD A toxicity in murine CGNs whereas nicotinamide can exert significant 
protective effect against stiiatal lesions induced by the mitochondrial toxin malonate (Beal et 
ah, 1994). Overall, this investigation into mechanisms of oxidative and excitotoxic cell death 
has furnished a number of very important clarifications. First, it showed that oxidative damage 
by H2 O2 in osteoblasts and neurones could involve simultaneous activation of apoptotic and 
necrotic pathways, neither of which could singly explain the induced cell death in both cell 
types. Second, excitotoxic cell death involves substantial activation of apoptotic and necrotic 
pathways, although we have not ruled out the possibility that PARP-1-mediated death in this
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paradigm could be intricately linked to apoptosis inducing factor (AIF), which is localized to 
the intermembrane space of the mitochondria and known to mediate caspase-independent 
apoptosis. Overactivation of PARP-1 could induce the translocation of AIF, first into the 
cytosol, and ultimately into the nucleus, where, due to its own lack of intrinsic endonuclease 
activity, it recmits downstream nucleases such as cyclophilin A and endonuclease G in order 
to elicit DNA damage leading to apoptotic cell death (Cande et ah, 2002; Wang et ah, 2002; 
Cande et ah, 2004; Dawson & Dawson, 2004). Overactivation of PARP has been previously 
observed in neuronal excitotoxicity (Leist et ah, 1997). Since the translocation of AIF and its 
subsequent DNA damage precede the release of cytochrome c from the mitochondria and thus 
the activation of caspase-3, we propose that the event of membrane permeability transition 
which heralds cytoclirome c release occurs downstream of AIF-induced damage in delayed 
glutamate-induced neurotoxicity. This could explain why inhibitors of caspases are not 
effective in certain types of apoptotic death, since the recruitment of AIF itself could 
effectively induce cell death much before caspase activation is achieved. Energy failure and 
free radical generation also contribute to caspase-independent neuronal death (Lang-Rollin et 
ah, 2003).
However, despite all these reports, the subject of whether cell death by glutamate-induced 
excitotoxicity is apoptotic or necrotic is still a matter of intense investigation. For example, 
Kure et ah (1991) concluded excitotoxicity to be an active suicide process (apoptosis or 
programmed cell death), since endonuclease and mRNA synthesis inhibitors prevented cell 
death. On the other hand, workers like Dessi et ah (1993) contended that excitotoxicity in 
granule neurones is non-apoptotic, because protein synthesis inhibitors and an endonuclease 
inhibitor, aurintricarboxylic acid, could not prevent cell death in these cells, an observation 
similar to that of Chihab et ah (1998) who showed that, though glutamate could not induce cell 
death in neurones less than 6  days old, it was able to induce necrosis, but not apoptosis, at 13 
days. In their own work, Ankarcrona et ah (1995) reported glutamate-induced neuronal death 
as a succession of necrosis and apoptosis, depending on mitochondrial function. An attempt to 
resolve these obvious disparities could consider some of the points earlier mentioned to 
conclude that excitotoxic cell death may be far from identical in every neuronal type, due to 
the high diversity in the expression, localization and function of glutamate receptor subtypes 
and second messenger systems. Moreover, even though it is a common assumption that cells
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die by necrosis when they are exposed to severe insults and by apoptosis when they are 
subjected to mild trauma (Cheung et ah, 1998; Banasiak et ah, 2000), excitotoxicity may be an 
exception to this lule. For instance, Gwag et ah (1997) showed that cultured murine cortical 
neurones exposed to low concentrations of NMDA, AMP A and kainate showed the classical 
morphological features o f necrosis. In newborn rats, excitotoxic activation o f NMDA and non- 
NMDA glutamate receptors causes neuronal death, with phenotypes ranging from the 
apoptotic to the necrotic (see Martin et ah, 1998). The authors described in their review 
“structurally different forms of dying cells: a classic apoptotic form; a vacuolated form, 
similar to the endocytic-autophagic type, and a classic necrotic form”. When they examined 
the progression o f excitotoxin-induced neuronal apoptosis in the newborn brain, it was noticed 
“the vacuolated form is a precursor stage of apoptosis with many similarities to programmed 
cell death occurring in the developing brain”. In their own work, Cheung et al, (1998) showed 
that micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum 
of insult-dependent, excitotoxic injury in cultured cortical neurones. From all of these 
arguments, it is clear that excitotoxicity should not be seen as either strictly apoptotic or 
strictly necrotic, but rather as an intermediate or hybrid fonn of cell death, lying along a 
structural continuum, with apoptosis and necrosis at the extremes. The neuronal swelling that 
occms early following massive glutamate-induced influx of sodium and chloride ions and 
water heralds cell lysis and death by necrosis, while the subsequent neurotoxicity occumng 
several hours after the insult results from caspase-dependent and -independent apoptosis. It is 
therefore reasonable to say that in glutamate-induced excitotoxicity, neurones die early by 
necrosis and those neurones that have survived this early death later succumb to
neurodegeneration from apoptosis (see Hou & MacManus, 2002).
5.10. Roles of adenosine Ai and Â2a receptors
Using Ai and A 2 A adenosine receptor agonists and antagonists, the ability of adenosine and its
.receptors to modulate basal viability and oxidative damage in MC3T3-E1 cultures and also to 
modulate oxidative and excitotoxic damage in CGN cultures was examined.
5,10.1. Modulation o f viability and oxidative damage in osteoblasts 
Application of adenosine (lOpM - ImM) at 10 div resulted in no significant effect on basal 
viability o f the MC3T3-E1 cultures, but when these cultures were exposed at 4 div, a slight 
trophic effect was obtained with adenosine at lOOpM. However, both the A| receptor agonist 
CPA (lOOiiM) and antagonist DPCPX (50nM, lOOnM) significantly enhanced basal viability 
when applied at 1 0  div for 1 h, an effect that was also seen with the A2 A receptor agonist 
CGS21680 (lOOnM). The effects o f the A2 A antagonist ZM241385 were biphasic, with 50pM 
showing a tendency to be toxic but lOOpM enhancing viability when applied for 1 h. Shimegi 
(1996) reported that ATP and adenosine acted as mitogens in the MC3T3-E1 osteoblast cells, 
although the effects of adenosine were to a lesser extent; two years later, the same author 
showed that the mechanisms of adenosine mitogenicity involved two pathways at least, one 
mediated by xanthine-sensitive receptor and PTX-sensitive G protein and the other through an 
unknown xanthine- and PTX-insensitive process (Shimegi, 1998). However, consistent with 
our findings, PI agonists adenosine and AMP had no effect on intracellular calcium levels in 
primary osteoblast cultures at 8  div, whereas the nucleotides (P2 agonists) ATP, UDP and 
ADP triggered increases in intracellular calcium, demonstrating that P2 agonists may be more 
important in modulating osteoblast responses during differentiation (Orriss et ah, 2006).
Effects o f adenosine have been verified in other tissues. Sexl and co-workers (1995) did 
observe increased proliferation in human umbilical vein endothelial cells following A2 A and 
Ai receptor stimulation, even though Ai receptor activation was much less potent. Subsequent 
studies by the same group confirmed that the stimulation of proliferation by A2 A receptor 
activation was mediated by MAP kinase (Sexl et ah, 1997). In glial cells, activation of the A2 A 
adenosine receptor inhibits nitric oxide production (Brodie et ah, 1998). According to 
Rathbone et al. (1999), it is possible that, generally speaking, low adenosine concentrations 
induce cellular proliferation whereas high concentrations induce apoptosis in a variety of cell 
types.
In relation to cytoprotection, adenosine itself was unable to modify damage by H2 O2 (SOOpM), 
but its more stable analogue, 2 -chloroadenosine, offered significant, though partial, protection, 
indicating that adenosine is possibly being too rapidly degraded intracellulaiiy to be able to 
produce any observable response or protection in these cultures. It would therefore be 
interesting to test whether inhibitors o f enzymes such as adenosine deaminase (which degrades
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adenosine), could stabilise adenosine and therefore enhance its neuroprotection. For example, 
in the post-ischaemic heart, adenosine deaminase inhibition prevents free radical-mediated 
injury (Xia et ah, 1996), possibly by increasing levels of adenosine which could serve as a 
potent antioxidant. Moreover, adenosine is Icnown to be produced by ROS-generating systems, 
attenuating the deleterious consequences of ROS thimigh Ai receptor activation (Almeida et 
ah, 2003). Extracellular adenosine levels could also be increased by inhibiting adenosine 
kinase (which phosphorylates adenosine to AMP), blocking its uptake, or facilitating its 
effects by allosteric modulation (de Mendonca et ah, 2000).
When tested for their own ability to protect against the same damage by H2 O2 (SOOpM), none 
o f the selective ligands elicited any improvement at 50nM, but at lOOnM, the Ai and A2 A 
agonists, CPA and CGS21680, respectively, each offered partial protection, whereas both 
antagonists (DPCPX and ZM241385, respectively) were still unable to modify the oxidative 
damage, suggesting that, while high levels of adenosine receptor agonists may be required to 
produce observable protective effects against oxidant injury in MC3T3-E1 cells, the 
antagonists have little effect in protecting these cells against oxidative damage, although they 
may help to improve basal viability. Even though their roles in protection against oxidant 
injury have been studied in other tissue types, this study seems to be the first to report 
adenosine receptor roles in protection against H2 O2 -induced damage, specifically in MC3T3- 
E1 osteoblast cells. Similar to our obseiwation, the activation of Ai and A2 A receptors in 
immortalized human proximal tubule (HK-2) cells was seen to attenuate H 2 0 2 -induced injury, 
involving distinct signalling pathways that are dependent on gene transcription and new 
protein synthesis. Clironic treatments with a non-selective adenosine receptor agonist 
abolished the protection by adenosine while chr onic treatments with a non-selective adenosine 
receptor antagonist increased the endogenous tolerance of HK-2 cells to hydrogen peroxide 
(Lee & Emala, 2002). This could be explained, at least, in part, by the already reported hint 
that long-term (e.g., 24 h) treatments with adenosine receptor antagonists can have effects that 
resemble the acute (e.g., 1 h) effects of adenosine receptor agonists, and vice-versa (Jacobson 
et ah, 1996).
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5.10.2. Protection against oxidative and excitotoxic damage in neurones
While Ai receptor activation or A2 A receptor blockade has been variously reported to be 
neuroprotective in neui'onal cultures, Ai receptor blockade or A2 A receptor activation is known 
to induce damage. The direct roles of adenosine receptors in the context of neuroprotection 
were therefore verified in this study in vitro by testing the abilities o f the Ai receptor agonist 
CPA and the A2 A receptor antagonist ZM241385 to elicit protection against a very neurotoxic 
concentration (30|iiM) of H2 O2 , as well as examining the abilities of the Ai receptor antagonist 
DPCPX and the A2 A receptor agonist CGS21680 to exacerbate damage by a moderately 
neurotoxic concentration (lOpM) of H 2 O2 . Based on previous experiments, the ligands were 
each tested at lOOnM for 1 h and cultures were pretreated with antagonists for 15 min. The 
possible effect o f the broad-spectrum adenosine receptor agonist, 2 -chloroadenosine, on 
peroxide damage was also investigated, the result of which showed that it lacked any ability to
modulate the damage, despite the fact that adenosine has been previously reported to promote 
neuronal recovery from ROS-induced lesion in hippocampal slices (Almeida et ah, 2003), thus
suggesting that the protective effects of adenosine or its analogues may not be uniform across 
brain regions and could also depend on the experimental models used. Both CPA and 
ZM241385 protected partially against damage induced by 30pM of H2 O2 , thus confirming that 
either Ai receptor activation or A2 A blockade is protective against oxidative damage in 
neurones, including the CGNs. hi contrast, however, exacerbation of peroxide damage was not 
found with DPCPX or CGS21680, suggesting that in CGNs, at least, blockade of Ai receptors 
or the activation of A2 A receptors may not sufficiently exacerbate oxidative damage in the 
absence o f other potentiating factors or cellular events. Interestingly, a similar result was 
obtained when these adenosine receptor ligands were tested for their ability to modify 
glutamate-induced excitotoxicity: CPA offered complete protection, ZM241385 offered 
almost complete protection, DPCPX tended to exacerbate neuronal damage (effect was not 
significant), and CGS21680 had no effect. It is Imown that the adenosine concentration in the 
extracellular fluid (ECF) is normally in the low micromolar range or less, but this can increase 
dramatically in conditions like hypoxia, hypoglycaemia or ischaemia, during which 
endogenous adenosine then becomes sufficient to reduce glutamate-induced currents mediated 
via the NMDA receptor, thus eliciting a degree o f neuroprotection, although this really 
depends on the degree of ischaemia and the individual dynamics of the adenosine system
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(Stone & Addae, 2002). As part of its mechanism of action, the adenosine Ai receptor is able 
to inliibit glutamate release into the synaptic cleft from the presynaptic neurone and can also 
cause hyperpolarization of the postsynaptic membrane tlirough the ATP-sensitive potassium 
channels ( K a t p )  as well as direct inhibition of certain kinds of Ca^ "^  channels (Wu & Saggau, 
1994; Ribeiro, 1995). All these processes contribute to the net result of neuroprotection by 
decreasing Ca^^ entry, which is a key step in excitotoxic damage. Ai adenosine receptor 
upregulation and activation has been shown to attenuate neuroinflammation and demyelination 
in a model of multiple sclerosis (Tsutsui et ah, 2004). However, despite their impressive 
protective ability, there is an increasing level of concern with the prospect of using Ai receptor 
agonists as neuroprotective agents, owing to the discovery that activation o f the NMDA 
receptor reduces neuronal sensitivity to adenosine (Bartrup & Stone, 1988; 1990; Nikbaldit & 
Stone, 2001; Shalu’aki & Stone, 2003). In order to circumvent this potential problem, 
antagonists at the A2 A receptors, such as SCH58261 and ZM241385, are now of particular 
interest with a growing literature indicating an ability to protect neurones against damage 
caused by a range of toxins, including glutamate and NMDA receptor agonists (Jones et a l, 
1998a; 1998b), and in situations involving oxidative stress such as cerebral hypoxia and 
ischaemia (Stone, 2002). This has led to the development of A 2 A receptor antagonists for use 
in neurodegenerative disorder clinical trials (Phillis & Goshgarian, 2001). Indeed, it has been 
demonstrated that antagonists at adenosine A2 A receptors are neuroprotective in animal models 
of ischaemia (Sheardown & Knutsen, 1996; Monopoli et a l , 1998; Ongini, et a l, 1997) and 
excitotoxicity (Jones et a l , 1998a; 1998b; Stone et a l, 2001). The use o f knockout models has 
also enabled confirmation that the effects of A2 A receptor antagonists are due to the blockade 
of receptors, rather than to an unrecognized or non-specific action o f the compounds (Stone,
2005). An A 2A receptor antagonist, KW-6002 (istradefylline), has shown potential in a 
recently completed phase II clinical trial as a novel treatment for Parkinson’s disease and has 
now entered phase III trials (Hauser et a l, 2003; Weiss et a l , 2003), and others such as 
V2006, which was derived from the antimalarial dmg mefloquine and is well tolerated in high 
doses, are in development (Weiss et a l, 2003; Matasi et a l, 2005; Peng et a l, 2004). Because 
the A 2 A receptors are low-affmity receptors for adenosine as opposed to the high-affinity Ai 
receptors, blockade of A 2 A receptors is therefore not likely to impair the beneficial effects of 
A] receptor activation by endogenous adenosine. Activation o f A 2 A receptors- and even A3
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receptors (von Lubitz, 1999)- could inhibit Ai receptor activation. Using A2 A receptor 
antagonists, this inhibitory effect of the A 2 A receptor on Ai receptor activation could therefore 
be removed, resulting in additional neuroprotective effect furnished by the latter. It is now 
well known that the mechanism of damage by activation of A 2 A receptors involves their 
enhancement of glutamate release, which can facilitate oxidative stress in the cell. A2A 
receptors can also mediate inhibition of NMDA receptor function, although A ja antagonists 
may be unable to directly inhibit NMDA effects (Popoli et ah, 2003). hi conditions like 
hypoxia, hypoglycaemia, and ischaemia, the balance between adenosine A2 A receptor- 
mediated direct inhibition of NMDA receptor function and their stimulation of glutamate 
release could be critical to neuroprotection. When elevation of extracellular levels of 
adenosine is within the range 1 - lOpM, it will begin to activate the potentially protective 
adenosine Ai receptor population (von Lubitz et al., 1988; von Lubitz et al., 1989; MacGregor 
& Stone, 1993; MacGregor et al., 1993). However, should the levels of adenosine rise further 
to around 20pM or above, the activation o f adenosine A2 A receptors may begin to predominate 
and since these receptors increase the release o f glutamate and some other transmitters, these 
high adenosine levels could result in an exacerbation of neuronal damage. The protection by 
Ai receptor activation or A 2 A receptor blockade against oxidative and excitotoxic damage in 
this study suggests that the mechanism of adenosine protection against glutamate-induced 
excitotoxicity could involve substantial antioxidant action, thus providing further evidence 
that oxidative stress is a critical downstream effector of glutamate-induced excitotoxicity and 
that adenosine has significant antioxidant properties, possibly thi'ough facilitation o f Aj 
receptors. Despite the impressive potential o f A2 A receptor antagonists as neuroprotective 
agents, a study by Blum et al. (2003) has cautioned that their therapeutic use, especially in 
Huntington's disease, could exhibit undesirable biphasic neuroprotective-neurotoxic effects 
because blockade of A 2 A receptors has differential effects on striatal cell death in vivo, 
depending on its ability to modulate presynaptic over postsynaptic receptor activity. With 
regard to this, Sebastiao & Ribeiro (1996) have suggested that this effect may only be specific 
to receptors from this brain region that are already proposed as being atypical, owing to their 
enhanced Gg coupling. Nevertheless, blockade of A ia  adenosine receptors has been shown to 
prevent basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary 
astrocytes (Brambilla et ah, 2003).
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In our in vitro study, no neuroprotective or neurodetrimental effect was found with A 2A 
receptor activation, but in vivo data have shown that both adenosine A 2 A receptor agonists and 
antagonists are neuroprotective. The neuroprotection that is paradoxically seen with adenosine 
A2 A receptor activation in vivo could be attributed to effects on cerebral blood flow, glucose 
utilization, platelet aggregation and superoxide generation from neutrophils. Activation of A2 A 
receptors increases cerebral blood flow and inhibits platelet aggregation (Stella et ah, 1996; 
Hourani, 1996). These effects would increase blood and nutrient supply to any ischaemically 
compromised area of the brain. Adenosine A2 A receptor activation also depresses cerebral 
glucose utilization in the cortex (Nehlig et ah, 1994), which may be of help to neuronal 
viability by reducing the requirement for depleted nutrients during ischaemia. Activation of 
adenosine A2 A receptors decreases superoxide anion production in neutrophils (Cronstein et 
ah, 1985) and it is possible that adenosine could reduce free radical-associated cell damage 
that occurs in ischaemia and excitotoxicity (Lafon-Cazal et ah, 1993; Reynolds & Hastings, 
1995; Patel et ah, 1996). Adenosine A 2 A receptors may therefore exert neuroprotection in vivo 
via peripheral mechanisms of action. Centrally, it is known that, adenosine A2 A receptor can 
enhance evoked G ABA release from hippocampal synaptosomes (Cunha & Ribeiro, 2000a) 
and this could result in a general reduction of neuronal excitability and hence limit cell death 
during an ischaemic insult. In addition, it is also now clear that adenosine A2 A receptor has a 
wide range of intracellular effectors, which can influence neuronal excitability and viability, 
thus exerting a direct neuroprotective effect. In the striatum, this receptor couples to Gg and in 
this brain region, CGS21680 inhibits the conductance of NMDA receptor channels by a 
mechanism that involves the PLC / IP3 / calmodulin and calmodulin kinase II pathway 
(Wirkner et ah, 2000). The adenosine A 2 A receptor can also inhibit N-type calcium channels in 
PC 12 cells (Park et ah, 1998). It causes the activation of ATP-sensitive potassium channels 
( K a t p )  and large conductance calcium-activated potassium channels (BKca) in the rat 
epididymis, meaning that, if  the same effector activation occurs in the CNS, it could exert a 
hyperpolarizing effect on neurones and so limit their death during an excitotoxic insult 
(Haynes, 2000). In PC 12 cells, adenosine A 2 A receptors have a close synergistic relationship 
with growth factors, especially NGF (Arslan et ah, 1997; Arslan & Fredholm, 2000). 
Microglial NGF is enhanced by adenosine A2 A receptors (Heese et ah, 1997) and this 
relationship may be found in other cells also. Furthermore, it has been discovered that
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adenosine A ja receptors can directly activate Trk neiirotrophin receptors in the absence of 
neurotrophins, thus protecting against apoptosis induced by growth factor withdrawal in 
hippocampal neurones (Lee & Chao, 2001; Lee et ah, 2002). While there is evidence for the 
stimulation of expression for the adenosine A 2 A receptor gene by hypoxia in PC 12 cells 
(Kobayashi & Millhorn, 1999), chionic hypoxia reduces adenosine A2 A receptor-mediated 
inhibition of calcium current in rat PC 12 cells via downregulation of protein kinase A 
(Kobayashi et al., 1998).
In relation to the involvement o f non-neuronal cells in the neuroprotective effects of purines, 
Ciccarelli et al. (2001) has argued that there is an involvement of astrocytes in purine- 
mediated reparative processes in the brain. AIT-082 is neuroprotective against kainate-induced 
neuronal injury in rats. It is a hypoxanthine derivative that stimulates in vitro neurite 
outgrowth and the production o f adenosine and neurotrophins from astrocytes (Di lorio et ah, 
2001). Ferreira & Paes-de-Cai*valho (2001) showed that adenosine inhibits glutamate toxicity 
in retinal neurones through a long-term activation o f A 2 A receptors and elevation of 
intracellular cyclic AMP levels.
5.11. Areas of further research
It is certain from the results of this study that many more areas of investigations would be 
worth pursuing in fiiture. O f late, there has arisen a lot of active interest in signalling pathways 
involving a multiplicity o f intra- and inter-cellular factors and mediators. Studies of these 
intriguing cascades o f signalling networks now provide experimental evidence helping to fine- 
tune explanations of complex phenomena, including mechanisms of cell proliferation, cell 
damage and death, and cytoprotection. Most o f these attempts invariably involve the powerflil 
tools o f cell and molecular biology. Investigating at the molecular level the various signalling 
pathways that could be involved in the observed differential effects o f glutamate and other 
agents on osteoblastic and neuronal viability may therefore further tremendously the 
interesting phannacological endeavours described in this study. Possible answers may lie in 
differences in the pattern of genetic regulation o f intracellular mediators or events, either at the 
transcriptional, translational, or post-translational level.
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6. CONCLUSIONS
The following conclusions may be drawn from the results presented in this thesis:
1. The alamar blue reduction assay for the routine detemiination o f cell viability and 
the quantification of effects o f toxicants is a quick and simple method that is 
accurate and gives reproducible results.
2. The MC3T3-E1 osteoblast-like cell line is a suitable model for osteogenic 
development in vitro.
3. Osteoblasts may represent a less fastidious cell type than neuronal cells in their 
requirements for suiwival in culture.
4. (3-glycerol phosphate acts synergistically with ascorbate to increase osteoblastic 
proliferation and differentiation and these supplements are capable of increasing 
alkaline phophatase (ALP) activity up to four-fold.
5. The increased differentiation of osteoblasts in the presence o f ascorbate and 13- 
glycerol phosphate sensitizes the cells to oxidative damage.
6. Glutamate or NMDA has trophic rather than toxic effects on osteoblasts, even at 
concenti'ations that are known to be profoundly n euro toxic. Glutamate toxicity may 
therefore not extend to bone tissue, although in the presence o f inducers o f 
oxidative or nitrosative stress, toxicity may result.
7. Glutamate toxicity in cerebellar granule neurones occurs mainly tluough 
overstimulation of the NMDA receptor and involves substantial activation of both 
apoptotic and necrotic death pathways.
8. Neuronal cultures are more sensitive to oxidative stress resulting from a variety of 
sources including hydi'ogen peroxide, xanthine/xanthine oxidase and kynurenines 
(e.g., 3-hydroxykynurenine) than osteoblast cultures. The same is true for 
nitrosative stress. It is therefore possible that, while neurones depend critically on 
oxidative phosphorylation for the generation o f energy (ATP), the osteoblasts may 
preferentially rely on the glycolytic pathway.
9. Hydrogen peroxide-induced oxidative damage to osteoblasts and neurones occurs 
through both apoptosis and necrosis.
10. Scavengers o f the hydroxyl radical such as mannitol may precipitate paradoxical 
toxicity under certain conditions, possibly related to a disturbance o f cellular ionic 
homeostasis.
11. Under certain experimental conditions, the superoxide-generating mixture of 
xanthine and xanthine oxidase may generate predominantly hydrogen peroxide.
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12. The mitochondrial poisons potassium cyanide and 3-nitropropionic acid elicit 
neurotoxicity via activation o f the NMDA receptor.
13. Adenosine and its receptors participate in protection against damage and death in 
osteoblasts and neurones, though possibly via different mechanisms in these cell 
types. While both Ai and A2 A agonists were protective against peroxide-induced 
damage in osteoblasts and antagonists lacked any protective effect, it was Ai 
agonists and A 2 A antagonists that showed protection against the same damage in 
neurones, while Ai antagonists and A 2 A agonists failed to exacerbate damage. 
Following treatment of CGNs with glutamate, the same pattern o f protection by 
adenosine receptors against peroxide damage in these cultures was observed.
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